Processing 00000000.tx.1: Large Meta-Analysis Establishes the ACE Insertion-Deletion Polymorphism as a Marker of Alzheimer's Disease Donald J. 

Phrase: "Large Meta-Analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0282458:Meta-Analysis [Intellectual Product]
   901   C0920317:Meta-Analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1042496:Meta [Eukaryote]
   827   C1524024:analysis [Functional Concept]

Phrase: "Establishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "the ACE Insertion-Deletion Polymorphism as a Marker"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   738   C0021107:Insertion [Therapeutic or Preventive Procedure]
   738   C0032529:Polymorphism [Genetic Function]
   738   C0441587:Insertion [Health Care Activity]
   738   C1442161:Deletion [Cell or Molecular Dysfunction]
   738   C1511760:Deletion [Genetic Function]
   738   C1512796:Insertion [Genetic Function]
   738   C1880274:Deletion [Activity]
   738   C1882417:Polymorphism [Qualitative Concept]
   738   C1883719:Insertion [Functional Concept]

Phrase: "of Alzheimer's Disease Donald J."
Processing 00000000.tx.2: Lehmann1, Mario Cortina-Borja2, Donald R. 

Phrase: "Lehmann1,"

Phrase: "Mario Cortina-Borja2,"

Phrase: "Donald R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.3: Warden1, A. 

Phrase: "Warden1,"

Phrase: "A."
Processing 00000000.tx.4: David Smith1, Kristel Sleegers3, Jonathan A. 

Phrase: "David Smith1,"

Phrase: "Kristel Sleegers3,"

Phrase: "Jonathan A."
Processing 00000000.tx.5: Prince4, Cornelia M. van Duijn3 and Patrick G. 

Phrase: "Prince4,"

Phrase: "Cornelia M. van Duijn3"

Phrase: "and"

Phrase: "Patrick G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.6: Kehoe5 1 The Oxford Project to Investigate Memory and Ageing (OPTIMA), Department of Pharmacology, University of Oxford, Oxford, United Kingdom 2 Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, University College London, London, United Kingdom 3 Department of Epidemiology and Biostatistics, Erasmus MC, Rotterdam, the Netherlands 4 Center for Genomics and Bioinformatics, Karolinska Institute, Stockholm, Sweden 5 Care of the Elderly, Department of Clinical Science at North Bristol, University of Bristol, Frenchay Hospital, Bristol, United Kingdom Correspondence to D. 

Phrase: "Kehoe5 1"

Phrase: "The Oxford Project to Investigate Memory and Ageing (OPTIMA),"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   793   C0001811:Ageing [Organism Function]
   793   C0025260:Memory [Mental Process]
   793   C0700327:memory [Finding]
   793   C1292732:investigate [Functional Concept]
   793   C1706377:Memory [Manufactured Object]
   793   C1709701:Project [Conceptual Entity]
   737 E C0679055:mnemonic [Mental Process]

Phrase: "Department of Pharmacology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "University of Oxford,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Oxford,"

Phrase: "United Kingdom 2 Centre for Paediatric Epidemiology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Biostatistics,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005544:biostatistics [Research Activity]
  1000   C2717898:Biostatistics [Research Activity]
  1000   C2718322:Biostatistics [Occupation or Discipline]

Phrase: "Institute of Child Health,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "University College London,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0023973:London [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C0557806:College [Manufactured Object]

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "United Kingdom 3 Department of Epidemiology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Biostatistics,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005544:biostatistics [Research Activity]
  1000   C2717898:Biostatistics [Research Activity]
  1000   C2718322:Biostatistics [Occupation or Discipline]

Phrase: "Erasmus MC,"

Phrase: "Rotterdam,"

Phrase: "the Netherlands 4 Center for Genomics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Bioinformatics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1140694:Bio-Informatics [Biomedical Occupation or Discipline]

Phrase: "Karolinska Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Stockholm,"

Phrase: "Sweden 5 Care of the Elderly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1947933:Care [Activity]

Phrase: "Department of Clinical Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "at North Bristol,"

Phrase: "University of Bristol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Frenchay Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Bristol,"

Phrase: "United Kingdom Correspondence to D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0282413:Correspondence [Intellectual Product]
Processing 00000000.tx.7: J. 

Phrase: "J."
Processing 00000000.tx.8: Lehmann, University Department of Pharmacology, Mansfield Road, Oxford OX1 3QT, United Kingdom (e-mail: donald.lehmann{at}pharm.ox.ac.uk ). 

Phrase: "Lehmann,"

Phrase: "University Department of Pharmacology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041740:University [Manufactured Object,Organization]
   770   C1704729:Department [Organization]

Phrase: "Mansfield Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442650:Road [Manufactured Object]

Phrase: "Oxford OX1 3QT,"

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: "(e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "donald.lehmann{at}pharm.ox.ac.uk"

Phrase: ")."
Processing 00000000.tx.9: Received for publication January 5, 2005. 

Phrase: "Received for publication January 5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2005."
Processing 00000000.tx.10: Accepted for publication March 22, 2005.  

Phrase: "Accepted for publication March 22,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2005."
Processing 00000000.tx.11: ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION References  Apolipoprotein E 4 (APOE*4) is the only fully established susceptibility allele for Alzheimer's disease. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Apolipoprotein E 4 (APOE*4)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "the only fully established susceptibility allele for Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.12: One of the most studied candidates is the insertion (I)/deletion (D) polymorphism (indel) of the gene for angiotensin I-converting enzyme (ACE). 

Phrase: "One of the most studied candidates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "the insertion (I)/deletion (D) polymorphism"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   827   C0021107:Insertion [Therapeutic or Preventive Procedure]
   827   C0032529:Polymorphism [Genetic Function]
   827   C0441587:Insertion [Health Care Activity]
   827   C1442161:Deletion [Cell or Molecular Dysfunction]
   827   C1511760:Deletion [Genetic Function]
   827   C1512796:Insertion [Genetic Function]
   827   C1880274:Deletion [Activity]
   827   C1882417:Polymorphism [Qualitative Concept]
   827   C1883719:Insertion [Functional Concept]

Phrase: "(indel) of the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1956002:Indel [Genetic Function]

Phrase: "for angiotensin I-converting enzyme (ACE)."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.13: This study aimed to clarify its association with Alzheimer's disease. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "aimed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1947946:Aim [Idea or Concept]
   966   C2948600:Aim [Pharmacologic Substance]
   966   C3540471:AIM [Gene or Genome]
   966   C3540472:AIM [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "its association with Alzheimer's disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1511978:Disease Association [Temporal Concept]
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
Processing 00000000.tx.14: The meta-analysis included 39 samples, comprising 6,037 cases of Alzheimer's disease and 12,099 controls, using mainly primary data. 

Phrase: "The meta-analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "39 samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "comprising"

Phrase: "6,037 cases of Alzheimer's disease"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "12,099 controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mainly primary data."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2827398:Primary Data [Idea or Concept]
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
Processing 00000000.tx.15: Potential interactions with gender, age, ethnic group, and carrier status of the apolipoprotein E 4 allele were all examined. 

Phrase: "Potential interactions with gender,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]

Phrase: "age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "ethnic group,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0015031:Ethnic group [Population Group]
           ETHNIC
  1000   C1879937:Ethnic Group [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0680174:ethnic [Finding]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "carrier status of the apolipoprotein E 4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449439:Carrier status [Finding]
   744   C0449438:Status [Qualitative Concept]

Phrase: "were"

Phrase: "all"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.16: D homozygotes were at reduced risk of Alzheimer's disease (odds ratio = 0.81, 95% confidence interval: 0.72, 0.90; 

Phrase: "D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "were at reduced risk of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C1281905:disease risk [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0035647:Risk [Qualitative Concept]
   748   C0392756:Reduced [Qualitative Concept]

Phrase: "(odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 0.81,"

Phrase: "95% confidence interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.72,"

Phrase: "0.90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.17: corrected p = 0.0004); 

Phrase: "corrected p = 0.0004"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0205202:Corrected [Qualitative Concept]
   779 E C2349182:Correct [Qualitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.18: I homozygotes showed no association with Alzheimer's disease, while heterozygotes were at increased risk. 

Phrase: "I homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no association with Alzheimer's disease,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1511978:Disease Association [Temporal Concept]
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "while"

Phrase: "heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]

Phrase: "were at increased risk."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035647:Risk [Qualitative Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
Processing 00000000.tx.19: Although there were clear differences among the three ethnic groups examined (North Europeans, South Caucasians, and East Asians), in all groups D homozygotes were at reduced risk. 

Phrase: "Although"

Phrase: "there"

Phrase: "were"

Phrase: "clear differences among the three ethnic groups"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0682076:ethnic differences [Finding]
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(North Europeans,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0239307:European [Population Group]
   827   C1535514:European [Population Group]

Phrase: "South Caucasians,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007457:Caucasians [Population Group]
   861   C0043157:Caucasians [Population Group]

Phrase: "and"

Phrase: "East Asians"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0078988:Asians [Population Group]

Phrase: ")"

Phrase: ","

Phrase: "in all"

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "were at reduced risk."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035647:Risk [Qualitative Concept]
   770   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.20: These results confirm the association of the angiotensin I-converting enzyme indel with Alzheimer's disease across diverse populations, although this is probably due to linkage disequilibrium with the true risk factor. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the association of the angiotensin I-converting enzyme indel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "with Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "across diverse populations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "although"

Phrase: "this"

Phrase: "is"

Phrase: "probably due to linkage disequilibrium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   806   C0678226:Due to [Functional Concept]
           due
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
   760   C0750492:Probably [Idea or Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "with the true risk factor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0035648:Risk factor [Quantitative Concept]
   827   C0035647:Risk [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.21: Further, in North Europeans, both association and Hardy-Weinberg analysis suggested partial heterosis, that is, an increased risk for heterozygotes, due to a hidden interaction with another, as yet unknown, risk factor. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "in North Europeans,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0239307:European [Population Group]
   827   C1535514:European [Population Group]

Phrase: "both association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Hardy-Weinberg analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "partial heterosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020201:Heterosis [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: ","

Phrase: "an increased risk for heterozygotes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "due to a hidden interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]

Phrase: "with another,"

Phrase: "as yet unknown, risk factor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035648:Risk factor [Quantitative Concept]
   812   C0035647:Risk [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.22: This interaction warrants further investigation. 

Phrase: "This interaction warrants further investigation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C1261322:Investigation [Health Care Activity]
   812   C1552578:investigation [Idea or Concept]
   741 E C1517586:Investigational [Qualitative Concept]
   741 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.23: Alzheimer disease; 

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.24: heterogeneity; 

Phrase: "heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.25: meta-analysis Abbreviations: ACE, angiotensin I-converting enzyme (protein); 

Phrase: "meta-analysis Abbreviations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0000723:Abbreviations [Intellectual Product]
   734   C0282458:Meta-Analysis [Intellectual Product]
   734   C0920317:Meta-Analysis [Research Activity]

Phrase: ":"

Phrase: "ACE,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "angiotensin I-converting enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "(protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.26: ACE, angiotensin I-converting enzyme (gene); 

Phrase: "ACE,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "angiotensin I-converting enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "(gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.27: APOE*4, apolipoprotein E 4 (allele)  INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION References  In 1999, Kehoe et al. 

Phrase: "APOE*4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "apolipoprotein E 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: ")"

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References  In 1999,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514811:Reference [Idea or Concept]
   790   C1706462:Reference [Conceptual Entity]

Phrase: "Kehoe et al."
Processing 00000000.tx.28: (1) first proposed an association with Alzheimer's disease of the insertion (I)/deletion (D) polymorphism (indel) in intron 16 of the gene for angiotensin I-converting enzyme (ACE) on chromosome 17q23. 

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "an association with Alzheimer's disease of the insertion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1511978:Disease Association [Temporal Concept]
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "(I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]

Phrase: ")"

Phrase: "/deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "(D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: ")"

Phrase: "polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(indel) in intron 16 of the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1956002:Indel [Genetic Function]

Phrase: "for angiotensin I-converting enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "(ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ")"

Phrase: "on chromosome 17q23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520780:17q23 [Cell Component]
Processing 00000000.tx.29: The enzyme converts angiotensin I to angiotensin II, which is potently hypertensive. 

Phrase: "The enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "converts"

Phrase: "angiotensin I to angiotensin II,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021107:Insertion [Therapeutic or Preventive Procedure]
   760   C0441587:Insertion [Health Care Activity]
   760   C1512796:Insertion [Genetic Function]
   760   C1883719:Insertion [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "potently hypertensive."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0857121:hypertensive [Finding]
Processing 00000000.tx.30: The D allele is associated with raised plasma levels of the enzyme (2, 3). 

Phrase: "The D allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "associated with raised plasma levels of the enzyme"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   767   C0014440:enzyme levels [Laboratory Procedure]
   767   C1287349:enzyme levels [Laboratory or Test Result]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0032105:Plasma [Body Substance]
   744   C0441889:Levels [Qualitative Concept]
   744   C0442818:Raised [Quantitative Concept]
   744   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   711 E C0456079:Level [Classification]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1547707:Level [Geographic Area]
   711 E C1706221:Associate [Professional or Occupational Group]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.31: Kehoe et al. 

Phrase: "Kehoe et al."
Processing 00000000.tx.32: (1) found that I positives, that is, DI + II, were at increased risk of Alzheimer's disease. 

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that I positives,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: ","

Phrase: "DI + II,"

Phrase: "were at increased risk of Alzheimer's disease."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C1281905:disease risk [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0035647:Risk [Qualitative Concept]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   728   C0277564:Acquired disease [Disease or Syndrome]
Processing 00000000.tx.33: The study comprised three samples, from Cardiff and London in Britain and Belfast in Northern Ireland, with strikingly similar results. 

Phrase: "The study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "comprised"

Phrase: "three samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "from Cardiff"

Phrase: "and"

Phrase: "London in Britain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0023973:London [Geographic Area]

Phrase: "and"

Phrase: "Belfast in Northern Ireland,"

Phrase: "with strikingly similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]
Processing 00000000.tx.34: Since then, this potential association has been examined in over 40 samples (4, 5) (table 1) from around the world. 

Phrase: "Since then,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1711239:Since [Temporal Concept]
   861   C1883708:Then [Temporal Concept]

Phrase: "this potential association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "has"

Phrase: "been"

Phrase: "examined in over 40 samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332128:Examined [Finding]
   760   C0439509:/40 [Temporal Concept]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "(table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "from"

Phrase: "around the world."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700280:World [Population Group]
Processing 00000000.tx.35: Several studies replicated the report of increased risk for I positives, just a few contradicted it, and many found no association with Alzheimer's disease. 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "replicated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205173:replicated [Functional Concept]
   966 E C0205341:Replicate [Functional Concept]
   966 E C1883725:Replicate [Qualitative Concept]

Phrase: "the report of increased risk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C3273238:Report [Intellectual Product]

Phrase: "for I positives,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "just"

Phrase: "a few contradicted"

Phrase: "it,"

Phrase: "and"

Phrase: "many"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no association with Alzheimer's disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1511978:Disease Association [Temporal Concept]
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
Processing 00000000.tx.36: One study suggested an effect of age on the association (6), and another proposed an influence of gender (7). 

Phrase: "One study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "an effect of age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "another"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "an influence of gender"

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.37: An association with onset age of Alzheimer's disease has also been proposed (8). 

Phrase: "An association with onset age of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1511978:Disease Association [Temporal Concept]
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.38: View this table: [in this window] [in a new window]  TABLE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.39: Cohorts used in the meta-analysis of the ACE* insertion-deletion polymorphism in Alzheimer's disease  The association has recently been studied in the longitudinal, observational cohorts of the Oxford Project to Investigate Memory and Ageing (OPTIMA) and the Rotterdam Study (9). 

Phrase: "Cohorts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599755:cohorts [Population Group]

Phrase: "used in the meta-analysis of the ACE"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   797   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   797   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   756   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   756   C0282458:Meta-Analysis [Intellectual Product]
   756   C0920317:Meta-Analysis [Research Activity]
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0014442:Enzyme [Enzyme,Organic Chemical]
   738   C0021966:I- [Inorganic Chemical]
   738   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0936012:Analysis [Research Activity]
   738   C1042496:Meta [Eukaryote]
   738   C1273517:used [Finding]
   738   C1524024:analysis [Functional Concept]
   737   C1524063:Use of [Functional Concept]
   704 E C0042153:use [Functional Concept]
   704 E C0457083:Use [Functional Concept]
   704 E C1947944:Use [Intellectual Product]

Phrase: "* insertion-deletion polymorphism in Alzheimer's disease"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0021107:Insertion [Therapeutic or Preventive Procedure]
   753   C0032529:Polymorphism [Genetic Function]
   753   C0441587:Insertion [Health Care Activity]
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1512796:Insertion [Genetic Function]
   753   C1880274:Deletion [Activity]
   753   C1882417:Polymorphism [Qualitative Concept]
   753   C1883719:Insertion [Functional Concept]

Phrase: "The association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "studied in the longitudinal, observational cohorts"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   767   C0023981:Longitudinal Study [Research Activity]
   767   C1518527:Observational Study [Research Activity]
           OBSERVATIONAL
   753   C0205127:Longitudinal [Spatial Concept]
   753   C0599755:cohorts [Population Group]
   753   C1964257:Observational [Diagnostic Procedure]
   750   C0009247:Cohort Study [Quantitative Concept]
   731 E C0552617:Study observation [Functional Concept]
   719   C0557651:Study [Manufactured Object]
   719   C2603343:Study [Research Activity]

Phrase: "of the Oxford Project to Investigate Memory and Ageing"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   791   C0001811:Ageing [Organism Function]
   791   C0025260:Memory [Mental Process]
   791   C0332285:Of [Spatial Concept]
   791   C0700327:memory [Finding]
   791   C1292732:investigate [Functional Concept]
   791   C1706377:Memory [Manufactured Object]
   791   C1709701:Project [Conceptual Entity]
   735 E C0679055:mnemonic [Mental Process]

Phrase: "(OPTIMA"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   795   C0001811:Ageing [Organism Function]
   795   C0025260:Memory [Mental Process]
   795   C0700327:memory [Finding]
   795   C1292732:investigate [Functional Concept]
   795   C1706377:Memory [Manufactured Object]
   795   C1709701:Project [Conceptual Entity]
   740 E C0679055:mnemonic [Mental Process]

Phrase: ")"

Phrase: "and"

Phrase: "the Rotterdam Study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.40: Both groups found a suggestion of a gender difference in their results, consistent with a previous report (7). 

Phrase: "Both groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "a suggestion of a gender difference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0038659:Suggestion [Idea or Concept]
   753   C1705535:suggestion [Idea or Concept]

Phrase: "in their results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "consistent with a previous report"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.41: We therefore undertook a meta-analysis of studies of the association of the ACE indel with Alzheimer's disease, stratified by gender, by age, by ethnic group, and by apolipoprotein E 4 allele (APOE*4) carrier status, using mainly primary data, supplied by authors. 

Phrase: "We therefore"

Phrase: "undertook"

Phrase: "a meta-analysis of studies of the association"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0282458:Meta-Analysis [Intellectual Product]
   770   C0920317:Meta-Analysis [Research Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1042496:Meta [Eukaryote]
   744   C1524024:analysis [Functional Concept]

Phrase: "of the ACE indel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1956002:Indel [Genetic Function]
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "with Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "stratified by gender,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0079399:Gender [Organism Attribute]
   790   C0205363:Stratified [Qualitative Concept]
   790   C0804628:Gender [Clinical Attribute]
   790   C1522384:Gender [Organism Attribute]

Phrase: "by age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "by ethnic group,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0015031:Ethnic group [Population Group]
           ETHNIC
  1000   C1879937:Ethnic Group [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0680174:ethnic [Finding]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and by apolipoprotein E 4 allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   833   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0002085:Allele [Gene or Genome]
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1515981:And [Idea or Concept]

Phrase: "(APOE*4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "carrier status,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449439:Carrier status [Finding]
   861   C0449438:Status [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mainly primary data,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2827398:Primary Data [Idea or Concept]
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "supplied by authors."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0221193:Authors [Professional or Occupational Group]
   790   C1999230:Supplied [Activity]
   756 E C0243163:supply [Idea or Concept]
   756 E C0699914:supply [Quantitative Concept]
   756 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   756 E C1561604:supply [Functional Concept]
   756 E C1875802:SUPPLY [Medical Device]
Processing 00000000.tx.42: Although three previous meta-analyses of ACE studies had been reported (1012), subsequent studies have now made further data available. 

Phrase: "Although"

Phrase: "three previous meta-analyses of ACE studies"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0920317:meta-analyses [Research Activity]
   739   C1042496:Meta [Eukaryote]
   726 E C0282458:Meta-Analysis [Intellectual Product]
   706   C0002778:Analysis [Laboratory Procedure]
   706   C0936012:Analysis [Research Activity]
   706   C1524024:analysis [Functional Concept]

Phrase: "had"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(1012"

Phrase: ")"

Phrase: ","

Phrase: "subsequent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "further data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "available."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]
Processing 00000000.tx.43: Compared even with the latest meta-analysis (12), 10 more samples from eight studies were available to us (9, 1318, and the above study of the Oxford Project to Investigate Memory and Ageing). 

Phrase: "Compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "even with the latest meta-analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0282458:Meta-Analysis [Intellectual Product]
   790   C0920317:Meta-Analysis [Research Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1042496:Meta [Eukaryote]
   753   C1524024:analysis [Functional Concept]
   719   C0205087:Late [Temporal Concept]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "10 more samples from eight studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0370003:Sample [Substance]
   719   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "available to us (9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "1318,"

Phrase: "and"

Phrase: "the above study of the Oxford Project to Investigate Memory and Ageing"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   736   C0001811:Ageing [Organism Function]
   736   C0025260:Memory [Mental Process]
   736   C0557651:Study [Manufactured Object]
   736   C0700327:memory [Finding]
   736   C1292732:investigate [Functional Concept]
   736   C1706377:Memory [Manufactured Object]
   736   C1709701:Project [Conceptual Entity]
   736   C2603343:Study [Research Activity]

Phrase: ")."
Processing 00000000.tx.44: In addition, all previous meta-analyses were based on published data, that is, largely unstratified, and were thus limited in the interpretations they allowed. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "all previous meta-analyses"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0920317:meta-analyses [Research Activity]
   867 E C0282458:Meta-Analysis [Intellectual Product]
   827   C1042496:Meta [Eukaryote]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "based on published data,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   802   C0242356:data base [Intellectual Product]
   802   C0993637:Data Base [Intellectual Product]
   770   C0034037:Published [Occupational Activity]
   770   C1511726:Data [Idea or Concept]
   770   C1527178:Based [Functional Concept]
   770   C1704324:Published [Intellectual Product]
   770   C1705938:Based [Idea or Concept]
   770   C3245479:data [Medical Device]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that"

Phrase: "is"

Phrase: ","

Phrase: "largely unstratified,"

Phrase: "and"

Phrase: "were"

Phrase: "thus"

Phrase: "limited in the interpretations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0439801:Limited [Functional Concept]
   770   C0459471:interpretations [Intellectual Product]
   770   C3542948:Limited [Intellectual Product]
   737 E C1549649:Limit [Idea or Concept]
   737 E C2349209:Limit [Conceptual Entity]
   737 E C3173575:Interpretation [Clinical Attribute]

Phrase: "they"

Phrase: "allowed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]
Processing 00000000.tx.45: Using primary data, we were able to explore more deeply, searching for sources of heterogeneity. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primary data,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2827398:Primary Data [Idea or Concept]
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "explore"

Phrase: "more deeply,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "searching for sources of heterogeneity."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0019409:Heterogeneity [Qualitative Concept]
   760   C0449416:sources [Finding]
   726   C1552603:search [Intellectual Product]
   726 E C1705919:Source [Idea or Concept]
   726   C1706202:Search [Activity]
Processing 00000000.tx.46: Two previous stratified meta-analyses of Alzheimer's disease genes (19, 20), based on primary data, have both deepened our understanding. 

Phrase: "Two previous stratified meta-analyses of Alzheimer's disease genes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   764   C0920317:meta-analyses [Research Activity]
   742   C1042496:Meta [Eukaryote]
   731 E C0282458:Meta-Analysis [Intellectual Product]
   708   C0002778:Analysis [Laboratory Procedure]
   708   C0936012:Analysis [Research Activity]
   708   C1524024:analysis [Functional Concept]

Phrase: "(19,"

Phrase: "20"

Phrase: ")"

Phrase: ","

Phrase: "based on primary data,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C2827398:Primary Data [Idea or Concept]
   802   C0242356:data base [Intellectual Product]
   802   C0993637:Data Base [Intellectual Product]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C1511726:Data [Idea or Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C3245479:data [Medical Device]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "have"

Phrase: "both"

Phrase: "deepened"

Phrase: "our understanding."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]
Processing 00000000.tx.47: Egger et al. 

Phrase: "Egger et al."
Processing 00000000.tx.48: (21) have stressed the need to examine sources of heterogeneity in meta-analyses of case-control studies. 

Phrase: "(21"

Phrase: ")"

Phrase: "have"

Phrase: "stressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038435:stressed [Finding]

Phrase: "the need to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027552:Need [Qualitative Concept]
   861   C0686904:need [Functional Concept]

Phrase: "examine"

Phrase: "sources of heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0449416:sources [Finding]
   756 E C1705919:Source [Idea or Concept]

Phrase: "in meta-analyses"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0920317:meta-analyses [Research Activity]
   966 E C0282458:Meta-Analysis [Intellectual Product]
   861   C1042496:Meta [Eukaryote]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "of case-control studies."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
  1000   C0007328:Case-Control Studies [Research Activity]
   913   C0085973:Case Studies [Intellectual Product]
   901   C0872128:case control [Health Care Activity]
   827   C0243148:control [Qualitative Concept]
   827   C0868928:Case [Functional Concept]
   827   C0947630:studies [Laboratory Procedure]
   827   C1550141:Control [Substance]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
Processing 00000000.tx.49: We therefore divided our analysis into two phases: first, a broad overall analysis and, second, the detailed examination of sources of heterogeneity. 

Phrase: "We therefore"

Phrase: "divided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:Divided [Functional Concept]

Phrase: "our analysis into two phases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C2986798:Phase Analysis [Occupational Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: ":"

Phrase: "first,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "a broad overall analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: ","

Phrase: "second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "the detailed examination of sources of heterogeneity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   776   C0939974:Detail of examination [Functional Concept]
Processing 00000000.tx.50: We aimed to discover whether the ACE indel is associated with Alzheimer's disease and, if so, the nature of that association.  

Phrase: "We"

Phrase: "aimed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1947946:Aim [Idea or Concept]
   966   C2948600:Aim [Pharmacologic Substance]
   966   C3540471:AIM [Gene or Genome]
   966   C3540472:AIM [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "discover"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880355:Discover [Activity]

Phrase: "whether"

Phrase: "the ACE indel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1956002:Indel [Genetic Function]
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "is"

Phrase: "associated with Alzheimer's disease"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: ","

Phrase: "if"

Phrase: "so,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "the nature of"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0349590:Nature [Idea or Concept]
   790   C1262865:Nature [Functional Concept]
   718 E C0205296:Natural [Functional Concept]

Phrase: "that association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]
Processing 00000000.tx.51: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION References  Phase 1: broad analysis In April 2003, following PubMed searches, the study of references and of abstracts, and communication with experts, we wrote to the authors of all association studies of the ACE indel and Alzheimer's disease known to us, 33 studies in all, involving 41 samples (4, 5) (table 1), including seven samples from unpublished studies. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Phase 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439559:Phase 1 [Temporal Concept]
   861   C0205390:Phase [Temporal Concept]

Phrase: ":"

Phrase: "broad analysis In April 2003,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "PubMed searches,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552603:search [Intellectual Product]
   827   C1706202:Search [Activity]

Phrase: "the study of references"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "and of abstracts,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0600678:Abstracts [Intellectual Product]
   790   C1515981:And [Idea or Concept]
   756 E C0000857:Abstract [Occupational Activity]
   756 E C1552863:Abstract [Idea or Concept]

Phrase: "and"

Phrase: "communication with experts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0009452:Communication [Social Behavior]

Phrase: "we"

Phrase: "wrote to the authors of all association"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0004083:Association [Mental Process]
   748   C0221193:Authors [Professional or Occupational Group]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]
   714   C0043266:write [Occupation or Discipline]
   714   C1576875:Write [Finding]
   714   C2584304:Write [Mental Process]

Phrase: "studies of the ACE indel"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   833   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   770   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   744   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021966:I- [Inorganic Chemical]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0557651:Study [Manufactured Object]
   744   C0947630:studies [Laboratory Procedure]
   744   C1956002:Indel [Genetic Function]
   744   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "known to us,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205309:Known [Qualitative Concept]

Phrase: "33 studies in all,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "41 samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "(table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "seven samples from unpublished studies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.52: The searches were updated in November 2004, without further data arising. 

Phrase: "The searches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552603:search [Intellectual Product]
   966   C1706202:Search [Activity]

Phrase: "were"

Phrase: "updated in November 2004,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1519814:Update [Temporal Concept]

Phrase: "without further data arising."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332284:arising [Qualitative Concept]
Processing 00000000.tx.53: For the stratified analyses, we used the raw data or stratified summaries received from authors on 26 samples. 

Phrase: "For the stratified analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the raw data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "or"

Phrase: "stratified summaries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552616:summary [Intellectual Product]
   827   C1706244:Summary [Intellectual Product]

Phrase: "received from authors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0221193:Authors [Professional or Occupational Group]
   790   C1514756:Received [Qualitative Concept]

Phrase: "on 26 samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.54: For the overall analyses, we also used published data, making 39 samples altogether (table 1). 

Phrase: "For the overall analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "we also"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "published data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "39 samples altogether"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "(table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.55: Very early onset cases (<50 years) and young controls (<50 years) were excluded, where identifiable, as were subjects with incomplete data. 

Phrase: "Very early onset cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "("

Phrase: "<50 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "young controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "<50 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "were"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: ","

Phrase: "where identifiable,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205396:Identifiable [Qualitative Concept]
   861   C1705683:Identifiable [Conceptual Entity]
   789 E C2986777:Identifiability [Conceptual Entity]

Phrase: "as"

Phrase: "were"

Phrase: "subjects with incomplete data."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C3242203:incomplete data [Idea or Concept]
   770   C0205257:Incomplete [Quantitative Concept]
   770   C0681850:Subject [Group]
   770   C0728938:incomplete [Quantitative Concept]
   770   C1511726:Data [Idea or Concept]
   770   C1548386:incomplete [Idea or Concept]
   770   C1550501:{Subject} [Idea or Concept]
   770   C1706203:Subject [Idea or Concept]
   770   C2349001:Subject [Human]
   770   C2697811:Subject [Functional Concept]
   770   C3245479:data [Medical Device]
Processing 00000000.tx.56: Distinct populations were treated separately, where possible. 

Phrase: "Distinct populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "separately,"

Phrase: "where possible."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.57: The large number of controls in the cohort of Sleegers et al. 

Phrase: "The large number of controls"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "in the cohort"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599755:Cohort [Population Group]

Phrase: "of Sleegers et al."
Processing 00000000.tx.58: (9) had all been fully assessed (22). 

Phrase: "(9"

Phrase: ")"

Phrase: "had"

Phrase: "all"

Phrase: "been"

Phrase: "fully"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.59: All samples had been genotyped for the ACE indel, except for the two of Prince et al. 

Phrase: "All samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "had"

Phrase: "been"

Phrase: "genotyped for the ACE indel,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   833   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   770   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   744   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021966:I- [Inorganic Chemical]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C1956002:Indel [Genetic Function]
   711   C0017431:Genotype [Organism Attribute]

Phrase: "except for the two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "of Prince et al."
Processing 00000000.tx.60: (23, 24), who had used the ACE rs4343 marker, which is in 8590 percent linkage disequilibrium with the indel in North Europeans. 

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")"

Phrase: ","

Phrase: "who"

Phrase: "had"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ACE rs4343 marker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0005516:Marker [Clinical Attribute]
   734   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   734   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "which"

Phrase: "is in 8590 percent linkage disequilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0023746:Linkage Disequilibrium [Quantitative Concept]
   753   C0023745:linkage [Molecular Function]
   753   C0281825:Disequilibrium [Finding]
   753   C0394006:Disequilibrium [Disease or Syndrome]
   753   C0439165:Percent [Quantitative Concept]

Phrase: "with the indel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1956002:Indel [Genetic Function]

Phrase: "in North Europeans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0239307:European [Population Group]
   827   C1535514:European [Population Group]
Processing 00000000.tx.61: Phase 2: examination of heterogeneity We examined six possible sources of heterogeneity. 

Phrase: "Phase 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439560:Phase 2 [Temporal Concept]
   861   C0205390:Phase [Temporal Concept]

Phrase: ":"

Phrase: "examination of heterogeneity"

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "six possible sources of heterogeneity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449416:sources [Finding]
   726 E C1705919:Source [Idea or Concept]
Processing 00000000.tx.62: We performed analyses stratified by age, gender, and APOE*4 status. 

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "stratified by age,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001779:Age [Organism Attribute]
   790   C0205363:Stratified [Qualitative Concept]

Phrase: "gender,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "and"

Phrase: "APOE*4 status."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449438:Status [Qualitative Concept]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.63: For the age stratifications (<65 years, 6575 years, and >75 years), we divided the samples into two groups, according to how the ages of cases had been defined, for example, at onset (first group) or at examination or death (second group). 

Phrase: "For the age stratifications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514983:Stratification [Research Activity]

Phrase: "("

Phrase: "<65 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "6575 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and >"

Phrase: "75 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "divided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:Divided [Functional Concept]

Phrase: "the samples into two groups,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "according to how"

Phrase: "the ages of cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001779:Age [Organism Attribute]

Phrase: "had"

Phrase: "been"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: ","

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "at onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "(first group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: ")"

Phrase: "or at examination"

Phrase: "or"

Phrase: "death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "(second group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   964   C0680398:secondary group [Population Group]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.64: We also conducted analyses restricted to controls and to diagnoses of probable or definite Alzheimer's disease according to criteria of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) (25) or of the National Institute of Neurological and Communicative Disorders and StrokeAlzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) (26) (26 full samples and two part samples). 

Phrase: "We also conducted analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "restricted to controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0443288:Restricted [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "and to diagnoses of probable"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   781   C0332148:Probable diagnosis [Qualitative Concept]
           Probable
   760   C0011900:Diagnoses [Finding]
   760   C0033204:Probable [Quantitative Concept]
   760   C1515981:And [Idea or Concept]
   726 E C1704338:diagnosis [Qualitative Concept]
   726 E C1704656:DIAGNOSIS [Research Activity]

Phrase: "or"

Phrase: "definite Alzheimer's disease according to criteria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]

Phrase: "of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD)"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0034975:Registry [Intellectual Product]
   793   C0443211:establish [Qualitative Concept]
   793   C1513822:Consortium [Professional or Occupational Group]
   793   C1880171:Consortium [Professional or Occupational Group]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]

Phrase: "(25"

Phrase: ")"

Phrase: "or of the National Institute of Neurological"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0021622:institute [Organization]
   748   C0205494:Neurological [Qualitative Concept]
   748   C1272753:Institute [Idea or Concept]
   748   C2707261:Neurological [Clinical Attribute]
   748   C3245503:national [Intellectual Product]

Phrase: "and"

Phrase: "Communicative Disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009460:Communicative Disorders [Mental or Behavioral Dysfunction]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "and"

Phrase: "StrokeAlzheimer's Disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Related Disorders Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "(NINCDS-ADRDA"

Phrase: ")"

Phrase: "(26"

Phrase: ")"

Phrase: "(26 full samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "two part samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.65: In separate analyses, we excluded eight samples where Hardy-Weinberg analysis and genotyping methods were compatible with mistyping. 

Phrase: "In separate analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "we"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "eight samples where Hardy-Weinberg analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   859   C1303103:Sample analysis [Laboratory Procedure]
   799   C0002778:Analysis [Laboratory Procedure]
   799   C0936012:Analysis [Research Activity]
   799   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "genotyping methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "were"

Phrase: "compatible with mistyping."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:compatible [Idea or Concept]
   790   C1524057:Compatible [Qualitative Concept]
Processing 00000000.tx.66: Underreporting of heterozygotes may occur unless either 5 percent dimethyl sulfoxide is included in the polymerase chain reaction (27) or the DD genotype is confirmed by an insertion-specific second amplification (28). 

Phrase: "Underreporting of heterozygotes"

Phrase: "may"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "unless"

Phrase: "either 5 percent dimethyl sulfoxide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0012403:Dimethyl Sulfoxide [Organic Chemical,Pharmacologic Substance]
   804   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C0038771:sulfoxide [Organic Chemical]
   804   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "included in the polymerase chain reaction"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0332257:included [Functional Concept]
   753   C0337112:Chain [Manufactured Object]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1524075:Chain [Idea or Concept]
   753   C3538986:INCLUDED [Gene or Genome]
   719 E C1552866:include [Idea or Concept]
   719 E C2700399:Include [Activity]

Phrase: "(27"

Phrase: ")"

Phrase: "or"

Phrase: "the DD genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "is"

Phrase: "confirmed by an insertion-specific second amplification"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   778   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   748   C0021107:Insertion [Therapeutic or Preventive Procedure]
   748   C0205369:Specific [Qualitative Concept]
   748   C0205436:Second [Quantitative Concept]
   748   C0441587:Insertion [Health Care Activity]
   748   C0457385:Second [Temporal Concept]
   748   C0565930:/second [Quantitative Concept]
   748   C0750484:Confirmed [Idea or Concept]
   748   C1512796:Insertion [Genetic Function]
   748   C1517480:Amplification [Molecular Biology Research Technique]
   748   C1521871:Amplification [Phenomenon or Process]
   748   C1552740:specific [Intellectual Product]
   748   C1561503:second [Idea or Concept]
   748   C1705190:Second [Qualitative Concept]
   748   C1705759:Amplification [Cell or Molecular Dysfunction]
   748   C1883719:Insertion [Functional Concept]
   714 E C1456348:Confirm [Qualitative Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.67: In further analyses, samples were placed where possible (34 of 39 samples) in one of three ethnic groups: North European (19 samples); 

Phrase: "In further analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "placed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0442504:Place [Spatial Concept]
   966   C1704765:Place [Functional Concept]
   966   C1882509:Place [Activity]
   966   C3496241:place [Disease or Syndrome]

Phrase: "where possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "(34 of 39 samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: "in one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "of three ethnic groups"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   901   C0015031:Ethnic Groups [Population Group]
           ETHNIC
   867 E C1879937:Ethnic Group [Intellectual Product]
   827   C0441833:Group [Idea or Concept]
   827   C0680174:ethnic [Finding]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: ":"

Phrase: "North European"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0239307:European [Population Group]
   861   C1535514:European [Population Group]

Phrase: "(19 samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.68: South Caucasian (11 samples), defined here as from the Mediterranean or from the Middle East; 

Phrase: "South Caucasian"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007457:Caucasian [Population Group]
   861   C0043157:Caucasian [Population Group]

Phrase: "(11 samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "here"

Phrase: "as from the Mediterranean"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0240321:Mediterranean [Population Group]

Phrase: "or from the Middle East"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0026068:Middle East [Geographic Area]
   760   C0444598:Middle [Spatial Concept]
   760   C0549183:middle [Spatial Concept]
   760   C1552826:middle [Idea or Concept]
   760   C1707877:East [Spatial Concept]
   704 E C0205098:Medial [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.69: and East Asian (four samples), from China or from Japan. 

Phrase: "and"

Phrase: "East Asian"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0078988:Asian [Population Group]

Phrase: "(four samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "from China"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008115:China [Geographic Area]

Phrase: "or from Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0022341:Japan [Geographic Area]
Processing 00000000.tx.70: Data analysis and statistical methods Three methods are commonly used to produce odds ratios in genetic association studies: method 1, allelic (i.e., D vs. I in this case); 

Phrase: "Data analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1524024:analysis [Functional Concept]
   861   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "statistical methods Three methods"

Phrase: "are"

Phrase: "commonly"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "odds ratios in genetic association studies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratios [Quantitative Concept]
   753   C0456603:Ratios [Quantitative Concept]
   753   C1610540:*Ratios [Quantitative Concept]
   719 E C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "method 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "allelic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0002085:Allele [Gene or Genome]

Phrase: "(i.e., D"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1442161:Deletion [Cell or Molecular Dysfunction]
   827   C1511760:Deletion [Genetic Function]
   827   C1880274:Deletion [Activity]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "vs. I in this case"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021107:Insertion [Therapeutic or Preventive Procedure]
   760   C0441587:Insertion [Health Care Activity]
   760   C1512796:Insertion [Genetic Function]
   760   C1883719:Insertion [Functional Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.71: method 2, comparing each genotype with one other in turn (e.g., DD vs. DI); 

Phrase: "method 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "each genotype with one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017431:Genotype [Organism Attribute]

Phrase: "other in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "DD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538867:DD [Gene or Genome]

Phrase: "vs. DI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538902:DI [Gene or Genome]
  1000   C3541881:DI [Idea or Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.72: method 3, comparing each genotype in turn with the other two combined. 

Phrase: "method 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "each genotype in turn with the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017431:Genotype [Organism Attribute]

Phrase: "other two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "combined."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]
Processing 00000000.tx.73: All three methods are subject to bias, the degree of bias depending on how imperfectly the model fits reality. 

Phrase: "All three methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "are subject to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0681850:Subject [Group]
   790   C1550501:{Subject} [Idea or Concept]
   790   C1551058:Are [Quantitative Concept]
   790   C1706203:Subject [Idea or Concept]
   790   C2349001:Subject [Human]
   790   C2697811:Subject [Functional Concept]

Phrase: "bias"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242568:Bias [Idea or Concept]
  1000   C1504315:Bias [Bird]

Phrase: ","

Phrase: "the degree of bias"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "depending on how imperfectly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0725813:depend [Medical Device]

Phrase: "the model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "fits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "reality."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0871222:reality [Idea or Concept]
   928 E C0237400:Real [Qualitative Concept]
   928 E C3272377:REAL [Intellectual Product]
Processing 00000000.tx.74: For instance, method 1 is best suited to testing a codominant model, where there is an allelic dose effect (e.g., DD > DI > II). 

Phrase: "For instance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "method 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "is"

Phrase: "best"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]
   966 E C0205170:Well [Qualitative Concept]
   966 E C3146287:Well [Manufactured Object]

Phrase: "suited to testing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0039593:Testing [Functional Concept]
   790   C0392366:testing [Intellectual Product]

Phrase: "a codominant model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "where there"

Phrase: "is"

Phrase: "an allelic dose effect"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0178602:Dose [Quantitative Concept]
   827   C0869039:Dose [Quantitative Concept]
   827   C1114758:Dose # [Clinical Attribute]
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "DD > DI > II"

Phrase: ")."
Processing 00000000.tx.75: Method 3, on the other hand, may be used to test either an I-dominant/D-recessive or a D-dominant/I-recessive model. 

Phrase: "Method 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "either"

Phrase: "an I-dominant/D-recessive"

Phrase: "or"

Phrase: "a D-dominant/I-recessive model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3161035:Model [Intellectual Product]
Processing 00000000.tx.76: We chose to follow the hypothesis-generating study (1) in using method 3, partly because preliminary examination of subsequent studies had shown no evidence of codominance. 

Phrase: "We"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "follow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "the hypothesis-generating study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "in"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "method 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "partly"

Phrase: "because"

Phrase: "preliminary examination of subsequent studies"

Phrase: "had"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no evidence of codominance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.77: We also used both methods 2 and 3 to examine heterosis (heterozygotes at greater or lesser risk than either homozygote). 

Phrase: "We also"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both methods 2"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "3 to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "examine"

Phrase: "heterosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020201:Heterosis [Quantitative Concept]

Phrase: "(heterozygotes at greater"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0019425:Heterozygotes [Organism Attribute]

Phrase: "or"

Phrase: "lesser risk than either homozygote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.78: Our main approach, method 3, gives an estimate of the risk associated with each genotype when compared with the rest of the population. 

Phrase: "Our main approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "method 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "an estimate of the risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1519101:Risk Estimate [Quantitative Concept]
   760   C0750572:Estimate [Quantitative Concept]

Phrase: "associated with each genotype"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0017431:Genotype [Organism Attribute]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "when"

Phrase: "compared with the rest of the population."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0032659:Population [Quantitative Concept]
   748   C0035253:Rest [Daily or Recreational Activity]
   748   C1257890:Population [Population Group]
   748   C1622890:ResT [Molecular Function]
   748   C1707455:Compared [Activity]
Processing 00000000.tx.79: Pooled odds ratios were calculated three times, by the fixed-effects method of Mantel and Haenszel (29), by the random-effects method of DerSimonian and Laird (30), and by the Bayesian random-effects method of Warn et al. 

Phrase: "Pooled odds ratios"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0028873:Odds Ratios [Quantitative Concept]
   827   C0456603:Ratios [Quantitative Concept]
   827   C1610540:*Ratios [Quantitative Concept]
   793 E C1547037:Ratio [Intellectual Product]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "three times,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "by the fixed-effects method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "of Mantel"

Phrase: "and"

Phrase: "Haenszel"

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "by the random-effects method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "of DerSimonian"

Phrase: "and"

Phrase: "Laird"

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "and by the Bayesian random-effects method of"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   767   C0242198:Bayesian Method [Quantitative Concept]
   744   C0025663:Method [Intellectual Product]
   744   C0034656:RANDOM [Research Activity]
   744   C0439605:Random [Qualitative Concept]
   744   C0449851:Method [Functional Concept]
   744   C0871511:METHOD [Intellectual Product]
   744   C1280500:effects [Qualitative Concept]
   744   C1515981:And [Idea or Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "Warn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871599:warn [Governmental or Regulatory Activity]

Phrase: "et al."
Processing 00000000.tx.80: (31). 

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.81: However, as the results of all three methods were very similar, only those of the first two are shown (table 2). 

Phrase: "However,"

Phrase: "as"

Phrase: "the results of all three methods"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "were"

Phrase: "very similar, only"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205171:Only [Quantitative Concept]
   827   C0442824:Very [Qualitative Concept]
   827   C1720467:Only [Intellectual Product]
   827   C2348205:Similar [Qualitative Concept]

Phrase: "those of the first two"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205435:First [Quantitative Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.82: The methods of meta-analysis permit the accumulation of results across independent studies, even where the number of subjects or the ratio of cases to controls varies considerably, as here in the cohort of Sleegers et al. 

Phrase: "The methods of meta-analysis"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   781   C2707190:Analysis method [Laboratory Procedure]
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0449851:Methods [Functional Concept]
   726 E C0871511:METHOD [Intellectual Product]

Phrase: "permit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "the accumulation of results"

Phrase: "across independent studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C0681367:independent study [Educational Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "even where"

Phrase: "the number of subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "or"

Phrase: "the ratio of cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: "to controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "varies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548673:Varies [Intellectual Product]

Phrase: "considerably,"

Phrase: "as"

Phrase: "here in the cohort of Sleegers et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0599755:Cohort [Population Group]
Processing 00000000.tx.83: (9), for example. 

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "for example."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]
Processing 00000000.tx.84: The heterogeneity test was by the method of Armitage (32). 

Phrase: "The heterogeneity test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "was by the method of Armitage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0025663:Method [Intellectual Product]
   753   C0043194:WAS [Disease or Syndrome]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
   753   C1421478:WAS [Gene or Genome]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.85: Logistic regression analysis was used to compare odds ratios among ethnic groups. 

Phrase: "Logistic regression analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0681925:logistic regression analysis [Research Activity]
   901   C0034980:Regression Analysis [Intellectual Product]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0206031:Logistic Regression [Research Activity]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "odds ratios among ethnic groups."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratios [Quantitative Concept]
   760   C0456603:Ratios [Quantitative Concept]
   760   C1610540:*Ratios [Quantitative Concept]
   726 E C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.86: Funnel plots (33) and cumulative meta-analysis (34) were used to investigate bias. 

Phrase: "Funnel plots"

Phrase: "(33"

Phrase: ")"

Phrase: "and"

Phrase: "cumulative meta-analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0282458:Meta-Analysis [Intellectual Product]
   901   C0920317:Meta-Analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1042496:Meta [Eukaryote]
   827   C1524024:analysis [Functional Concept]

Phrase: "(34"

Phrase: ")"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "bias."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0242568:Bias [Idea or Concept]
  1000   C1504315:Bias [Bird]
   966 E C1061346:Bia [Eukaryote]
   966 E C1704746:BIA [Diagnostic Procedure]
Processing 00000000.tx.87: Analyses were performed using "R" (35) and the package "rmeta" by Thomas Lumley (http://www.cran.r-project.org/src/contrib/Descriptions/rmeta.html). 

Phrase: "Analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: """R"" (35"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "the package ""rmeta"""

Phrase: "by Thomas Lumley"

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.cran.r-project.org/src/contrib/Descriptions/rmeta.html"

Phrase: ")."
Processing 00000000.tx.88: All tests of significance were two sided. 

Phrase: "All"

Phrase: "tests of significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0022885:Test [Laboratory Procedure]
   790   C0039593:Test [Functional Concept]
   790   C0237881:Significance [Quantitative Concept]
   790   C0392366:Tests [Intellectual Product]
   790   C0750502:Significance [Idea or Concept]
   718 E C1546944:Significant [Qualitative Concept]

Phrase: "were"

Phrase: "two sided."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205448:Two [Quantitative Concept]
   827   C0441987:Side [Spatial Concept]
   789 E C0457012:Sidedness [Spatial Concept]
Processing 00000000.tx.89: A Bonferroni correction factor of 3 was applied to all p values by genotype. 

Phrase: "A Bonferroni correction factor of 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   783   C0960756:factor A [Organic Chemical]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "was"

Phrase: "applied to all p values"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C1709380:P-Value [Quantitative Concept]
   760   C0042295:Values [Qualitative Concept]
   760   C0185125:Applied [Health Care Activity]
   726 E C1522609:Value [Quantitative Concept]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]

Phrase: "by genotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.90: View this table: [in this window] [in a new window]  TABLE 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.91: Odds ratios of Alzheimer's disease for each ACE* genotype versus the other two in the meta-analysis   RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION References  Phase 1: broad analysis Examination of bias. 

Phrase: "Odds ratios of Alzheimer's disease"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratios [Quantitative Concept]
   760   C0456603:Ratios [Quantitative Concept]
   760   C1610540:*Ratios [Quantitative Concept]
   726 E C1547037:Ratio [Intellectual Product]

Phrase: "for each ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "* genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "versus"

Phrase: "the other two in the meta-analysis   RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0205448:Two [Quantitative Concept]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Phase 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439559:Phase 1 [Temporal Concept]
   861   C0205390:Phase [Temporal Concept]

Phrase: ":"

Phrase: "broad analysis Examination of bias."
Processing 00000000.tx.92: We found no evidence of publication bias. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no evidence of publication bias."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.93: Funnel plots for the comparisons most commonly made, that is, for D homozygotes versus I positives (i.e., DI + II) and for I homozygotes versus D positives, are shown in figure 1. 

Phrase: "Funnel"

Phrase: "plots for the comparisons most commonly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1707455:Comparison [Activity]

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: ","

Phrase: "that"

Phrase: "is"

Phrase: ","

Phrase: "for D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "versus"

Phrase: "I positives"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "(i.e., DI + II"

Phrase: ")"

Phrase: "and for I homozygotes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0019904:Homozygotes [Organism Attribute]
   770   C0021107:Insertion [Therapeutic or Preventive Procedure]
   770   C0441587:Insertion [Health Care Activity]
   770   C1512796:Insertion [Genetic Function]
   770   C1515981:And [Idea or Concept]
   770   C1883719:Insertion [Functional Concept]

Phrase: "versus"

Phrase: "D positives,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "are"

Phrase: "shown in figure 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.94: These plots gave p = 0.19 and p = 0.21, respectively. 

Phrase: "These plots"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "p = 0.19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "p = 0.21,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively."
Processing 00000000.tx.95: Figure 2 shows the cumulative meta-analysis after each study from July 1998 to November 2004, for D homozygotes versus I positives, that is, the comparison made in the hypothesis-generating study of Kehoe et al. 

Phrase: "Figure 2"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the cumulative meta-analysis after each study"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0282458:Meta-Analysis [Intellectual Product]
   778   C0920317:Meta-Analysis [Research Activity]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1042496:Meta [Eukaryote]
   748   C1524024:analysis [Functional Concept]

Phrase: "from July 1998"

Phrase: "to November 2004,"

Phrase: "for D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "versus"

Phrase: "I positives,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: ","

Phrase: "the comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "made in the hypothesis-generating study of Kehoe et al."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0557651:Study [Manufactured Object]
   739   C1512571:Hypothesis [Idea or Concept]
   739   C2603343:Study [Research Activity]
   706   C1881534:Make [Functional Concept]
Processing 00000000.tx.96: (1). 

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.97: After only four of 39 cohorts had been studied, the odds ratio by DerSimonian and Laird (30) became significantly less than 1 and remained so thereafter. 

Phrase: "After"

Phrase: "only four of 39 cohorts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205171:Only [Quantitative Concept]
   760   C0205450:Four [Quantitative Concept]
   760   C0599755:cohorts [Population Group]
   760   C1720467:Only [Intellectual Product]

Phrase: "had"

Phrase: "been"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: ","

Phrase: "the odds ratio by DerSimonian"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratio [Quantitative Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "Laird"

Phrase: "(30"

Phrase: ")"

Phrase: "became"

Phrase: "significantly less than 1"

Phrase: "and"

Phrase: "remained"

Phrase: "so thereafter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037640:SO [Geographic Area]
Processing 00000000.tx.98: It changed very little from around 0.8 after 2001. 

Phrase: "It"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "very little from"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   790   C0700321:Little [Quantitative Concept]
   790   C2700395:Little [Quantitative Concept]

Phrase: "around 0.8"

Phrase: "after 2001."
Processing 00000000.tx.99: View larger version (18K): [in this window] [in a new window]  FIGURE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 1."
Processing 00000000.tx.100: Funnel plots of angiotensin I-converting enzyme gene (ACE) studies: A, D homozygotes versus (DI + II) (p = 0.21); 

Phrase: "Funnel"

Phrase: "plots of angiotensin I-converting enzyme gene"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   804   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   778   C1333402:Enzyme Gene [Gene or Genome]
   774   C1955829:Gene Insertion [Cell or Molecular Dysfunction]
   748   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0017337:Gene [Gene or Genome]
   748   C0021107:Insertion [Therapeutic or Preventive Procedure]
   748   C0441587:Insertion [Health Care Activity]
   748   C1512796:Insertion [Genetic Function]
   748   C1883719:Insertion [Functional Concept]

Phrase: "(ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ")"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "A,"

Phrase: "D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "versus"

Phrase: "(DI + II"

Phrase: ")"

Phrase: "(p = 0.21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.101: B, I homozygotes versus (DI + DD) (p = 0.19). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "I homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "versus"

Phrase: "(DI + DD) (p = 0.19"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C3538867:DD [Gene or Genome]
   804   C3538902:DI [Gene or Genome]
   804   C3541881:DI [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.102: D represents the deletion allele, and I represents the insertion allele. 

Phrase: "D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the deletion allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the insertion allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.103: Horizontal lines are 95% confidence intervals; 

Phrase: "Horizontal lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "are"

Phrase: "95% confidence intervals"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0009667:Confidence Intervals [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:intervals [Temporal Concept]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.104: dashed vertical lines are summary log odds ratios.  

Phrase: "dashed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827624:DASH [Intellectual Product]

Phrase: "vertical lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "are"

Phrase: "summary log odds ratios."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0028873:Odds Ratios [Quantitative Concept]
   812   C0456603:Ratios [Quantitative Concept]
   812   C1610540:*Ratios [Quantitative Concept]
   779 E C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.105: View larger version (45K): [in this window] [in a new window]  FIGURE 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(45K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 2."
Processing 00000000.tx.106: Cumulative meta-analysis of the odds ratio of Alzheimer's disease for ACE*D homozygotes versus I positives. 

Phrase: "Cumulative meta-analysis of the odds ratio of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0282458:Meta-Analysis [Intellectual Product]
   760   C0920317:Meta-Analysis [Research Activity]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1042496:Meta [Eukaryote]
   739   C1524024:analysis [Functional Concept]

Phrase: "for ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "*D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "versus"

Phrase: "I positives."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.107: D represents the deletion allele, and I represents the insertion allele. 

Phrase: "D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the deletion allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the insertion allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.108: Horizontal lines are 95% confidence intervals; 

Phrase: "Horizontal lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "are"

Phrase: "95% confidence intervals"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0009667:Confidence Intervals [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:intervals [Temporal Concept]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.109: the vertical dotted line is the summary odds ratio. 

Phrase: "the vertical dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "is"

Phrase: "the summary odds ratio."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0028873:Odds Ratio [Quantitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]
   827   C1552616:summary [Intellectual Product]
   827   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.110: OPTIMA, Oxford Project to Investigate Memory and Ageing; 

Phrase: "OPTIMA,"

Phrase: "Oxford Project to Investigate Memory and Ageing"

Phrase: ";"
Processing 00000000.tx.111: ACE, angiotensin I-converting enzyme gene. 

Phrase: "ACE,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "angiotensin I-converting enzyme gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1333402:Enzyme Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   722   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
Processing 00000000.tx.112: Additional study information is given in table 1.  

Phrase: "Additional study information"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1546922:Additional information [Temporal Concept]
   913   C1706499:ADDITIONAL INFORMATION [Intellectual Product]
   827   C1533716:Information [Idea or Concept]
   755 E C3242430:informational [Idea or Concept]

Phrase: "is"

Phrase: "given in table 1."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C1442162:GIVEN [Conceptual Entity]
   770   C1550718:given [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C3244317:given [Intellectual Product]
   737 E C1947971:Give [Functional Concept]
Processing 00000000.tx.113: Risk of Alzheimer's disease, by genotype. 

Phrase: "Risk of Alzheimer's disease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]

Phrase: "by genotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.114: The odds ratios for each genotype versus the other two are shown in figures 3, 4, and 5 and are summarized in table 2. 

Phrase: "The odds ratios for each genotype"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratios [Quantitative Concept]
   753   C0456603:Ratios [Quantitative Concept]
   753   C1610540:*Ratios [Quantitative Concept]
   719 E C1547037:Ratio [Intellectual Product]

Phrase: "versus"

Phrase: "the other two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "are"

Phrase: "shown in figures 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "4,"

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "summarized in table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.115: D homozygotes were at reduced risk of Alzheimer's disease, with an overall odds ratio of 0.81 (95 percent confidence interval: 0.72, 0.90; 

Phrase: "D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "were at reduced risk of Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C1281905:disease risk [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0035647:Risk [Qualitative Concept]
   748   C0392756:Reduced [Qualitative Concept]

Phrase: "with an overall odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0028873:Odds Ratio [Quantitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "of 0.81"

Phrase: "(95 percent confidence interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.72,"

Phrase: "0.90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.116: corrected p = 0.0004) by the method of DerSimonian and Laird (30). 

Phrase: "corrected p = 0.0004"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0205202:Corrected [Qualitative Concept]
   779 E C2349182:Correct [Qualitative Concept]

Phrase: ")"

Phrase: "by the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "of DerSimonian"

Phrase: "and"

Phrase: "Laird"

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.117: Heterozygotes were at increased risk of Alzheimer's disease, with an overall odds ratio of 1.12 (95 percent confidence interval: 1.04, 1.22; 

Phrase: "Heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]

Phrase: "were at increased risk of Alzheimer's disease,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C1281905:disease risk [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0035647:Risk [Qualitative Concept]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   728   C0277564:Acquired disease [Disease or Syndrome]

Phrase: "with an overall odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0028873:Odds Ratio [Quantitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "of 1.12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(95 percent confidence interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "1.04,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1.22"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.118: corrected p = 0.006). 

Phrase: "corrected p = 0.006"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0205202:Corrected [Qualitative Concept]
   779 E C2349182:Correct [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.119: The odds ratio of Alzheimer's disease for I homozygotes versus D positives did not differ significantly from 1. 

Phrase: "The odds ratio of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "for I homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "versus"

Phrase: "D positives"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ"

Phrase: "significantly from 1."
Processing 00000000.tx.120: Two of these three results were heterogeneous. 

Phrase: "Two of these three results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205448:Two [Quantitative Concept]

Phrase: "were"

Phrase: "heterogeneous."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneous [Qualitative Concept]
Processing 00000000.tx.121: View larger version (45K): [in this window] [in a new window]  FIGURE 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(45K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 3."
Processing 00000000.tx.122: Odds ratios of Alzheimer's disease for ACE*D homozygotes versus I positives. 

Phrase: "Odds ratios of Alzheimer's disease"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratios [Quantitative Concept]
   760   C0456603:Ratios [Quantitative Concept]
   760   C1610540:*Ratios [Quantitative Concept]
   726 E C1547037:Ratio [Intellectual Product]

Phrase: "for ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "*D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "versus"

Phrase: "I positives."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.123: D represents the deletion allele, and I represents the insertion allele. 

Phrase: "D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the deletion allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the insertion allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.124: Horizontal lines are 95% confidence intervals. 

Phrase: "Horizontal lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "are"

Phrase: "95% confidence intervals."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0009667:Confidence Intervals [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:intervals [Temporal Concept]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]
Processing 00000000.tx.125: OPTIMA, Oxford Project to Investigate Memory and Ageing; 

Phrase: "OPTIMA,"

Phrase: "Oxford Project to Investigate Memory and Ageing"

Phrase: ";"
Processing 00000000.tx.126: ACE, angiotensin I-converting enzyme gene. 

Phrase: "ACE,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "angiotensin I-converting enzyme gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1333402:Enzyme Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   722   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
Processing 00000000.tx.127: Additional study information is given in table 1.  

Phrase: "Additional study information"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1546922:Additional information [Temporal Concept]
   913   C1706499:ADDITIONAL INFORMATION [Intellectual Product]
   827   C1533716:Information [Idea or Concept]
   755 E C3242430:informational [Idea or Concept]

Phrase: "is"

Phrase: "given in table 1."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C1442162:GIVEN [Conceptual Entity]
   770   C1550718:given [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C3244317:given [Intellectual Product]
   737 E C1947971:Give [Functional Concept]
Processing 00000000.tx.128: View larger version (48K): [in this window] [in a new window]  FIGURE 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(48K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 4."
Processing 00000000.tx.129: Odds ratios of Alzheimer's disease for ACE heterozygotes versus all homozygotes. 

Phrase: "Odds ratios of Alzheimer's disease"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratios [Quantitative Concept]
   760   C0456603:Ratios [Quantitative Concept]
   760   C1610540:*Ratios [Quantitative Concept]
   726 E C1547037:Ratio [Intellectual Product]

Phrase: "for ACE heterozygotes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0019425:Heterozygotes [Organism Attribute]
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "versus"

Phrase: "all homozygotes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019904:Homozygotes [Organism Attribute]
Processing 00000000.tx.130: Horizontal lines are 95% confidence intervals. 

Phrase: "Horizontal lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "are"

Phrase: "95% confidence intervals."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0009667:Confidence Intervals [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:intervals [Temporal Concept]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]
Processing 00000000.tx.131: OPTIMA, Oxford Project to Investigate Memory and Ageing; 

Phrase: "OPTIMA,"

Phrase: "Oxford Project to Investigate Memory and Ageing"

Phrase: ";"
Processing 00000000.tx.132: ACE, angiotensin I-converting enzyme gene. 

Phrase: "ACE,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "angiotensin I-converting enzyme gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1333402:Enzyme Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   722   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
Processing 00000000.tx.133: Additional study information is given in table 1.  

Phrase: "Additional study information"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1546922:Additional information [Temporal Concept]
   913   C1706499:ADDITIONAL INFORMATION [Intellectual Product]
   827   C1533716:Information [Idea or Concept]
   755 E C3242430:informational [Idea or Concept]

Phrase: "is"

Phrase: "given in table 1."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C1442162:GIVEN [Conceptual Entity]
   770   C1550718:given [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C3244317:given [Intellectual Product]
   737 E C1947971:Give [Functional Concept]
Processing 00000000.tx.134: View larger version (46K): [in this window] [in a new window]  FIGURE 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(46K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 5."
Processing 00000000.tx.135: Odds ratios of Alzheimer's disease for ACE*I homozygotes versus D positives. 

Phrase: "Odds ratios of Alzheimer's disease"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratios [Quantitative Concept]
   760   C0456603:Ratios [Quantitative Concept]
   760   C1610540:*Ratios [Quantitative Concept]
   726 E C1547037:Ratio [Intellectual Product]

Phrase: "for ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "*I homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "versus"

Phrase: "D positives."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.136: D represents the deletion allele, and I represents the insertion allele. 

Phrase: "D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the deletion allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the insertion allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.137: Horizontal lines are 95% confidence intervals. 

Phrase: "Horizontal lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "are"

Phrase: "95% confidence intervals."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0009667:Confidence Intervals [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:intervals [Temporal Concept]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]
Processing 00000000.tx.138: OPTIMA, Oxford Project to Investigate Memory and Ageing; 

Phrase: "OPTIMA,"

Phrase: "Oxford Project to Investigate Memory and Ageing"

Phrase: ";"
Processing 00000000.tx.139: ACE, angiotensin I-converting enzyme gene. 

Phrase: "ACE,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "angiotensin I-converting enzyme gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1333402:Enzyme Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   722   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
Processing 00000000.tx.140: Additional study information is given in table 1.  

Phrase: "Additional study information"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1546922:Additional information [Temporal Concept]
   913   C1706499:ADDITIONAL INFORMATION [Intellectual Product]
   827   C1533716:Information [Idea or Concept]
   755 E C3242430:informational [Idea or Concept]

Phrase: "is"

Phrase: "given in table 1."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C1442162:GIVEN [Conceptual Entity]
   770   C1550718:given [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C3244317:given [Intellectual Product]
   737 E C1947971:Give [Functional Concept]
Processing 00000000.tx.141: Onset age of Alzheimer's disease. 

Phrase: "Onset age of Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]
Processing 00000000.tx.142: Onset age data were available from 13 samples, comprising 2,309 cases of Alzheimer's disease. 

Phrase: "Onset age data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0206132:Onset Age [Quantitative Concept]

Phrase: "were"

Phrase: "available from 13 samples,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "comprising"

Phrase: "2,309 cases of Alzheimer's disease."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.143: Both stratified analyses and linear regression analysis were performed on these data and also on a subset of 10 North European samples, comprising 1,822 cases of Alzheimer's disease. 

Phrase: "Both stratified analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "linear regression analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0034980:Regression Analysis [Intellectual Product]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0023733:Linear Regression [Quantitative Concept]
   734   C2346679:Linear Regression [Intellectual Product]

Phrase: "were"

Phrase: "performed on these data"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0884358:Performed [Functional Concept]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "also on a subset of 10 North European samples,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0239307:European [Population Group]
   742   C1515021:Subset [Classification]
   742   C1535514:European [Population Group]
   742   C1709269:North [Spatial Concept]
   708   C0370003:Sample [Substance]
   708   C2347026:Sample [Conceptual Entity]

Phrase: "comprising"

Phrase: "1,822 cases of Alzheimer's disease."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.144: No effect of ACE*I carrier status on onset age of Alzheimer's disease and, surprisingly, only a modest effect of APOE*4 carrier status on onset age were seen (data not shown). 

Phrase: "No effect of ACE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "*I carrier status on onset age of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0449439:Carrier status [Finding]
   742   C0449438:Status [Qualitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "surprisingly,"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a modest effect of APOE*4 carrier status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "on onset age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206132:Onset Age [Quantitative Concept]
   861   C0001779:Age [Organism Attribute]

Phrase: "were"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.145: Phase 2: examination of heterogeneity We examined six potential sources of heterogeneity: age, gender, race, APOE*4 status, misdiagnosis, and mistyping. 

Phrase: "Phase 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439560:Phase 2 [Temporal Concept]
   861   C0205390:Phase [Temporal Concept]

Phrase: ":"

Phrase: "examination of heterogeneity"

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "six potential sources of heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449416:sources [Finding]
   726 E C1705919:Source [Idea or Concept]

Phrase: ":"

Phrase: "age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "gender,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "race,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034510:Race [Population Group]
  1000   C1706779:RACE [Gene or Genome]

Phrase: "APOE*4 status,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449438:Status [Qualitative Concept]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "misdiagnosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679838:Misdiagnosis [Finding]

Phrase: "and"

Phrase: "mistyping."
Processing 00000000.tx.146: Stratification by gender and by APOE*4 status. 

Phrase: "Stratification by gender"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514983:Stratification [Research Activity]

Phrase: "and by APOE*4 status."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0449438:Status [Qualitative Concept]
   753   C1515981:And [Idea or Concept]
Processing 00000000.tx.147: No significant effects were seen of gender or of APOE*4 status on the associations with Alzheimer's disease, nor did stratification by either of these two factors remove the heterogeneity (data not shown). 

Phrase: "No significant effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "seen of gender"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0079399:Gender [Organism Attribute]
   790   C0205397:Seen [Qualitative Concept]
   790   C0804628:Gender [Clinical Attribute]
   790   C1522384:Gender [Organism Attribute]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "or of APOE*4 status"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0449438:Status [Qualitative Concept]

Phrase: "on the associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0004083:Associations [Mental Process]
   966 E C0439849:Association [Qualitative Concept]
   966 E C0596306:Association [Phenomenon or Process]
   966 E C0699792:association [Social Behavior]

Phrase: "with Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "nor"

Phrase: "did"

Phrase: "stratification by either of these two factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1514984:Stratification Factors [Functional Concept]
   748   C1514983:Stratification [Research Activity]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.148: Stratification by age. 

Phrase: "Stratification by age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514983:Stratification [Research Activity]
Processing 00000000.tx.149: We calculated the odds ratios of Alzheimer's disease for ACE*D homozygotes versus I positives when stratified by age (<65 years, 6575 years, and >75 years). 

Phrase: "We"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "the odds ratios of Alzheimer's disease"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratios [Quantitative Concept]
   753   C0456603:Ratios [Quantitative Concept]
   753   C1610540:*Ratios [Quantitative Concept]
   719 E C1547037:Ratio [Intellectual Product]

Phrase: "for ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "*D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "versus"

Phrase: "I positives"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "when"

Phrase: "stratified by age (<65 years,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C1510829:Age-Years [Temporal Concept]
   760   C0001779:Age [Organism Attribute]
   760   C0205363:Stratified [Qualitative Concept]
   760   C0439234:years [Temporal Concept]
   760   C0450385:65 [Intellectual Product]
   726 E C0439508:/year [Temporal Concept]

Phrase: "6575 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and >"

Phrase: "75 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.150: Rather little effect of age was seen on the association of D homozygotes with Alzheimer's disease (data not shown), nor was there any reduction in heterogeneity on stratification by age. 

Phrase: "Rather little effect of age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "seen on the association of D homozygotes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   748   C0004083:Association [Mental Process]
   748   C0019904:Homozygotes [Organism Attribute]
   748   C0205397:Seen [Qualitative Concept]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]
   748   C1442161:Deletion [Cell or Molecular Dysfunction]
   748   C1511760:Deletion [Genetic Function]
   748   C1880274:Deletion [Activity]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "with Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "nor"

Phrase: "was"

Phrase: "there"

Phrase: "any reduction in heterogeneity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "on stratification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514983:Stratification [Research Activity]

Phrase: "by age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.151: Examination of diagnosis. 

Phrase: "Examination of diagnosis."
Processing 00000000.tx.152: We repeated the overall analyses of the three genotypes, restricting the data to the 28 samples that could be limited to the more rigorous diagnoses of probable or definite Alzheimer's disease according to criteria of the Consortium to Establish a Registry for Alzheimer's Disease (25) or the National Institute of Neurological and Communicative Disorders and StrokeAlzheimer's Disease and Related Disorders Association (26). 

Phrase: "We"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "the overall analyses of the three genotypes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "restricting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443288:restricting [Functional Concept]

Phrase: "the data to the 28 samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "limited to the more rigorous diagnoses of probable"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   750   C0332148:Probable diagnosis [Qualitative Concept]
           Probable
   744   C0011900:Diagnoses [Finding]
   744   C0033204:Probable [Quantitative Concept]
   744   C0439801:Limited [Functional Concept]
   744   C3542948:Limited [Intellectual Product]
   711 E C1549649:Limit [Idea or Concept]
   711 E C1704338:diagnosis [Qualitative Concept]
   711 E C1704656:DIAGNOSIS [Research Activity]
   711 E C2349209:Limit [Conceptual Entity]

Phrase: "or"

Phrase: "definite Alzheimer's disease according to criteria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]

Phrase: "of the Consortium to Establish a Registry for Alzheimer's Disease"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0034975:Registry [Intellectual Product]
   793   C0443211:establish [Qualitative Concept]
   793   C1513822:Consortium [Professional or Occupational Group]
   793   C1880171:Consortium [Professional or Occupational Group]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]

Phrase: "(25"

Phrase: ")"

Phrase: "or"

Phrase: "the National Institute of Neurological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "Communicative Disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009460:Communicative Disorders [Mental or Behavioral Dysfunction]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "and"

Phrase: "StrokeAlzheimer's Disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Related Disorders Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.153: The odds ratios were similar to those shown in table 2, that is, significant odds ratios by the method of DerSimonian and Laird (30) of 0.77 for D homozygotes and of 1.15 for heterozygotes and a nonsignificant odds ratio of 1.10 for I homozygotes. 

Phrase: "The odds ratios"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "were"

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "shown in table 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "is"

Phrase: ","

Phrase: "significant odds ratios by the method of DerSimonian"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0028873:Odds Ratios [Quantitative Concept]
   744   C0456603:Ratios [Quantitative Concept]
   744   C1610540:*Ratios [Quantitative Concept]
   711 E C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "Laird"

Phrase: "(30"

Phrase: ")"

Phrase: "of 0.77"

Phrase: "for D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "and of 1.15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "for heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]

Phrase: "and"

Phrase: "a nonsignificant odds ratio of 1.10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0028873:Odds Ratio [Quantitative Concept]
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]

Phrase: "for I homozygotes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]
Processing 00000000.tx.154: Heterogeneity remained for D homozygotes (p = 0.005) but was no longer significant (p = 0.16) for I homozygotes. 

Phrase: "Heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "remained for D homozygotes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0019904:Homozygotes [Organism Attribute]
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "(p = 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "but"

Phrase: "was"

Phrase: "no longer significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(p = 0.16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "for I homozygotes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]
Processing 00000000.tx.155: Examination of genotyping. 

Phrase: "Examination of genotyping."
Processing 00000000.tx.156: There were 12 instances of Hardy-Weinberg disequilibrium in individual studies and four in the six groups of pooled cases and controls analyzed by race (table 3). 

Phrase: "There"

Phrase: "were"

Phrase: "12 instances of Hardy-Weinberg disequilibrium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1550608:Instance [Idea or Concept]

Phrase: "in individual studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "four in the six groups of pooled cases"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   744   C0205450:Four [Quantitative Concept]
   744   C0205452:Six [Quantitative Concept]
   744   C0441833:Group [Idea or Concept]
   744   C0687744:group [Population Group]
   744   C0868928:Cases [Functional Concept]
   744   C1257890:Group [Population Group]
   744   C1533148:Cases [Quantitative Concept]
   744   C1552516:Group [Health Care Related Organization]
   744   C1552839:groups [Idea or Concept]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]
   744   C1709595:Pooled [Conceptual Entity]
   744   C2349200:Pooled [Functional Concept]
   711 E C0337051:Pool [Geographic Area]
   711 E C1509144:pool [Clinical Attribute]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "analyzed by race"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034510:Race [Population Group]
   790   C0936012:Analyzed [Research Activity]
   790   C1706779:RACE [Gene or Genome]

Phrase: "(table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.157: We therefore excluded the eight samples where mistyping was considered possible, that is, underreporting of heterozygotes, taking into account both genotyping methods and Hardy-Weinberg analysis. 

Phrase: "We therefore"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "the eight samples where mistyping"

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "possible,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: ","

Phrase: "underreporting of heterozygotes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0019425:Heterozygotes [Organism Attribute]

Phrase: "taking into account"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1551359:account [Idea or Concept]
   790   C2741673:Account # [Clinical Attribute]
   790   C2981730:Account [Classification]
   756   C1515187:Take [Health Care Activity]

Phrase: "both genotyping methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "Hardy-Weinberg analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.158: We then repeated the overall analyses with the remaining 31 samples. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "the overall analyses with the remaining 31 samples."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   734   C1303103:Sample analysis [Laboratory Procedure]
   711   C0002778:Analysis [Laboratory Procedure]
   711   C0936012:Analysis [Research Activity]
   711   C1524024:analysis [Functional Concept]
Processing 00000000.tx.159: The odds ratios were similar to those in table 2, that is, significant odds ratios of 0.81 for D homozygotes and of 1.12 for heterozygotes and a nonsignificant odds ratio of 1.09 for I homozygotes. 

Phrase: "The odds ratios"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "were"

Phrase: "similar to those in table 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: ","

Phrase: "significant odds ratios of 0.81"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratios [Quantitative Concept]
   753   C0456603:Ratios [Quantitative Concept]
   753   C1610540:*Ratios [Quantitative Concept]
   719 E C1547037:Ratio [Intellectual Product]

Phrase: "for D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "and of 1.12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "for heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]

Phrase: "and"

Phrase: "a nonsignificant odds ratio of 1.09"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0028873:Odds Ratio [Quantitative Concept]
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]

Phrase: "for I homozygotes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]
Processing 00000000.tx.160: Heterogeneity remained for I homozygotes (p = 0.02) but was no longer significant for D homozygotes (p = 0.19). 

Phrase: "Heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "remained for I homozygotes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0019904:Homozygotes [Organism Attribute]
   770   C0021107:Insertion [Therapeutic or Preventive Procedure]
   770   C0441587:Insertion [Health Care Activity]
   770   C1512796:Insertion [Genetic Function]
   770   C1883719:Insertion [Functional Concept]

Phrase: "(p = 0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "but"

Phrase: "was"

Phrase: "no longer significant for D homozygotes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0237881:significant [Quantitative Concept]
   753   C0750502:Significant [Idea or Concept]
   753   C1546944:Significant [Qualitative Concept]

Phrase: "(p = 0.19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.161: View this table: [in this window] [in a new window]  TABLE 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.162: Odds ratios of Alzheimer's disease for each ACE* genotype in the meta-analysis, by ethnic group  Ethnic stratification. 

Phrase: "Odds ratios of Alzheimer's disease"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratios [Quantitative Concept]
   760   C0456603:Ratios [Quantitative Concept]
   760   C1610540:*Ratios [Quantitative Concept]
   726 E C1547037:Ratio [Intellectual Product]

Phrase: "for each ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "* genotype in the meta-analysis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017431:Genotype [Organism Attribute]

Phrase: "by ethnic group  Ethnic stratification."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514983:Stratification [Research Activity]
Processing 00000000.tx.163: The samples were divided into three ethnic groups, where possible: North European (19 samples), South Caucasian (Mediterranean and Middle Eastern, 11 samples), and East Asian (Chinese and Japanese, four samples). 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "divided into three ethnic groups,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   806   C0015031:Ethnic Groups [Population Group]
           ETHNIC
   773 E C1879937:Ethnic Group [Intellectual Product]
   760   C0205449:Three [Quantitative Concept]
   760   C0332849:Divided [Functional Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0680174:ethnic [Finding]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "where possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: ":"

Phrase: "North European"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0239307:European [Population Group]
   861   C1535514:European [Population Group]

Phrase: "(19 samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "South Caucasian"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007457:Caucasian [Population Group]
   861   C0043157:Caucasian [Population Group]

Phrase: "(Mediterranean"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0240321:Mediterranean [Population Group]

Phrase: "and"

Phrase: "Middle Eastern, 11 samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "East Asian"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0078988:Asian [Population Group]

Phrase: "(Chinese"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008120:chinese [Language]
  1000   C0152035:Chinese [Population Group]

Phrase: "and"

Phrase: "Japanese,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556094:Japanese [Population Group]

Phrase: "four samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.164: This removed nearly all heterogeneity (table 3). 

Phrase: "This removed nearly"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0849355:Removed [Qualitative Concept]
   827 E C1883720:Remove [Activity]
   827 E C3244314:remove [Functional Concept]

Phrase: "all heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "(table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.165: Table 3 shows clear differences among the three ethnic groups. 

Phrase: "Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "clear differences among the three ethnic groups."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0682076:ethnic differences [Finding]
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.166: There was no overlap whatsoever in allelic frequencies among the three groups. 

Phrase: "There"

Phrase: "was"

Phrase: "no overlap"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185027:overlap [Therapeutic or Preventive Procedure]
  1000   C1948020:Overlap [Conceptual Entity]

Phrase: "whatsoever in allelic frequencies"

Phrase: "among the three groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
Processing 00000000.tx.167: North Europeans and East Asians differed in the odds ratios for D homozygotes versus I positives (p = 0.0008) and for I homozygotes versus D positives (p = 0.0005). 

Phrase: "North Europeans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0239307:European [Population Group]
   827   C1535514:European [Population Group]

Phrase: "and"

Phrase: "East Asians"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0078988:Asians [Population Group]

Phrase: "differed in the odds ratios"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratios [Quantitative Concept]
   760   C0456603:Ratios [Quantitative Concept]
   760   C1610540:*Ratios [Quantitative Concept]
   726 E C1547037:Ratio [Intellectual Product]

Phrase: "for D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "versus"

Phrase: "I positives"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "(p = 0.0008"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and for I homozygotes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0019904:Homozygotes [Organism Attribute]
   770   C0021107:Insertion [Therapeutic or Preventive Procedure]
   770   C0441587:Insertion [Health Care Activity]
   770   C1512796:Insertion [Genetic Function]
   770   C1515981:And [Idea or Concept]
   770   C1883719:Insertion [Functional Concept]

Phrase: "versus"

Phrase: "D positives"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "(p = 0.0005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.168: South Caucasians also differed from East Asians in the odds ratio for D homozygotes versus I positives (p = 0.0003). 

Phrase: "South Caucasians also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0007457:Caucasians [Population Group]
   827   C0043157:Caucasians [Population Group]

Phrase: "differed from East Asians"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0078988:Asians [Population Group]
   770   C1707877:East [Spatial Concept]

Phrase: "in the odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "for D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "versus"

Phrase: "I positives"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "(p = 0.0003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.169: D homozygotes were at reduced risk in all groups, but particularly in East Asians. 

Phrase: "D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "were at reduced risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035647:Risk [Qualitative Concept]
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "in all groups,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "but"

Phrase: "particularly in East Asians."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0078988:Asians [Population Group]
   770   C1707877:East [Spatial Concept]
Processing 00000000.tx.170: Heterozygotes were at increased risk in North Europeans. 

Phrase: "Heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]

Phrase: "were at increased risk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035647:Risk [Qualitative Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "in North Europeans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0239307:European [Population Group]
   827   C1535514:European [Population Group]
Processing 00000000.tx.171: I homozygotes were at higher risk in East Asians, except by Bayesian analysis. 

Phrase: "I homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "were at higher risk"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0332167:High Risk [Qualitative Concept]
   799   C3272283:High Risk [Finding]
   770   C0035647:Risk [Qualitative Concept]
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "in East Asians,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0078988:Asians [Population Group]

Phrase: "except"

Phrase: "by Bayesian analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0242196:Bayesian Analysis [Quantitative Concept]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.172: We further examined heterosis (heterozygotes at greater risk) in North Europeans, by comparing DI with DD and with II in turn. 

Phrase: "We further examined heterosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020201:Heterosis [Quantitative Concept]

Phrase: "(heterozygotes at greater risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019425:Heterozygotes [Organism Attribute]

Phrase: ")"

Phrase: "in North Europeans,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0239307:European [Population Group]
   827   C1535514:European [Population Group]

Phrase: "by comparing DI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3538902:DI [Gene or Genome]
   861   C3541881:DI [Idea or Concept]

Phrase: "with DD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538867:DD [Gene or Genome]

Phrase: "and with II in turn."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0541749:turn [Finding]
   760   C1515981:And [Idea or Concept]
   760   C1709743:Turn [Spatial Concept]
Processing 00000000.tx.173: We found that heterozygotes were at higher risk than D homozygotes (odds ratio = 1.25, 95 percent confidence interval: 1.08, 1.45) but not significantly higher than I homozygotes (odds ratio = 1.08, 95 percent confidence interval: 0.95, 1.22).  

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]

Phrase: "were at higher risk"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0332167:High Risk [Qualitative Concept]
   799   C3272283:High Risk [Finding]
   770   C0035647:Risk [Qualitative Concept]
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "than D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "(odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 1.25,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95 percent confidence interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "1.08,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1.45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "but"

Phrase: "not significantly higher than I homozygotes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "(odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 1.08,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95 percent confidence interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.95,"

Phrase: "1.22"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.174: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION References  This was a large meta-analysis, by the standards of Alzheimer's disease genetics, with 39 samples, comprising 6,037 cases of Alzheimer's disease and 12,099 elderly controls (table 1). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This"

Phrase: "was"

Phrase: "a large meta-analysis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0282458:Meta-Analysis [Intellectual Product]
   901   C0920317:Meta-Analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1042496:Meta [Eukaryote]
   827   C1524024:analysis [Functional Concept]

Phrase: "by the standards"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038137:standards [Intellectual Product]
  1000   C0175675:Standards [Qualitative Concept]
   966 E C1442989:Standard [Qualitative Concept]
   966 E C2828392:Standard [Intellectual Product]

Phrase: "of Alzheimer's disease genetics,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0017398:Genetics [Biomedical Occupation or Discipline]
   827   C0017399:genetics [Biologic Function]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "with 39 samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "comprising"

Phrase: "6,037 cases of Alzheimer's disease"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "12,099 elderly controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0243148:control [Qualitative Concept]
   779   C1550141:Control [Substance]
   779   C1882979:Control [Conceptual Entity]
   779   C2587213:Control [Functional Concept]
   779   C3274648:Control [Qualitative Concept]

Phrase: "(table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.175: We found no evidence of publication bias. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no evidence of publication bias."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.176: ACE*D homozygotes were at reduced risk of Alzheimer's disease (table 2) in each of the three main ethnic groups examined (table 3). 

Phrase: "ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "*D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "were at reduced risk of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C1281905:disease risk [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0035647:Risk [Qualitative Concept]
   748   C0392756:Reduced [Qualitative Concept]

Phrase: "(table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "in each"

Phrase: "of the three main ethnic groups"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   861   C0015031:Ethnic Groups [Population Group]
           ETHNIC
   827 E C1879937:Ethnic Group [Intellectual Product]
   812   C0441833:Group [Idea or Concept]
   812   C0680174:ethnic [Finding]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1552839:groups [Idea or Concept]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.177: I homozygotes were neutral as regards Alzheimer's disease risk (table 2), except in East Asians, in whom I homozygotes may be at higher risk (table 3). 

Phrase: "I homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "were"

Phrase: "neutral as regards Alzheimer's disease risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1882074:Neutral [Qualitative Concept]
   753   C2825492:Neutral [Phenomenon or Process]

Phrase: "(table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "except"

Phrase: "in East Asians,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0078988:Asians [Population Group]

Phrase: "in whom I homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "may"

Phrase: "be at higher risk"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0332167:High Risk [Qualitative Concept]
   799   C3272283:High Risk [Finding]
   770   C0035647:Risk [Qualitative Concept]
   770   C2987476:Be [Conceptual Entity]
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "(table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.178: Heterozygotes were at increased risk of Alzheimer's disease overall (table 2) and mainly in North Europeans (table 3). 

Phrase: "Heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]

Phrase: "were at increased risk of Alzheimer's disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C1281905:disease risk [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0035647:Risk [Qualitative Concept]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   728   C0277564:Acquired disease [Disease or Syndrome]

Phrase: "overall"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "(table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "mainly in North Europeans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1709269:North [Spatial Concept]
   737   C0239307:European [Population Group]
   737   C1535514:European [Population Group]

Phrase: "(table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.179: This example of heterosis will be discussed below. 

Phrase: "This example of heterosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707959:Example [Conceptual Entity]

Phrase: "will"

Phrase: "be"

Phrase: "discussed below."
Processing 00000000.tx.180: Very similar results were achieved by three methods: fixed effects, random effects, and Bayesian random effects (refer to Materials and Methods and table 2). 

Phrase: "Very similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "were"

Phrase: "achieved by three methods"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0205449:Three [Quantitative Concept]
   770   C0449851:Methods [Functional Concept]
   737 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "fixed effects,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "random effects,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0034656:RANDOM [Research Activity]
   861   C0439605:Random [Qualitative Concept]
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "Bayesian random effects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0034656:RANDOM [Research Activity]
   827   C0439605:Random [Qualitative Concept]
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "("

Phrase: "refer to Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205543:refer [Functional Concept]
   790   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.181: Only genotypic comparisons were made (refer to Materials and Methods), which showed that there was no allelic dose effect, except in East Asians (table 3), and that thus allelic comparisons would have proved less informative. 

Phrase: "Only genotypic comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1707455:Comparison [Activity]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "("

Phrase: "refer to Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205543:refer [Functional Concept]
   790   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that there"

Phrase: "was"

Phrase: "no allelic dose effect,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0178602:Dose [Quantitative Concept]
   827   C0869039:Dose [Quantitative Concept]
   827   C1114758:Dose # [Clinical Attribute]
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "except"

Phrase: "in East Asians"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0078988:Asians [Population Group]

Phrase: "(table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "that thus allelic comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1707455:Comparison [Activity]

Phrase: "would"

Phrase: "have"

Phrase: "proved"

Phrase: "less informative."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986490:Informative [Qualitative Concept]
Processing 00000000.tx.182: These findings of odds ratios close to 1, even though significantly different from 1 (tables 2 and 3), suggest either linkage disequilibrium with the true risk factor or confounding by a hidden interaction or both. 

Phrase: "These findings of odds ratios"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0243095:Finding [Finding]
   726 E C2825141:Finding [Finding]

Phrase: "close to 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0587267:Close [Functional Concept]

Phrase: "even"

Phrase: "though"

Phrase: "significantly different from 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "(tables 2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0039224:tables [Manufactured Object]
   861   C1706074:Tables [Intellectual Product]
   827 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "either linkage disequilibrium with the true risk factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0023746:Linkage Disequilibrium [Quantitative Concept]
   744   C0023745:linkage [Molecular Function]
   744   C0281825:Disequilibrium [Finding]
   744   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "or"

Phrase: "confounding by a hidden interaction"

Phrase: "or"

Phrase: "both."
Processing 00000000.tx.183: The second possibility is discussed below. 

Phrase: "The second possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "discussed below."
Processing 00000000.tx.184: Regarding the former, Kehoe et al. 

Phrase: "Regarding"

Phrase: "the former, Kehoe et al."
Processing 00000000.tx.185: (1) in their study of ACE haplotypes gave evidence that the indel may not be the actual risk factor but rather in linkage disequilibrium with a nearby functional polymorphism that is the true risk factor. 

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "in their study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "of ACE haplotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0018591:Haplotypes [Organism Attribute]
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the indel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1956002:Indel [Genetic Function]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "the actual risk factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0035648:Risk factor [Quantitative Concept]
   827   C0035647:Risk [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "but"

Phrase: "rather in linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "with a nearby functional polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "the true risk factor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0035648:Risk factor [Quantitative Concept]
   827   C0035647:Risk [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.186: ACE haplotype analysis has also proved of value with other phenotypes, such as enzyme levels (36), insulin levels, myocardial infarction, and obesity (37). 

Phrase: "ACE haplotype analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0002778:Analysis [Laboratory Procedure]
   799   C0936012:Analysis [Research Activity]
   799   C1524024:analysis [Functional Concept]
   734   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   734   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "has"

Phrase: "also"

Phrase: "proved of value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1522609:Value [Quantitative Concept]

Phrase: "with other phenotypes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031437:Phenotypes [Organism Attribute]
   966 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "such as enzyme levels"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0014440:enzyme levels [Laboratory Procedure]
  1000   C1287349:enzyme levels [Laboratory or Test Result]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "insulin levels,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0202098:insulin levels [Laboratory Procedure]
  1000   C0428405:insulin levels [Laboratory or Test Result]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "myocardial infarction,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0027051:Myocardial Infarction [Disease or Syndrome]
  1000   C0428953:MYOCARDIAL INFARCTION [Finding]
  1000   C2926063:Myocardial infarction [Clinical Attribute]
   861   C0021308:Infarction [Pathologic Function]
   861   C0027061:Myocardial [Tissue]
   861   C1522564:Myocardial [Spatial Concept]
   789 E C0333541:Infarcted [Functional Concept]

Phrase: "and"

Phrase: "obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.187: Future Alzheimer's disease studies may do better to examine polymorphisms in the regulatory regions, rather than the indel. 

Phrase: "Future Alzheimer's disease studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "do"

Phrase: "better to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0332272:Better [Qualitative Concept]
   827 E C0205170:Well [Qualitative Concept]
   827 E C3146287:Well [Manufactured Object]

Phrase: "examine"

Phrase: "polymorphisms in the regulatory regions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0032529:polymorphisms [Genetic Function]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "rather than"

Phrase: "the indel."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1956002:Indel [Genetic Function]
Processing 00000000.tx.188: The overall results were consistent with those of Kehoe et al. 

Phrase: "The overall results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "consistent with those of Kehoe et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.189: (1) from 1999 and also with those of the recent meta-analyses of Kehoe et al. 

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "from 1999"

Phrase: "and"

Phrase: "also with those of the recent meta-analyses of Kehoe et al."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0920317:meta-analyses [Research Activity]
   736   C0332185:Recent [Temporal Concept]
   736   C1042496:Meta [Eukaryote]
   719 E C0282458:Meta-Analysis [Intellectual Product]
   703   C0002778:Analysis [Laboratory Procedure]
   703   C0936012:Analysis [Research Activity]
   703   C1524024:analysis [Functional Concept]
Processing 00000000.tx.190: (11) from 2003 and of Elkins et al. 

Phrase: "(11"

Phrase: ")"

Phrase: "from 2003"

Phrase: "and of Elkins et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.191: (12) from 2004. 

Phrase: "(12"

Phrase: ")"

Phrase: "from 2004."
Processing 00000000.tx.192: The latter report (12) also suggested an age difference, however, although actual ages were not available to them, only mean cohort ages, and they did not take into account the different ways of defining case ages (refer to Materials and Methods), a strongly confounding factor. 

Phrase: "The latter report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "(12"

Phrase: ")"

Phrase: "also"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "an age difference,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0699810:age difference [Age Group]
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "however,"

Phrase: "although"

Phrase: "actual ages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "were"

Phrase: "not available to them,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1548671:Not available [Idea or Concept]
   770   C0470187:Available [Functional Concept]

Phrase: "only mean cohort ages,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "they"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "take into"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515187:Take [Health Care Activity]

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: "the different ways of defining case ages"

Phrase: "("

Phrase: "refer to Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205543:refer [Functional Concept]
   790   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "a strongly"

Phrase: "confounding"

Phrase: "factor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.193: Because of the latter problem, we cannot exclude the possibility that the association might be stronger in younger cases, for example, in those aged less than 65 years at onset or less than 75 years at death. 

Phrase: "Because of the latter problem,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033213:Problem [Finding]

Phrase: "we"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "might"

Phrase: "be"

Phrase: "stronger in younger cases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0442821:Strong [Qualitative Concept]

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "in those aged less"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0001779:Aged [Organism Attribute]
   861   C0001792:Aged [Population Group]
   861   C1999167:aged [Population Group]

Phrase: "than 65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "at onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "or"

Phrase: "less than 75 years"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0439092:Less Than [Intellectual Product]
           less
   770   C0439234:years [Temporal Concept]
   770   C0547044:Less [Qualitative Concept]
   737 E C0439508:/year [Temporal Concept]

Phrase: "at death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]
Processing 00000000.tx.194: Heterogeneity Our overall results showed heterogeneity (table 2). 

Phrase: "Heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "Our overall results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "(table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.195: Heterogeneity may be due to differences in sample selection (e.g., in age, gender, or diagnosis) or in methods (e.g., of genotyping), or it may be due to real differences in populations (e.g., in race) or in interactions with other risk factors (e.g., APOE*4). 

Phrase: "Heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "may"

Phrase: "be due to differences"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0678226:Due to [Functional Concept]
           due
   770   C2987476:Be [Conceptual Entity]
   770   C3146286:Due [Idea or Concept]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "in sample selection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681875:sample selection [Research Activity]
   861   C0036576:selection [Genetic Function]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "in age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "gender,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "or"

Phrase: "diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: ")"

Phrase: "or in methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   756 E C0871511:METHOD [Intellectual Product]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "of genotyping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285573:Genotyping [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "it"

Phrase: "may"

Phrase: "be due to real differences"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0237400:Real [Qualitative Concept]
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]
   760   C3272377:REAL [Intellectual Product]
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "in populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "in race"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034510:Race [Population Group]
  1000   C1706779:RACE [Gene or Genome]

Phrase: ")"

Phrase: "or in interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704675:Interaction [Functional Concept]

Phrase: "with other risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035648:risk factors [Quantitative Concept]
  1000   C1553898:risk factors [Idea or Concept]
   861   C0035647:Risk [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "APOE*4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.196: We examined all of these potential sources of heterogeneity. 

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "all of these potential sources of heterogeneity."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0019409:Heterogeneity [Qualitative Concept]
   748   C0444868:All [Quantitative Concept]
   748   C0449416:sources [Finding]
   748   C3245505:Potential [Qualitative Concept]
   748   C3539085:All [Idea or Concept]
   714 E C1705919:Source [Idea or Concept]
Processing 00000000.tx.197: We found little effect of age, gender, or APOE*4 status, thus confounding our initial hypothesis. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "little effect of age,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "gender,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "or"

Phrase: "APOE*4 status,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449438:Status [Qualitative Concept]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "thus"

Phrase: "confounding"

Phrase: "our initial hypothesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.198: Both diagnostic and genotyping differences contributed some heterogeneity. 

Phrase: "Both diagnostic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011900:Diagnostic [Finding]
  1000   C0348026:Diagnostic [Functional Concept]

Phrase: "and"

Phrase: "genotyping differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "some heterogeneity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]
Processing 00000000.tx.199: The former was mainly due to the diagnosis of "possible Alzheimer's disease," reported to have a poor record of confirmation at autopsy (38). 

Phrase: "The former"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Former [Temporal Concept]
  1000   C0750523:FORMER [Idea or Concept]

Phrase: "was"

Phrase: "mainly due to the diagnosis of ""possible Alzheimer's disease,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C0678226:Due to [Functional Concept]
           due
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   762   C2362652:Possible diagnosis [Qualitative Concept]
           Possible
   742   C0011900:Diagnosis [Finding]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0332149:Possible [Qualitative Concept]
   742   C1704338:diagnosis [Qualitative Concept]
   742   C1704656:DIAGNOSIS [Research Activity]
   742   C1705910:Possible [Qualitative Concept]
   742   C3146286:Due [Idea or Concept]

Phrase: """"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a poor record of confirmation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034869:Record [Intellectual Product]

Phrase: "at autopsy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004398:Autopsy [Diagnostic Procedure]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.200: The latter was largely due to certain genotyping methods that may lead to underreporting of heterozygotes (27, 28), as shown by Hardy-Weinberg analysis. 

Phrase: "The latter"

Phrase: "was"

Phrase: "largely due to certain genotyping methods"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0025663:Methods [Intellectual Product]
   753   C0025664:methods [Intellectual Product]
   753   C0449851:Methods [Functional Concept]
   753   C1285573:Genotyping [Laboratory Procedure]
   753   C3146286:Due [Idea or Concept]
   719 E C0017431:Genotype [Organism Attribute]
   719 E C0871511:METHOD [Intellectual Product]

Phrase: "that"

Phrase: "may"

Phrase: "lead to underreporting of heterozygotes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0019425:Heterozygotes [Organism Attribute]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(27,"

Phrase: "28"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "shown by Hardy-Weinberg analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.201: However, the greatest source of heterogeneity was ethnic differences. 

Phrase: "However,"

Phrase: "the greatest source of heterogeneity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]

Phrase: "was"

Phrase: "ethnic differences."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0682076:ethnic differences [Finding]
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.202: Ethnic stratification removed nearly all heterogeneity (table 3). 

Phrase: "Ethnic stratification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514983:Stratification [Research Activity]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "nearly"

Phrase: "all heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "(table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.203: There were clear contrasts among the three ethnic groups examined (North Europeans, South Caucasians, and East Asians) in allelic frequencies and in odds ratios (table 3). 

Phrase: "There"

Phrase: "were"

Phrase: "clear contrasts among the three ethnic groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1979874:Contrast [Qualitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(North Europeans,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0239307:European [Population Group]
   827   C1535514:European [Population Group]

Phrase: "South Caucasians,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007457:Caucasians [Population Group]
   861   C0043157:Caucasians [Population Group]

Phrase: "and"

Phrase: "East Asians"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0078988:Asians [Population Group]

Phrase: ")"

Phrase: "in allelic frequencies"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   983   C0017270:allelic frequency [Quantitative Concept]
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "and in odds ratios"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0028873:Odds Ratios [Quantitative Concept]
   770   C0456603:Ratios [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C1610540:*Ratios [Quantitative Concept]
   737 E C1547037:Ratio [Intellectual Product]

Phrase: "(table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.204: The latter might be due to differences in linkage disequilibrium with the true risk polymorphism (see above). 

Phrase: "The latter"

Phrase: "might"

Phrase: "be due to differences"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0678226:Due to [Functional Concept]
           due
   770   C2987476:Be [Conceptual Entity]
   770   C3146286:Due [Idea or Concept]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "in linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "with the true risk polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.205: Some of these ethnic differences had previously been pointed out by Panza et al. 

Phrase: "Some of these ethnic differences"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0682076:ethnic differences [Finding]
   760   C0015031:ETHNIC [Population Group]
   760   C0205392:Some [Quantitative Concept]
   760   C0680174:ethnic [Finding]
   760   C3540770:Some [Intellectual Product]
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "had"

Phrase: "previously"

Phrase: "been"

Phrase: "pointed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552961:Point [Quantitative Concept]
   966   C2347617:point [Quantitative Concept]

Phrase: "out by Panza et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.206: (17, 39), by Buss et al. 

Phrase: "(17,"

Phrase: "39"

Phrase: ")"

Phrase: ","

Phrase: "by Buss et al."
Processing 00000000.tx.207: (40), and by Elkins et al. 

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and by Elkins et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.208: (12). 

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.209: These contrasts highlight the dangers of combining ethnic groups within a single cohort, even North and South Europeans, as indicated by Panza et al. 

Phrase: "These contrasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1979874:Contrast [Qualitative Concept]

Phrase: "highlight"

Phrase: "the dangers of combining ethnic groups"

Phrase: "within a single cohort,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599755:Cohort [Population Group]

Phrase: "even North"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709269:North [Spatial Concept]

Phrase: "and"

Phrase: "South Europeans,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0239307:European [Population Group]
   827   C1535514:European [Population Group]

Phrase: "as"

Phrase: "indicated by Panza et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1444656:Indicated [Finding]
Processing 00000000.tx.210: (17, 39). 

Phrase: "(17,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.211: Unfortunately, there was only one cohort of African origin, from the United States (41). 

Phrase: "Unfortunately,"

Phrase: "there"

Phrase: "was"

Phrase: "only one cohort of African origin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0599755:Cohort [Population Group]
   742   C1706962:Birth Cohort [Quantitative Concept]

Phrase: "from the United States"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0041703:United States [Geographic Area]
   861   C1301808:states [Geographic Area]
   827   C0166872:unite [Biomedical or Dental Material]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.212: Thus, no conclusions could be drawn about Africans. 

Phrase: "Thus,"

Phrase: "no conclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: "could"

Phrase: "be"

Phrase: "drawn about Africans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0013113:Draw [Intellectual Product]
   756   C0027567:African [Population Group]
Processing 00000000.tx.213: Heterosis Deviations from Hardy-Weinberg equilibrium are common in studies of the ACE indel, as previously pointed out by Buss et al. 

Phrase: "Heterosis Deviations from Hardy-Weinberg equilibrium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0012727:Deviation [Spatial Concept]
   719   C0205419:Deviation [Qualitative Concept]
   719   C1705236:Deviation [Finding]

Phrase: "are"

Phrase: "common in studies of the ACE indel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0205214:Common [Quantitative Concept]
   739   C1522138:Common [Functional Concept]
   739   C3245511:common [Intellectual Product]

Phrase: "as"

Phrase: "previously"

Phrase: "pointed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552961:Point [Quantitative Concept]
   966   C2347617:point [Quantitative Concept]

Phrase: "out by Buss et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.214: (40). 

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.215: This may be due to either mistyping or heterosis. 

Phrase: "This"

Phrase: "may"

Phrase: "be due to either mistyping"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0678226:Due to [Functional Concept]
           due
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]

Phrase: "or"

Phrase: "heterosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020201:Heterosis [Quantitative Concept]
Processing 00000000.tx.216: Several cases of such disequilibrium were indeed compatible with mistyping. 

Phrase: "Several cases of such disequilibrium"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "indeed compatible with mistyping."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:compatible [Idea or Concept]
   770   C1524057:Compatible [Qualitative Concept]
Processing 00000000.tx.217: Most examples of disequilibrium in North Europeans, however, were of an excess of heterozygotes in Alzheimer's disease, which requires another explanation. 

Phrase: "Most examples of disequilibrium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1707959:Example [Conceptual Entity]

Phrase: "in North Europeans,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0239307:European [Population Group]
   827   C1535514:European [Population Group]

Phrase: "however,"

Phrase: "were of an excess of heterozygotes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0019425:Heterozygotes [Organism Attribute]
   753   C1979886:Excess [Qualitative Concept]

Phrase: "in Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "which"

Phrase: "requires"

Phrase: "another explanation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681841:Explanation [Intellectual Product]
Processing 00000000.tx.218: We believe that explanation is heterosis. 

Phrase: "We"

Phrase: "believe"

Phrase: "that explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "heterosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020201:Heterosis [Quantitative Concept]
Processing 00000000.tx.219: Heterosis occurs when heterozygotes show either a greater or lesser association with a given trait than does either group of homozygotes. 

Phrase: "Heterosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020201:Heterosis [Quantitative Concept]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "when"

Phrase: "heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "either"

Phrase: "a greater"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0443228:greater [Quantitative Concept]
  1000   C1704243:Greater [Quantitative Concept]
   966 E C0549177:Great [Quantitative Concept]

Phrase: "or"

Phrase: "lesser association with a given trait"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "than"

Phrase: "does"

Phrase: "either group of homozygotes."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
Processing 00000000.tx.220: In this case, in North Europeans, both an excess of heterozygotes in Alzheimer's disease and an association of heterozygotes with Alzheimer's disease were found. 

Phrase: "In this case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "in North Europeans,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0239307:European [Population Group]
   827   C1535514:European [Population Group]

Phrase: "both"

Phrase: "an excess of heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1979886:Excess [Qualitative Concept]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "an association of heterozygotes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "were"

Phrase: "found."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]
Processing 00000000.tx.221: Comings and MacMurray (42) have suggested three explanations for heterosis, of which their second can be applied here. 

Phrase: "Comings"

Phrase: "and"

Phrase: "MacMurray"

Phrase: "(42"

Phrase: ")"

Phrase: "have"

Phrase: "suggested three explanations for heterosis, of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0681841:Explanations [Intellectual Product]

Phrase: "their second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "can"

Phrase: "be"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "here."
Processing 00000000.tx.222: This proposes that heterosis may follow from the inadvertent combination of two unlike subsets due to a hidden interaction with another, unknown risk factor. 

Phrase: "This"

Phrase: "proposes"

Phrase: "that heterosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020201:Heterosis [Quantitative Concept]

Phrase: "may"

Phrase: "follow from the inadvertent combination of two"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205195:Combination [Qualitative Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C0332283:follow [Temporal Concept]
   748   C1719822:Follow [Intellectual Product]
   748   C1947911:Combination [Physical Object]

Phrase: "unlike subsets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515021:Subset [Classification]

Phrase: "due to a hidden interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]

Phrase: "with another,"

Phrase: "unknown risk factor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0035648:Risk factor [Quantitative Concept]
   827   C0035647:Risk [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.223: To test this proposal, we constructed a mathematical model with two equal subsets based on a median split of an unknown factor X (table 4). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this proposal,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1555306:proposal [Idea or Concept]
  1000   C1948033:Proposal [Intellectual Product]

Phrase: "we"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "a mathematical model with two equal subsets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0876936:Mathematical Model [Intellectual Product]
   748   C0024934:Mathematical [Occupation or Discipline]
   748   C3161035:Model [Intellectual Product]

Phrase: "based on a median split of an unknown factor X (table 4"
Meta Candidates (Total=22; Excluded=4; Pruned=0; Remaining=18)
   753   C0015518:Factor X [Amino Acid, Peptide, or Protein,Enzyme]
   753   C3274394:Factor X [Laboratory Procedure]
   751 E C0616407:X-Factor [Organic Chemical]
   751   C0960756:factor A [Organic Chemical]
   736   C0039224:Table [Manufactured Object]
   736   C0439673:Unknown [Qualitative Concept]
   736   C0549183:Median [Spatial Concept]
   736   C0876920:Median [Quantitative Concept]
   736   C1521761:Factor [Functional Concept]
   736   C1527178:Based [Functional Concept]
   736   C1534709:Split [Functional Concept]
   736   C1705938:Based [Idea or Concept]
   736   C1706073:Table [Medical Device]
   736   C1706074:Table [Intellectual Product]
   736   C1881714:SPLIT [Phenomenon or Process]
   736   C2347635:Median [Quantitative Concept]
   736   C2348144:Median [Quantitative Concept]
   736   C2827422:Factor [Conceptual Entity]
   736   C2939193:Median [Spatial Concept]
   703 E C0002055:base [Inorganic Chemical]
   703 E C0178499:Base [Chemical Viewed Functionally]
   703 E C1880279:Base [Biomedical or Dental Material]

Phrase: ")."
Processing 00000000.tx.224: The model illustrates how, although heterozygotes may have intermediate odds ratios in each subset, they can emerge with the highest odds ratio when the subsets are combined (i.e., heterosis). 

Phrase: "The model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "illustrates"

Phrase: "how,"

Phrase: "although"

Phrase: "heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]

Phrase: "may"

Phrase: "have"

Phrase: "intermediate odds ratios in each subset,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratios [Quantitative Concept]
   753   C0456603:Ratios [Quantitative Concept]
   753   C1610540:*Ratios [Quantitative Concept]
   719 E C1547037:Ratio [Intellectual Product]

Phrase: "they"

Phrase: "can"

Phrase: "emerge with the highest odds ratio"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1522410:Highest [Qualitative Concept]
   753   C1547037:Ratio [Intellectual Product]
   719 E C0205250:High [Qualitative Concept]
   719 E C1299351:High [Qualitative Concept]
   719 E C2700149:HIGH [Intellectual Product]

Phrase: "when"

Phrase: "the subsets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515021:Subset [Classification]

Phrase: "are"

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "(i.e., heterosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020201:Heterosis [Quantitative Concept]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: ")."
Processing 00000000.tx.225: The overall results of this illustrative model (table 4) were very close to those of the present meta-analysis (table 2). 

Phrase: "The overall results of this illustrative model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "(table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "very"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442824:Very [Qualitative Concept]

Phrase: "close to those of the present meta-analysis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0282458:Meta-Analysis [Intellectual Product]
   770   C0920317:Meta-Analysis [Research Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]
   744   C0587267:Close [Functional Concept]
   744   C0936012:Analysis [Research Activity]
   744   C1042496:Meta [Eukaryote]
   744   C1524024:analysis [Functional Concept]

Phrase: "(table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.226: We should stress, however, that heterosis was found only in North Europeans. 

Phrase: "We"

Phrase: "should"

Phrase: "stress,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0038435:Stress [Finding]
   928 E C0231297:Stressful [Functional Concept]

Phrase: "however,"

Phrase: "that heterosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020201:Heterosis [Quantitative Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "only in North Europeans."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205171:Only [Quantitative Concept]
   770   C1709269:North [Spatial Concept]
   770   C1720467:Only [Intellectual Product]
   737   C0239307:European [Population Group]
   737   C1535514:European [Population Group]
Processing 00000000.tx.227: Moreover, although heterozygotes were at greater risk than D homozygotes (odds ratio = 1.25, 95 percent confidence interval: 1.08, 1.45), they were not at significantly higher risk than I homozygotes (odds ratio = 1.08, 95 percent confidence interval: 0.95, 1.22). 

Phrase: "Moreover,"

Phrase: "although"

Phrase: "heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]

Phrase: "were at greater risk"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0035647:Risk [Qualitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "than D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "(odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 1.25,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95 percent confidence interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "1.08,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1.45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "they"

Phrase: "were"

Phrase: "not at significantly higher risk"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   773   C0332167:High Risk [Qualitative Concept]
   773   C3272283:High Risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
   760   C1518422:Not [Functional Concept]
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "than I homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "(odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 1.08,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95 percent confidence interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.95,"

Phrase: "1.22"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.228: Thus, partial heterosis better describes this case. 

Phrase: "Thus,"

Phrase: "partial heterosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020201:Heterosis [Quantitative Concept]

Phrase: "better"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332272:Better [Qualitative Concept]

Phrase: "describes"

Phrase: "this case."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.229: View this table: [in this window] [in a new window]  TABLE 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.230: Model to show how heterosis may follow from the combination of two unlike subsets  A hidden interaction Partial heterosis in North Europeans suggests an interaction with another risk factor for Alzheimer's disease, another potential source of heterogeneity. 

Phrase: "Model to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "how heterosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020201:Heterosis [Quantitative Concept]

Phrase: "may"

Phrase: "follow from the combination of two"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205195:Combination [Qualitative Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C0332283:follow [Temporal Concept]
   753   C1719822:Follow [Intellectual Product]
   753   C1947911:Combination [Physical Object]

Phrase: "unlike subsets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515021:Subset [Classification]

Phrase: "A hidden interaction Partial heterosis in North Europeans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0020201:Heterosis [Quantitative Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an interaction with another risk factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "for Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "another potential source of heterogeneity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]
Processing 00000000.tx.231: Candidates include cardiovascular risk factors, since many also contribute to Alzheimer's disease risk and since the ACE indel has been associated with cardiovascular risk (4347). 

Phrase: "Candidates"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "cardiovascular risk factors,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0850624:cardiovascular risk factor [Disease or Syndrome]
   901   C0035648:risk factors [Quantitative Concept]
   901   C1553898:risk factors [Idea or Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "since"

Phrase: "many also"

Phrase: "contribute to Alzheimer's disease risk"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1281905:disease risk [Finding]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0035647:Risk [Qualitative Concept]
   760   C1880177:Contribute [Activity]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "since"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711239:Since [Temporal Concept]

Phrase: "the ACE indel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1956002:Indel [Genetic Function]
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "associated with cardiovascular risk"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0007226:Cardiovascular [Body System]
   770   C0035647:Risk [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(4347"

Phrase: ")."
Processing 00000000.tx.232: Biologic background Full discussion of the biologic basis of these associations is outside the scope of this mainly analytical study. 

Phrase: "Biologic background Full discussion of the biologic basis of these associations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0557061:Discussion [Therapeutic or Preventive Procedure]
   738   C2584313:Discussion [Social Behavior]

Phrase: "is"

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "the scope of this mainly analytical study."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710028:Scope [Conceptual Entity]
Processing 00000000.tx.233: However, we note the associations of the ACE indel and of nearby polymorphisms with various phenotypes, including cardiovascular risk (37, 4347). 

Phrase: "However,"

Phrase: "we"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the associations of the ACE indel"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0004083:Associations [Mental Process]
   708 E C0439849:Association [Qualitative Concept]
   708 E C0596306:Association [Phenomenon or Process]
   708 E C0699792:association [Social Behavior]

Phrase: "and of nearby polymorphisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0032529:polymorphisms [Genetic Function]
   770   C1515981:And [Idea or Concept]
   737 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "with various phenotypes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cardiovascular risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007226:Cardiovascular [Body System]
   861   C0035647:Risk [Qualitative Concept]

Phrase: "(37,"

Phrase: "4347"

Phrase: ")."
Processing 00000000.tx.234: In addition, ACE protein levels are raised in certain brain regions with Alzheimer's disease (4850), the enzyme has been reported to modify -amyloid aggregation (51), ACE inhibitors have been reported to maintain memory in aged rats (52) and in human patients (53), and brain-penetrating ACE inhibitors have been associated with both reduced incidence of Alzheimer's disease in elderly hypertensive patients (54) and less cognitive decline in cases with mild-to-moderate Alzheimer's disease (55). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "ACE protein levels"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   876   C0441925:i levels [Intellectual Product]
   858   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   839   C0014440:enzyme levels [Laboratory Procedure]
   839   C1287349:enzyme levels [Laboratory or Test Result]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0441889:Levels [Qualitative Concept]
   793   C0428479:Protein level [Laboratory or Test Result]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   734   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   734   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "are"

Phrase: "raised in certain brain regions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1273723:brain regions [Body Location or Region]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0442818:Raised [Quantitative Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "with Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(4850"

Phrase: ")"

Phrase: ","

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "modify -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "amyloid aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "(51"

Phrase: ")"

Phrase: ","

Phrase: "ACE inhibitors"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
  1000   C0003015:Angiotensin I-Converting Enzyme Inhibitors [Pharmacologic Substance]
           Angiotensin-Converting Enzyme Inhibitors
   937   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   937   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   933   C2757044:Angiotensin-converting Enzyme Inhibitors [Molecular Function]
   922 E C3536837:Angiotensin Converting Enzyme Inhibitor [Pharmacologic Substance]
   840   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C0014432:Enzyme Inhibitors [Pharmacologic Substance]
   840   C1152555:enzyme inhibitors [Molecular Function]
   840   C2756995:Enzyme Inhibitors [Molecular Function]
   806 E C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   804   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0243077:inhibitors [Chemical Viewed Functionally]
   771 E C1999216:Inhibitor [Qualitative Concept]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "memory in aged rats"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0025260:Memory [Mental Process]
   770   C0700327:memory [Finding]
   770   C1706377:Memory [Manufactured Object]
   715 E C0679055:mnemonic [Mental Process]

Phrase: "(52"

Phrase: ")"

Phrase: "and in human patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0086418:Human [Human]
   770   C1515981:And [Idea or Concept]

Phrase: "(53"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "brain-penetrating ACE inhibitors"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   913   C0003015:Angiotensin I-Converting Enzyme Inhibitors [Pharmacologic Substance]
           Angiotensin-Converting Enzyme Inhibitors
   879   C2757044:Angiotensin-converting Enzyme Inhibitors [Molecular Function]
   877   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   877   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   868 E C3536837:Angiotensin Converting Enzyme Inhibitor [Pharmacologic Substance]
   818   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   818   C0014432:Enzyme Inhibitors [Pharmacologic Substance]
   818   C1152555:enzyme inhibitors [Molecular Function]
   818   C2756995:Enzyme Inhibitors [Molecular Function]
   795   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   795   C0014442:Enzyme [Enzyme,Organic Chemical]
   795   C0021966:I- [Inorganic Chemical]
   795   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0243077:inhibitors [Chemical Viewed Functionally]
   785 E C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   762 E C1999216:Inhibitor [Qualitative Concept]
   712 E C0014445:enzymes [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "associated with both reduced incidence of Alzheimer's disease"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   767   C0243083:associated disease [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0021149:Incidence [Quantitative Concept]
   744   C0220856:incidence [Functional Concept]
   744   C0392756:Reduced [Qualitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in elderly hypertensive patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "(54"

Phrase: ")"

Phrase: "and"

Phrase: "less cognitive decline in cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "with mild-to-moderate Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   804   C0012634:Disease [Disease or Syndrome]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   717   C1299392:Mild to moderate [Qualitative Concept]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.235: Sleegers et al. 

Phrase: "Sleegers et al."
Processing 00000000.tx.236: (9) have recently provided evidence from magnetic resonance imaging of increased atrophy in both the hippocampus and amygdala of nondemented women homozygous for the ACE*I allele, together with a modest but significant increase in risk of Alzheimer's disease, independent of vascular factors. 

Phrase: "(9"

Phrase: ")"

Phrase: "have"

Phrase: "recently provided evidence from magnetic resonance imaging of increased atrophy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in both"

Phrase: "the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "amygdala of nondemented women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0002708:Amygdala [Body Part, Organ, or Organ Component]

Phrase: "homozygous for the ACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0019904:Homozygous [Organism Attribute]

Phrase: "*I allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "together with a modest"

Phrase: "but"

Phrase: "significant increase in risk of Alzheimer's disease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "independent of vascular factors."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.237: The D allele is associated with raised plasma levels of ACE (2), but that association is thought to be due to linkage disequilibrium with other nearby polymorphisms (3, 36). 

Phrase: "The D allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "associated with raised plasma levels of ACE"
Meta Candidates (Total=22; Excluded=5; Pruned=0; Remaining=17)
   806   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   806   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   760   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0332281:Associated with [Qualitative Concept]
           Associated
   757   C0014440:enzyme levels [Laboratory Procedure]
   757   C0441925:i levels [Intellectual Product]
   757   C1287349:enzyme levels [Laboratory or Test Result]
   739   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0014442:Enzyme [Enzyme,Organic Chemical]
   739   C0021966:I- [Inorganic Chemical]
   739   C0032105:Plasma [Body Substance]
   739   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0441889:Levels [Qualitative Concept]
   739   C0442818:Raised [Quantitative Concept]
   739   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   706 E C0456079:Level [Classification]
   706 E C0750490:Associate [Idea or Concept]
   706 E C1547707:Level [Geographic Area]
   706 E C1706221:Associate [Professional or Occupational Group]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "that association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be due to linkage disequilibrium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   806   C0678226:Due to [Functional Concept]
           due
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]

Phrase: "with other nearby polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.238: There is an apparent conflict between the benefits of ACE inhibitor therapy and the associations of the indel with Alzheimer's disease risk and pathology and with plasma levels of ACE. 

Phrase: "There"

Phrase: "is"

Phrase: "an apparent conflict between the benefits of ACE inhibitor therapy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0009671:Conflict [Individual Behavior]
   735   C1705242:Conflict [Qualitative Concept]

Phrase: "and"

Phrase: "the associations of the indel"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0004083:Associations [Mental Process]
   726 E C0439849:Association [Qualitative Concept]
   726 E C0596306:Association [Phenomenon or Process]
   726 E C0699792:association [Social Behavior]

Phrase: "with Alzheimer's disease risk"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1281905:disease risk [Finding]
   827   C0035647:Risk [Qualitative Concept]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "and"

Phrase: "pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "and with plasma levels of ACE."
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   818   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   818   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   764   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   762   C0014440:enzyme levels [Laboratory Procedure]
   762   C0441925:i levels [Intellectual Product]
   762   C1287349:enzyme levels [Laboratory or Test Result]
   742   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0021966:I- [Inorganic Chemical]
   742   C0032105:Plasma [Body Substance]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441889:Levels [Qualitative Concept]
   742   C1515981:And [Idea or Concept]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.239: However, the influence of ACE polymorphisms on brain levels of the enzyme is not yet known and cannot be assumed to reflect the levels in plasma. 

Phrase: "However,"

Phrase: "the influence of ACE polymorphisms"

Phrase: "on brain levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0441889:Levels [Qualitative Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "and"

Phrase: "cannot"

Phrase: "be"

Phrase: "assumed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242379:Assumed [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the levels in plasma."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.240: This subject warrants fuller discussion than is possible here. 

Phrase: "This subject warrants fuller discussion than"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557061:Discussion [Therapeutic or Preventive Procedure]
   753   C2584313:Discussion [Social Behavior]

Phrase: "is"

Phrase: "possible here."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.241: A more detailed discussion is given by Kehoe (56), although it will need to be reconsidered and perhaps revised in the light of any interacting factor or factors that may emerge in future studies. 

Phrase: "A more detailed discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "is"

Phrase: "given by Kehoe"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1442162:GIVEN [Conceptual Entity]
   790   C1550718:given [Idea or Concept]
   790   C3244317:given [Intellectual Product]
   756 E C1947971:Give [Functional Concept]

Phrase: "(56"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "it"

Phrase: "will"

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "reconsidered"

Phrase: "and"

Phrase: "perhaps"

Phrase: "revised in the light of any interacting factor"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   744   C0023693:Light [Natural Phenomenon or Process]
   744   C1306462:Light [Functional Concept]
   744   C1521761:Factor [Functional Concept]
   744   C1527075:Revised [Therapeutic or Preventive Procedure]
   744   C1881376:Light [Qualitative Concept]
   744   C2827422:Factor [Conceptual Entity]
   711 E C3244319:revise [Functional Concept]

Phrase: "or"

Phrase: "factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "may"

Phrase: "emerge in future studies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0016884:Future [Temporal Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.242: Limitations of this meta-analysis The lack of information from some authors was a limitation, but we obtained full data on 84 percent of subjects. 

Phrase: "Limitations of this meta-analysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449295:limitations [Functional Concept]

Phrase: "The lack of information"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "from some authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "was"

Phrase: "a limitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449295:Limitation [Functional Concept]

Phrase: "but"

Phrase: "we"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "full data on 84 percent of subjects."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]
Processing 00000000.tx.243: The quality of diagnosis and of genotyping varied among studies, but our overall results were not changed when these questions were taken into account. 

Phrase: "The quality of diagnosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0920456:diagnosis quality [Qualitative Concept]
   770   C0332306:Quality [Qualitative Concept]

Phrase: "and of genotyping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1285573:Genotyping [Laboratory Procedure]
   790   C1515981:And [Idea or Concept]

Phrase: "varied among studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "but"

Phrase: "our overall results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "when"

Phrase: "these questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1522634:Question [Intellectual Product]

Phrase: "were"

Phrase: "taken into account."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1551359:account [Idea or Concept]
   790   C1883727:Taken [Conceptual Entity]
   790   C2741673:Account # [Clinical Attribute]
   790   C2981730:Account [Classification]
   756 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.244: There was considerable heterogeneity in our initial results. 

Phrase: "There"

Phrase: "was"

Phrase: "considerable heterogeneity in our initial results."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0019409:Heterogeneity [Qualitative Concept]
Processing 00000000.tx.245: However, we found the main sources of that heterogeneity and were able to remove it. 

Phrase: "However,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "the main sources of"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0449416:sources [Finding]
   737 E C1705919:Source [Idea or Concept]

Phrase: "that heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "and"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "it."
Processing 00000000.tx.246: Since cardiovascular factors are strong candidates for a potential interaction with ACE variants, the lack of data available to us on those factors was a limitation, which we hope will be overcome by future studies. 

Phrase: "Since"

Phrase: "cardiovascular factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "strong candidates for a potential interaction"

Phrase: "with ACE variants,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205419:variants [Qualitative Concept]
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "the lack of data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "available to us"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: "on those factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "was"

Phrase: "a limitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449295:Limitation [Functional Concept]

Phrase: "which"

Phrase: "we"

Phrase: "hope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392347:Hope [Mental Process]

Phrase: "will"

Phrase: "be"

Phrase: "overcome by future studies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2983310:Overcome [Activity]
Processing 00000000.tx.247: Cardiovascular factors might also have influenced our results through selective mortality. 

Phrase: "Cardiovascular factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "might"

Phrase: "also"

Phrase: "have"

Phrase: "influenced"

Phrase: "our results through selective mortality."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]
Processing 00000000.tx.248: However, D homozygotes have only a very slightly increased risk of cardiovascular complications (4347, 57) and little evidence of any association with reduced life span (5762). 

Phrase: "However,"

Phrase: "D homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "have"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a very slightly increased risk of cardiovascular complications"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0035647:Risk [Qualitative Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]

Phrase: "(4347,"

Phrase: "57"

Phrase: ")"

Phrase: "and"

Phrase: "little evidence of any association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with reduced life span"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0870809:life span [Group Attribute]
   827   C0376558:Life [Idea or Concept]
   827   C1711300:Span [Conceptual Entity]
   827   C2700613:Span [Quantitative Concept]
   743 E C0595998:lives [Finding]

Phrase: "(5762"

Phrase: ")."
Processing 00000000.tx.249: Thus, the influence of selective mortality, if any, is likely to be very small and not enough to provide an alternative explanation for our findings. 

Phrase: "Thus,"

Phrase: "the influence of selective mortality,"

Phrase: "if"

Phrase: "any,"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "very small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0700321:Small [Quantitative Concept]

Phrase: "and"

Phrase: "not enough to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an alternative explanation for our findings."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanation [Intellectual Product]
Processing 00000000.tx.250: Conclusions We suggest that this large study has established the ACE indel as a marker of Alzheimer's disease risk, since we found no evidence of bias, we found and removed the main sources of heterogeneity, we excluded various potential interactions, and significant results remained in each of the three ethnic groups examined. 

Phrase: "Conclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: "We"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this large study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "the ACE indel as a marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1956002:Indel [Genetic Function]

Phrase: "of Alzheimer's disease risk,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1281905:disease risk [Finding]
   827   C0035647:Risk [Qualitative Concept]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "since"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no evidence of bias,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "the main sources of heterogeneity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449416:sources [Finding]
   726 E C1705919:Source [Idea or Concept]

Phrase: "we"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "various potential interactions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "significant results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "remained in each of the three ethnic groups"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   770   C0015031:Ethnic Groups [Population Group]
           ETHNIC
   744   C0205449:Three [Quantitative Concept]
   744   C0441833:Group [Idea or Concept]
   744   C0680174:ethnic [Finding]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1552516:Group [Health Care Related Organization]
   744   C1552839:groups [Idea or Concept]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]
   737 E C1879937:Ethnic Group [Intellectual Product]

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.251: The indel, however, is probably in linkage disequilibrium with the true risk polymorphism (11). 

Phrase: "The indel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1956002:Indel [Genetic Function]

Phrase: "however,"

Phrase: "is"

Phrase: "probably in linkage disequilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]
   770   C0750492:Probably [Idea or Concept]

Phrase: "with the true risk polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.252: There were marked contrasts among the three ethnic groups studied (table 3). 

Phrase: "There"

Phrase: "were"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "contrasts among the three ethnic groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1979874:Contrast [Qualitative Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "(table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.253: We also found evidence of an interaction with another risk factor in North Europeans. 

Phrase: "We also found evidence of an interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with another risk factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035648:Risk factor [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "in North Europeans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0239307:European [Population Group]
   827   C1535514:European [Population Group]
Processing 00000000.tx.254: Potential interactions with other factors than age, gender, and APOE*4 status should be examined, particularly interactions with cardiovascular risk factors.  

Phrase: "Potential interactions with other factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "than age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "gender,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "and"

Phrase: "APOE*4 status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449438:Status [Qualitative Concept]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "should"

Phrase: "be"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ","

Phrase: "particularly interactions with cardiovascular risk factors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.255: ACKNOWLEDGMENTS  Financial support was received from Bristol Myers Squibb, Phytopharm plc, the Medical Research Council, the Norman Collisson Foundation, and the Takayama Foundation. 

Phrase: "ACKNOWLEDGMENTS  Financial support"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0016118:Financial Support [Idea or Concept]
   827   C0183683:Support [Medical Device]
   827   C0376243:financial [Quantitative Concept]
   827   C1521721:Support [Conceptual Entity]
   827   C2350008:Financial [Qualitative Concept]

Phrase: "was"

Phrase: "received from Bristol Myers Squibb,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0331797:Bristol-Myers [Health Care Related Organization]
   760   C0331904:Squibb [Health Care Related Organization]
   760   C1514756:Received [Qualitative Concept]

Phrase: "Phytopharm plc,"

Phrase: "the Medical Research Council,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0079816:Medical Research [Research Activity]
   901   C1556038:Medical Research [Professional or Occupational Group]
   827   C0035168:research [Research Activity]
   827   C0205476:Medical [Functional Concept]
   827   C0242481:Research [Research Activity]
   827   C1551807:Council [Population Group]

Phrase: "the Norman Collisson Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "the Takayama Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.256: Dr. 

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.257: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.258: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.259: Kehoe is supported by a Gestetner Foundation Fellowship. 

Phrase: "Kehoe"

Phrase: "is"

Phrase: "supported by a Gestetner Foundation Fellowship."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0015770:Fellowship [Educational Activity]
   753   C0016617:Foundation [Organization]
   753   C1521721:Supported [Conceptual Entity]
   719 E C0183683:Support [Medical Device]
Processing 00000000.tx.260: The authors thank all those groups who have undertaken ACE/Alzheimer's disease association studies, thereby providing the data for these analyses. 

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "all those groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "who"

Phrase: "have"

Phrase: "undertaken ACE/Alzheimer's disease association studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   791   C0947630:studies [Laboratory Procedure]
   758 E C0557651:Study [Manufactured Object]
   758 E C2603343:Study [Research Activity]

Phrase: "thereby"

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "the data for these analyses."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0010992:Data Analyses [Occupational Activity]
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]
Processing 00000000.tx.261: They especially thank those authors who generously responded to requests for primary data: Dr. 

Phrase: "They especially"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "those authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "who generously"

Phrase: "responded to requests"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0686900:requests [Functional Concept]
   756 E C1272683:Request [Functional Concept]
   756 E C1522634:Request [Intellectual Product]

Phrase: "for primary data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2827398:Primary Data [Idea or Concept]
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ":"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.262: V. 

Phrase: "V."
Processing 00000000.tx.263: Alvarez, Dr. 

Phrase: "Alvarez,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.264: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.265: Arboleda, Dr. 

Phrase: "Arboleda,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.266: A. 

Phrase: "A."
Processing 00000000.tx.267: Capurso, Dr. 

Phrase: "Capurso,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.268: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.269: Cook, Dr. 

Phrase: "Cook,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335326:Cook [Daily or Recreational Activity]
  1000   C1306756:Cook [Professional or Occupational Group]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.270: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.271: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.272: Esiri, Dr. 

Phrase: "Esiri,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.273: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.274: Fellin, Dr. 

Phrase: "Fellin,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.275: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.276: Fernndez-Novoa, Dr. 

Phrase: "Fernndez-Novoa,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.277: U. 

Phrase: "U."
Processing 00000000.tx.278: Finkh, Dr. 

Phrase: "Finkh,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.279: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.280: C. 

Phrase: "C."
Processing 00000000.tx.281: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.282: Go, Dr. 

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.283: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.284: Gurling, Dr. 

Phrase: "Gurling,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.285: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.286: Helbecque, Dr. 

Phrase: "Helbecque,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.287: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.288: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.289: Keikhaee, Dr. 

Phrase: "Keikhaee,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.290: C. 

Phrase: "C."
Processing 00000000.tx.291: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.292: Lendon, Dr. 

Phrase: "Lendon,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.293: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.294: Lovestone, Dr. 

Phrase: "Lovestone,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.295: D. 

Phrase: "D."
Processing 00000000.tx.296: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.297: Mann, Dr. 

Phrase: "Mann,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.298: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.299: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.300: Mattila, Dr. 

Phrase: "Mattila,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.301: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.302: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.303: McIlroy, Dr. 

Phrase: "McIlroy,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.304: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.305: Myllykangas, Dr. 

Phrase: "Myllykangas,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.306: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.307: Panza, Dr. 

Phrase: "Panza,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.308: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.309: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.310: Perry, Dr. 

Phrase: "Perry,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.311: D. 

Phrase: "D."
Processing 00000000.tx.312: C. 

Phrase: "C."
Processing 00000000.tx.313: Rubinsztein, Dr. 

Phrase: "Rubinsztein,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.314: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.315: Scacchi, Dr. 

Phrase: "Scacchi,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.316: D. 

Phrase: "D."
Processing 00000000.tx.317: Seripa, Dr. 

Phrase: "Seripa,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.318: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.319: Weiner, Dr. 

Phrase: "Weiner,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.320: C. 

Phrase: "C."
Processing 00000000.tx.321: Wu, and Dr. 

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.322: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.323: Zuliani. 

Phrase: "Zuliani."
Processing 00000000.tx.324: The authors are particularly grateful to Dr. 

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "are"

Phrase: "particularly grateful to Dr."
Processing 00000000.tx.325: U. 

Phrase: "U."
Processing 00000000.tx.326: Finkh and colleagues for highlighting the issue of Hardy-Weinberg disequilibrium in ACE studies (40) and to them and to Dr. 

Phrase: "Finkh"

Phrase: "and"

Phrase: "colleagues for highlighting"

Phrase: "the issue of Hardy-Weinberg disequilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033213:Issue [Finding]
   753   C1706387:Issue [Intellectual Product]

Phrase: "in ACE studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0947630:studies [Laboratory Procedure]
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771 E C0557651:Study [Manufactured Object]
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   771 E C2603343:Study [Research Activity]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and to them"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "and to Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1515981:And [Idea or Concept]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.327: A. 

Phrase: "A."
Processing 00000000.tx.328: Capurso and colleagues (17, 39) for pointing out the ethnic differences in ACE indel frequencies. 

Phrase: "Capurso"

Phrase: "and"

Phrase: "colleagues"

Phrase: "(17,"

Phrase: "39"

Phrase: ")"

Phrase: "for pointing out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "the ethnic differences in ACE indel frequencies."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0682076:ethnic differences [Finding]
   706   C1705241:*Difference [Quantitative Concept]
   706   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.329: The authors also warmly thank Dr. 

Phrase: "The authors also warmly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0221193:Authors [Professional or Occupational Group]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.330: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.331: Pembrey for advice on genetics, Dr. 

Phrase: "Pembrey for advice"

Phrase: "on genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.332: J. 

Phrase: "J."
Processing 00000000.tx.333: Marchini for advice on statistics, C. 

Phrase: "Marchini for advice"

Phrase: "on statistics,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]

Phrase: "C."
Processing 00000000.tx.334: A. 

Phrase: "A."
Processing 00000000.tx.335: Aldridge for administrative support, M. 

Phrase: "Aldridge for administrative support,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.336: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.337: Lehmann for help with mathematical calculations, and Dr. 

Phrase: "Lehmann for"

Phrase: "help with mathematical calculations,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0018896:Help [Social Behavior]
   770   C0024934:Mathematical [Occupation or Discipline]
   770   C1552861:help [Idea or Concept]
   737   C1441506:Calculation [Activity]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.338: J. 

Phrase: "J."
Processing 00000000.tx.339: Wu for Chinese translations. 

Phrase: "Wu for Chinese translations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.340: Conflict of interest: none declared. 

Phrase: "Conflict of interest"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0079152:Conflict of Interest [Idea or Concept]
   827   C0009671:Conflict [Individual Behavior]
   827   C0543488:Interest [Mental Process]
   827   C1705242:Conflict [Qualitative Concept]

Phrase: ":"

Phrase: "none"

Phrase: "declared."
Processing 00000000.tx.341: Note added in proof: Two further association studies have been published since submission of this article: Klsch et al. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "added in proof"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0556981:% proof [Quantitative Concept]
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: ":"

Phrase: "Two further association studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "been"

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "since"

Phrase: "submission of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515022:Submission [Functional Concept]
   770   C1515023:Submission [Functional Concept]

Phrase: ":"

Phrase: "Klsch et al."
Processing 00000000.tx.342: (Neurosci Lett 2005;377:379) and Zhang et al. 

Phrase: "(Neurosci Lett 2005"

Phrase: ";377"

Phrase: ":"

Phrase: "379"

Phrase: ")"

Phrase: "and"

Phrase: "Zhang et al."
Processing 00000000.tx.343: (Dement Geriatr Cogn Disord 2005;20:526).  

Phrase: "(Dement Geriatr Cogn Disord 2005"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0860630:dement [Mental or Behavioral Dysfunction]
   704 E C0011265:dementia [Mental or Behavioral Dysfunction]
   704 E C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ";20"

Phrase: ":"

Phrase: "526"

Phrase: ")."
Processing 00000000.tx.344: References TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION References  Kehoe PG, Russ C, McIlroy S, et al. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Kehoe PG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]

Phrase: "Russ C,"

Phrase: "McIlroy S,"

Phrase: "et al."
Processing 00000000.tx.345: Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. 

Phrase: "Variation in DCP1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variation [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "ACE,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "associated with susceptibility"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0012655:Susceptibility [Clinical Attribute]
   790   C0220898:Susceptibility [Organism Attribute]
   790   C1264642:Susceptibility [Functional Concept]
   790   C1547045:*Susceptibility [Quantitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C0231204:Susceptible [Functional Concept]
   718 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.346: Nat Genet 1999;21:712.[CrossRef][ISI][Medline] Rigat B, Hubert C, Alhenc-Gelas F, et al. 

Phrase: "Nat Genet 1999"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ";21"

Phrase: ":"

Phrase: "712."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rigat B,"

Phrase: "Hubert C,"

Phrase: "Alhenc-Gelas F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.347: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. 

Phrase: "An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   751   C0017260:Gene Deletion [Genetic Function]
   751   C0678951:gene polymorphism [Genetic Function]
   751   C1442161:Gene Deletion [Cell or Molecular Dysfunction]
           Deletion
   751   C1955829:Gene Insertion [Cell or Molecular Dysfunction]
   736   C0021107:Insertion [Therapeutic or Preventive Procedure]
   736   C0032529:Polymorphism [Genetic Function]
   736   C0441587:Insertion [Health Care Activity]
   736   C1511760:Deletion [Genetic Function]
   736   C1512796:Insertion [Genetic Function]
   736   C1880274:Deletion [Activity]
   736   C1882417:Polymorphism [Qualitative Concept]
   736   C1883719:Insertion [Functional Concept]

Phrase: "for half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825407:Half [Quantitative Concept]

Phrase: "the variance of serum enzyme levels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1711260:Variance [Qualitative Concept]
   753   C2348152:Variance [Quantitative Concept]
Processing 00000000.tx.348: J Clin Invest 1990;86:13436.[ISI][Medline] Tiret L, Rigat B, Visvikis S, et al. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "1990"

Phrase: ";86"

Phrase: ":"

Phrase: "13436."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tiret L,"

Phrase: "Rigat B,"

Phrase: "Visvikis S,"

Phrase: "et al."
Processing 00000000.tx.349: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. 

Phrase: "Evidence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "from combined segregation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0080141:segregation [Social Behavior]

Phrase: "and"

Phrase: "linkage analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0796345:linkage analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0023745:linkage [Molecular Function]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "that"

Phrase: "a variant of the angiotensin I-converting enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:Variant [Qualitative Concept]

Phrase: "(ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ")"

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "plasma ACE levels."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   858   C0441925:i levels [Intellectual Product]
   827   C0014440:enzyme levels [Laboratory Procedure]
   827   C1287349:enzyme levels [Laboratory or Test Result]
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   734   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   734   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
Processing 00000000.tx.350: Am J Hum Genet 1992;51:197205.[ISI][Medline] Nacmias B, Tedde A, Forleo P, et al. 

Phrase: "Am"

Phrase: "J Hum Genet 1992"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ";51"

Phrase: ":"

Phrase: "197205."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nacmias B,"

Phrase: "Tedde A,"

Phrase: "Forleo P,"

Phrase: "et al."
Processing 00000000.tx.351: Angiotensin converting enzyme polymorphism in sporadic and presenilin-linked Alzheimer's disease families. 

Phrase: "Angiotensin converting enzyme polymorphism in sporadic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032529:Polymorphism [Genetic Function]
   753   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "presenilin-linked Alzheimer's disease families."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0344339:disease family [Finding]
   804   C0015576:Families [Family Group]
   804   C1704727:Family [Conceptual Entity]
   721 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.352: (Abstract). 

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.353: Neurology 1999;52 (suppl 2):A323. 

Phrase: "Neurology 1999"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";52"

Phrase: "(suppl 2"

Phrase: ")"

Phrase: ":"

Phrase: "A323."
Processing 00000000.tx.354: Wakutani Y, Kowa H, Kusumi M, et al. 

Phrase: "Wakutani Y,"

Phrase: "Kowa H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kusumi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.355: Genetic analysis of vascular factors in Alzheimer's disease. 

Phrase: "Genetic analysis of vascular factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0679560:genetic analysis [Laboratory Procedure]
   806   C0796344:Genetic Analysis [Laboratory Procedure]
   797   C0085801:analysis factors [Quantitative Concept]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.356: Ann N Y Acad Sci 2002;977:2328.[Abstract/Free FullText] Farrer LA, Sherbatich T, Keryanov SA, et al. 

Phrase: "Ann N Y Acad Sci 2002"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0268596:ACAD [Disease or Syndrome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ";977"

Phrase: ":"

Phrase: "2328."

Phrase: "[Abstract/Free FullText"

Phrase: "] Farrer LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Sherbatich T,"

Phrase: "Keryanov SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "et al."
Processing 00000000.tx.357: Association between angiotensin-converting enzyme and Alzheimer disease. 

Phrase: "Association between angiotensin-converting enzyme"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.358: Arch Neurol 2000;57:21014.[Abstract/Free FullText] Crawford F, Abdullah L, Schinka J, et al. 

Phrase: "Arch Neurol 2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ";57"

Phrase: ":"

Phrase: "21014."

Phrase: "[Abstract/Free FullText"

Phrase: "] Crawford F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Abdullah L,"

Phrase: "Schinka J,"

Phrase: "et al."
Processing 00000000.tx.359: Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease. 

Phrase: "Gender-specific association of the angiotensin converting enzyme gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.360: Neurosci Lett 2000;280:21519.[CrossRef][ISI][Medline] Kehoe PG, Katzov H, Andreasen N, et al. 

Phrase: "Neurosci Lett 2000"

Phrase: ";280"

Phrase: ":"

Phrase: "21519."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kehoe PG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]

Phrase: "Katzov H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Andreasen N,"

Phrase: "et al."
Processing 00000000.tx.361: Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease. 

Phrase: "Common variants of ACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:variants [Qualitative Concept]

Phrase: "contribute to variable age-at-onset of Alzheimer's disease."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   818   C1843930:Variable age at onset [Finding]
   804   C1846355:Variable age of onset [Finding]
   781   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   762   C0277793:disease onset [Temporal Concept]
   742   C0001779:Age [Organism Attribute]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0332162:Onset [Qualitative Concept]
   742   C0439828:Variable [Qualitative Concept]
   742   C1880177:Contribute [Activity]
Processing 00000000.tx.362: Hum Genet 2004;114:47883.[CrossRef][ISI][Medline] Sleegers K, den Heijer T, van Dijk EJ, et al. 

Phrase: "Hum Genet 2004"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ";114"

Phrase: ":"

Phrase: "47883."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sleegers K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "den Heijer T,"

Phrase: "van Dijk EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1718783:Ej [Immunologic Factor]

Phrase: "et al."
Processing 00000000.tx.363: ACE gene is associated with Alzheimer's disease and atrophy of hippocampus and amygdala. 

Phrase: "ACE gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1333402:Enzyme Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "is"

Phrase: "associated with Alzheimer's disease"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "atrophy of hippocampus"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0333641:Atrophy [Pathologic Function]
   718 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "and"

Phrase: "amygdala."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002708:Amygdala [Body Part, Organ, or Organ Component]
Processing 00000000.tx.364: Neurobiol Aging 2005;26:11539.[CrossRef][ISI][Medline] Narain Y, Yip A, Murphy T, et al. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "2005"

Phrase: ";26"

Phrase: ":"

Phrase: "11539."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Narain Y,"

Phrase: "Yip A,"

Phrase: "Murphy T,"

Phrase: "et al."
Processing 00000000.tx.365: The ACE gene and Alzheimer's disease susceptibility. 

Phrase: "The ACE gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1333402:Enzyme Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer's disease susceptibility."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0012655:Disease susceptibility [Clinical Attribute]
           Susceptibility
   827   C0220898:Susceptibility [Organism Attribute]
   827   C1264642:Susceptibility [Functional Concept]
   827   C1547045:*Susceptibility [Quantitative Concept]
   755 E C0231204:Susceptible [Functional Concept]
   755 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.366: J Med Genet 2000;37:6957.[Abstract/Free FullText] Kehoe PG, Katzov H, Feuk L, et al. 

Phrase: "J Med Genet 2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ";37"

Phrase: ":"

Phrase: "6957."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kehoe PG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]

Phrase: "Katzov H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Feuk L,"

Phrase: "et al."
Processing 00000000.tx.367: Haplotypes extending across ACE are associated with Alzheimer's disease. 

Phrase: "Haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "extending across ACE"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   882   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   790   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   753   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0439792:Extending [Spatial Concept]
   719 E C0231448:Extend [Functional Concept]

Phrase: "are"

Phrase: "associated with Alzheimer's disease."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.368: Hum Mol Genet 2003;12:85967.[Abstract/Free FullText] Elkins JS, Douglas VC, Johnston SC. 

Phrase: "Hum Mol Genet 2003"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ";12"

Phrase: ":"

Phrase: "85967."

Phrase: "[Abstract/Free FullText"

Phrase: "] Elkins JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Douglas VC,"

Phrase: "Johnston SC."
Processing 00000000.tx.369: Alzheimer disease risk and genetic variation in ACE. 

Phrase: "Alzheimer disease risk"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1281905:disease risk [Finding]
   827   C0035647:Risk [Qualitative Concept]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "and"

Phrase: "genetic variation in ACE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0042333:Genetic Variation [Natural Phenomenon or Process]
   748   C0205419:Variation [Qualitative Concept]
Processing 00000000.tx.370: A meta-analysis. 

Phrase: "A meta-analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.371: Neurology 2004;62:3638.[Abstract/Free FullText] Camelo D, Arboleda G, Yunis JJ, et al. 

Phrase: "Neurology 2004"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";62"

Phrase: ":"

Phrase: "3638."

Phrase: "[Abstract/Free FullText"

Phrase: "] Camelo D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "Arboleda G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Yunis JJ,"

Phrase: "et al."
Processing 00000000.tx.372: Angiotensin-converting enzyme and alpha-2-macroglobulin gene polymorphisms are not associated with Alzheimer's disease in Colombian patients. 

Phrase: "Angiotensin-converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "alpha-2-macroglobulin gene polymorphisms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0678951:gene polymorphisms [Genetic Function]
   804   C0032529:polymorphisms [Genetic Function]
   771 E C1882417:Polymorphism [Qualitative Concept]
   717   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   708   C1537647:ALPHA GENE [Gene or Genome]
   708   C2985256:Alpha Gene [Gene or Genome]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with Alzheimer's disease"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "in Colombian patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.373: J Neurol Sci 2004;218:4751.[CrossRef][ISI][Medline] Fernndez-Novoa L, Lombardi VRM, Seoane S, et al. 

Phrase: "J Neurol Sci 2004"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3642273:SCI [Professional or Occupational Group]

Phrase: ";218"

Phrase: ":"

Phrase: "4751."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fernndez-Novoa L,"

Phrase: "Lombardi VRM,"

Phrase: "Seoane S,"

Phrase: "et al."
Processing 00000000.tx.374: The ACE gene in Alzheimer's disease. 

Phrase: "The ACE gene in Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1333402:Enzyme Gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   734   C1416989:MAL gene [Gene or Genome]
Processing 00000000.tx.375: In: Hanin I, Fisher A, Cacabelos R, eds. 

Phrase: "In"

Phrase: ":"

Phrase: "Hanin I,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021107:Insertion [Therapeutic or Preventive Procedure]
   861   C0441587:Insertion [Health Care Activity]
   861   C1512796:Insertion [Genetic Function]
   861   C1883719:Insertion [Functional Concept]

Phrase: "Fisher A,"

Phrase: "Cacabelos R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "eds."
Processing 00000000.tx.376: New trends in Alzheimer and Parkinson related disorders. 

Phrase: "New trends in Alzheimer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040833:trends [Temporal Concept]
   770   C1521798:Trends [Temporal Concept]

Phrase: "and"

Phrase: "Parkinson related disorders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.377: Bologna, Italy: Monduzzi Editore, 2004:1236. 

Phrase: "Bologna,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: ":"

Phrase: "Monduzzi Editore,"

Phrase: "2004"

Phrase: ":"

Phrase: "1236."
Processing 00000000.tx.378: Keikhaee MR, Najmabadi H, Pasalar P. 

Phrase: "Keikhaee MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Najmabadi H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Pasalar P."
Processing 00000000.tx.379: Angiotensin-converting enzyme and apolipoprotein E genotype in Alzheimer's disease in Iranian population. 

Phrase: "Angiotensin-converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "apolipoprotein E genotype in Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017431:Genotype [Organism Attribute]

Phrase: "in Iranian population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.380: (Abstract). 

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.381: Neurobiol Aging 2002;23(suppl):S404. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "2002"

Phrase: ";23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "(suppl):S404."
Processing 00000000.tx.382: Lendon CL, Thaker U, Harris JM, et al. 

Phrase: "Lendon CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Thaker U,"

Phrase: "Harris JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "et al."
Processing 00000000.tx.383: The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease. 

Phrase: "The angiotensin 1-converting enzyme insertion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0021107:Insertion [Therapeutic or Preventive Procedure]
   804   C0441587:Insertion [Health Care Activity]
   804   C1512796:Insertion [Genetic Function]
   804   C1883719:Insertion [Functional Concept]
   722   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "(I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]

Phrase: ")"

Phrase: "/deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "(D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: ")"

Phrase: "polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "the extent of amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "or"

Phrase: "tau pathology in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030664:Pathology [Biomedical Occupation or Discipline]
   770   C0205469:pathology [Functional Concept]
   770   C0677042:pathology [Pathologic Function]

Phrase: "with sporadic Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205422:Sporadic [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.384: Neurosci Lett 2002;328:31418.[CrossRef][ISI][Medline] Panza F, Solfrizzi V, D'Introno A, et al. 

Phrase: "Neurosci Lett 2002"

Phrase: ";328"

Phrase: ":"

Phrase: "31418."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Panza F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Solfrizzi V,"

Phrase: "D'Introno A,"

Phrase: "et al."
Processing 00000000.tx.385: Lack of association between ACE polymorphism and Alzheimer's disease in southern Italy. 

Phrase: "Lack of association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332268:lack [Qualitative Concept]

Phrase: "between ACE polymorphism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0032529:Polymorphism [Genetic Function]
   804   C1882417:Polymorphism [Qualitative Concept]
   771   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   771   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer's disease in southern Italy."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.386: Arch Gerontol Geriatr Suppl 2002;8:23945.[CrossRef][Medline] Seripa D, Dal Forno G, Matera MG, et al. 

Phrase: "Arch Gerontol Geriatr Suppl 2002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0230467:arch [Body Location or Region]
   804   C0741204:ARCH [Body Space or Junction]

Phrase: ";8"

Phrase: ":"

Phrase: "23945."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Seripa D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "Dal Forno G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Matera MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "et al."
Processing 00000000.tx.387: Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohorts of Alzheimer patients. 

Phrase: "Methylenetetrahydrofolate reductase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0066357:Methylene Tetrahydrofolate Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "angiotensin converting enzyme gene polymorphisms in two genetically"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0678951:gene polymorphisms [Genetic Function]
   744   C0032529:polymorphisms [Genetic Function]
   711 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "diagnostically distinct cohorts of Alzheimer patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0599755:cohorts [Population Group]
Processing 00000000.tx.388: Neurobiol Aging 2003;24:9339.[CrossRef][ISI][Medline] Farrer LA, Cupples LA, Haines JL, et al. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "2003"

Phrase: ";24"

Phrase: ":"

Phrase: "9339."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Farrer LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Cupples LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Haines JL,"

Phrase: "et al."
Processing 00000000.tx.389: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. 

Phrase: "Effects of age,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "sex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "ethnicity on the association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015031:Ethnicity [Population Group]
   770   C0243103:ethnicity [Qualitative Concept]

Phrase: "between apolipoprotein E genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "a meta-analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.390: JAMA 1997;278:134956.[Abstract] Lehmann DJ, Williams J, McBroom J, et al. 

Phrase: "JAMA 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: ";278"

Phrase: ":"

Phrase: "134956."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lehmann DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Williams J,"

Phrase: "McBroom J,"

Phrase: "et al."
Processing 00000000.tx.391: Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "meta-analysis to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0282458:Meta-Analysis [Intellectual Product]
   901   C0920317:Meta-Analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1042496:Meta [Eukaryote]
   827   C1524024:analysis [Functional Concept]

Phrase: "explain"

Phrase: "the diversity of results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880371:Diversity [Qualitative Concept]

Phrase: "in genetic studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C2827447:Genetic Study [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "of late-onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "high-risk subgroups."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C1079230:subgroups [Virus]
   793 E C1515021:Subgroup [Classification]
   734   C0332167:High Risk [Qualitative Concept]
   734   C3272283:High Risk [Finding]
Processing 00000000.tx.392: Neuroscience 2001;108:54154.[CrossRef][ISI][Medline] Egger M, Davey Smith G, Altman DGE. 

Phrase: "Neuroscience 2001"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: ";108"

Phrase: ":"

Phrase: "54154."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Egger M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Davey Smith G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Altman DGE."
Processing 00000000.tx.393: Systematic reviews in health care: meta-analysis in context. 

Phrase: "Systematic reviews in health care"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   781   C0262501:HEALTH REVIEW [Health Care Activity]
   773   C1955832:Review, Systematic [Intellectual Product]
   760   C0220922:systematic [Functional Concept]
   760   C0282443:reviews [Intellectual Product]
   726 E C1552617:Review [Idea or Concept]

Phrase: ":"

Phrase: "meta-analysis in context."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0282458:Meta-Analysis [Intellectual Product]
   833   C0920317:Meta-Analysis [Research Activity]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1042496:Meta [Eukaryote]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.394: London, United Kingdom: BMJ Books, 2001. 

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: ":"

Phrase: "BMJ Books,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006002:Books [Intellectual Product]

Phrase: "2001."
Processing 00000000.tx.395: Ott A, Breteler MM, van Harskamp F, et al. 

Phrase: "Ott"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1423088:OTT [Gene or Genome]
  1000   C3273338:OTT [Gene or Genome]

Phrase: "A,"

Phrase: "Breteler MM,"

Phrase: "van Harskamp F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.396: Incidence and risk of dementia. 

Phrase: "Incidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021149:Incidence [Quantitative Concept]
  1000   C0220856:incidence [Functional Concept]
   928 E C1551358:incident [Idea or Concept]

Phrase: "and"

Phrase: "risk of dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.397: The Rotterdam Study. 

Phrase: "The Rotterdam Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.398: Am J Epidemiol 1998;147:57480.[Abstract] Prince JA, Feuk L, Sawyer SL, et al. 

Phrase: "Am"

Phrase: "J Epidemiol 1998"

Phrase: ";147"

Phrase: ":"

Phrase: "57480."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Prince JA,"

Phrase: "Feuk L,"

Phrase: "Sawyer SL,"

Phrase: "et al."
Processing 00000000.tx.399: Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. 

Phrase: "Lack of replication of association findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332268:lack [Qualitative Concept]

Phrase: "in complex disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "an analysis of 15 polymorphisms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0796451:polymorphism analysis [Diagnostic Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in prior candidate genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1332838:Candidate Genes [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "for sporadic Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205422:Sporadic [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.400: Eur J Hum Genet 2001;9:43744.[CrossRef][ISI][Medline] Prince J, Feuk L, Brookes A, et al. 

Phrase: "Eur J Hum Genet 2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0325074:Genet [Mammal]

Phrase: ";9"

Phrase: ":"

Phrase: "43744."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Prince J,"

Phrase: "Feuk L,"

Phrase: "Brookes A,"

Phrase: "et al."
Processing 00000000.tx.401: Genetic variation in ACE influences the severity of Alzheimer's disease. 

Phrase: "Genetic variation in ACE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0042333:Genetic Variation [Natural Phenomenon or Process]
   748   C0205419:Variation [Qualitative Concept]

Phrase: "influences"

Phrase: "the severity of Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0521117:disease severity [Qualitative Concept]
   760   C0439793:Severity [Qualitative Concept]
   760   C2983285:Severity [Intellectual Product]
Processing 00000000.tx.402: (Abstract). 

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.403: Neurobiol Aging 2002;23(suppl):S319.[CrossRef] Mirra SS, Heyman A, McKeel D, et al. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "2002"

Phrase: ";23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "(suppl):S319."

Phrase: "[CrossRef"

Phrase: "] Mirra SS,"

Phrase: "Heyman A,"

Phrase: "McKeel D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "et al."
Processing 00000000.tx.404: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). 

Phrase: "The Consortium to Establish a Registry for Alzheimer's Disease"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0034975:Registry [Intellectual Product]
   793   C0443211:establish [Qualitative Concept]
   793   C1513822:Consortium [Professional or Occupational Group]
   793   C1880171:Consortium [Professional or Occupational Group]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]

Phrase: "(CERAD"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0034975:Registry [Intellectual Product]
   793   C0443211:establish [Qualitative Concept]
   793   C1513822:Consortium [Professional or Occupational Group]
   793   C1880171:Consortium [Professional or Occupational Group]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.405: Part II. 

Phrase: "Part II."
Processing 00000000.tx.406: Standardization of the neuropathologic assessment of Alzheimer's disease. 

Phrase: "Standardization of the neuropathologic assessment of Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0038136:Standardization [Research Activity]
Processing 00000000.tx.407: Neurology 1991;41:47986.[Abstract] McKhann G, Drachman D, Folstein M, et al. 

Phrase: "Neurology 1991"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";41"

Phrase: ":"

Phrase: "47986."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] McKhann G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Drachman D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "Folstein M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.408: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. 

Phrase: "Clinical diagnosis of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332140:Diagnosis, clinical [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: ":"

Phrase: "report of the NINCDS-ADRDA work group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0684224:Report [Intellectual Product]
   748   C0700287:Report [Health Care Activity]
   748   C3273238:Report [Intellectual Product]

Phrase: "under the auspices"

Phrase: "of Department of Health and Human Services task force"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0162458:Task Force [Governmental or Regulatory Activity]
   793   C0441722:Force [Phenomenon or Process]
   793   C0563538:Force [Phenomenon or Process]
   793   C3540678:Task [Occupational Activity]
   756   C0041711:Department of Health and Human Services [Health Care Related Organization]
           department health human services
   737 E C0729333:Dynamic [Functional Concept]

Phrase: "on Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.409: Neurology 1984;34:93944.[Abstract] Fogarty DG, Maxwell AP, Doherty CC, et al. 

Phrase: "Neurology 1984"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";34"

Phrase: ":"

Phrase: "93944."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Fogarty DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Maxwell AP,"

Phrase: "Doherty CC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538933:CC [Cell Component]

Phrase: "et al."
Processing 00000000.tx.410: ACE gene typing. 

Phrase: "ACE gene typing."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0441704:Typing [Health Care Activity]
   799   C0872404:typing [Occupational Activity]
   734   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   734   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
Processing 00000000.tx.411: (Letter). 

Phrase: "(Letter"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1096774:Letter [Intellectual Product]
  1000   C2360551:Letter [Clinical Attribute]
   944 E C0079691:Levothyroxine Sodium [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C0282413:letters [Intellectual Product]
   916 E C0728762:Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.412: Lancet 1994;343:851.[ISI][Medline] Shanmugam V, Sell KW, Saha BK. 

Phrase: "Lancet 1994"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ";343"

Phrase: ":"

Phrase: "851."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shanmugam V,"

Phrase: "Sell KW,"

Phrase: "Saha BK."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006100:BK [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1537501:BK [Gene or Genome]
Processing 00000000.tx.413: Mistyping ACE heterozygotes. 

Phrase: "Mistyping ACE heterozygotes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0019425:Heterozygotes [Organism Attribute]
   734   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   734   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
Processing 00000000.tx.414: PCR Methods Appl 1993;3:1201.[ISI][Medline] Mantel N, Haenszel W. 

Phrase: "PCR Methods Appl 1993"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0449851:Methods [Functional Concept]
   812   C0677874:pCR [Finding]
   812   C1858559:APPL [Gene or Genome]
   779 E C0871511:METHOD [Intellectual Product]

Phrase: ";3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "1201."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mantel N,"

Phrase: "Haenszel W."
Processing 00000000.tx.415: Statistical aspects of the analysis of data from retrospective studies of disease. 

Phrase: "Statistical aspects of the analysis of data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1524024:analysis aspect [Functional Concept]
   714   C1547011:Aspect [Quantitative Concept]
   714   C1879746:Aspect [Qualitative Concept]

Phrase: "from retrospective studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0035363:Retrospective Studies [Research Activity]
           retrospective
   861   C0947630:studies [Laboratory Procedure]
   861   C1514923:Retrospective [Qualitative Concept]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "of disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.416: J Natl Cancer Inst 1959;22:71948.[ISI][Medline] DerSimonian R, Laird N. 

Phrase: "J Natl Cancer Inst 1959"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0006826:Cancer [Neoplastic Process]
   804   C0998265:Cancer [Eukaryote]
   804   C1306459:Cancer [Finding]

Phrase: ";22"

Phrase: ":"

Phrase: "71948."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] DerSimonian R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Laird N."
Processing 00000000.tx.417: Meta-analysis in clinical trials. 

Phrase: "Meta-analysis in clinical trials."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0282458:Meta-Analysis [Intellectual Product]
   806   C0920317:Meta-Analysis [Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1042496:Meta [Eukaryote]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.418: Control Clin Trials 1986;7:17788.[CrossRef][ISI][Medline] Warn DE, Thompson SG, Spiegelhalter DJ. 

Phrase: "Control Clin Trials 1986"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0243148:control [Qualitative Concept]
   812   C1315013:CLIN [Intellectual Product]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   779   C0008976:Trial [Research Activity]

Phrase: ";7"

Phrase: ":"

Phrase: "17788."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "Warn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871599:warn [Governmental or Regulatory Activity]

Phrase: "DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011198:DE [Geographic Area]
  1000   C0017480:DE [Geographic Area]
  1000   C3541240:DE [Idea or Concept]

Phrase: "Thompson SG,"

Phrase: "Spiegelhalter DJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]
Processing 00000000.tx.419: Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. 

Phrase: "Bayesian random effects meta-analysis of trials"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0282458:Meta-Analysis [Intellectual Product]
   778   C0920317:Meta-Analysis [Research Activity]
   774   C0242196:Bayesian Analysis [Quantitative Concept]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1042496:Meta [Eukaryote]
   748   C1524024:analysis [Functional Concept]

Phrase: "with binary outcomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1274040:Outcome [Functional Concept]

Phrase: ":"

Phrase: "methods for the absolute risk difference"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0025663:Methods [Intellectual Product]
   753   C0025664:methods [Intellectual Product]
   753   C0449851:Methods [Functional Concept]
   719 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "relative risk scales."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0175659:Scales [Medical Device]
   827   C0222045:Scales [Body Part, Organ, or Organ Component]
   793 E C0349674:Scale [Intellectual Product]
   793 E C1947916:Scale [Activity]
   793 E C3536777:Scale [Manufactured Object]
   743 E C1710017:Scalar [Qualitative Concept]
   734   C0242492:Relative Risk [Quantitative Concept]
Processing 00000000.tx.420: Stat Med 2002;21:160123.[CrossRef][ISI][Medline] Armitage P. 

Phrase: "Stat Med 2002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205548:Stat [Temporal Concept]

Phrase: ";21"

Phrase: ":"

Phrase: "160123."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Armitage P."
Processing 00000000.tx.421: Statistical methods in medical research. 

Phrase: "Statistical methods in medical research."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C0086912:Research Methods [Research Activity]
   790   C1710191:Statistical Method [Research Activity]
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0449851:Methods [Functional Concept]
   726 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.422: Oxford, United Kingdom: Blackwell Scientific Publications, 1983. 

Phrase: "Oxford,"

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: ":"

Phrase: "Blackwell Scientific Publications,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C1704324:Scientific Publications [Intellectual Product]
       E   Publication
   827   C0034036:Publications [Intellectual Product,Manufactured Object]
   793 E C0034037:Publication [Occupational Activity]

Phrase: "1983."
Processing 00000000.tx.423: Egger M, Davey Smith G, Schneider M, et al. 

Phrase: "Egger M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Davey Smith G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Schneider M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.424: Bias in meta-analysis detected by a simple, graphical test. 

Phrase: "Bias in meta-analysis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0242568:Bias [Idea or Concept]
   770   C1504315:Bias [Bird]
   737 E C1061346:Bia [Eukaryote]
   737 E C1704746:BIA [Diagnostic Procedure]

Phrase: "detected by a simple, graphical test."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0205352:Simple [Qualitative Concept]
   753   C0392366:test [Intellectual Product]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.425: BMJ 1997;315:62934.[Abstract/Free FullText] Lau J, Antman EM, Jimenez-Silva J, et al. 

Phrase: "BMJ 1997"

Phrase: ";315"

Phrase: ":"

Phrase: "62934."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lau J,"

Phrase: "Antman EM,"

Phrase: "Jimenez-Silva J,"

Phrase: "et al."
Processing 00000000.tx.426: Cumulative meta-analysis of therapeutic trials for myocardial infarction. 

Phrase: "Cumulative meta-analysis of therapeutic trials"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0282458:Meta-Analysis [Intellectual Product]
   790   C0920317:Meta-Analysis [Research Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1042496:Meta [Eukaryote]
   753   C1524024:analysis [Functional Concept]

Phrase: "for myocardial infarction."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0027051:Myocardial Infarction [Disease or Syndrome]
  1000   C0428953:MYOCARDIAL INFARCTION [Finding]
  1000   C2926063:Myocardial infarction [Clinical Attribute]
   861   C0021308:Infarction [Pathologic Function]
   861   C0027061:Myocardial [Tissue]
   861   C1522564:Myocardial [Spatial Concept]
   789 E C0333541:Infarcted [Functional Concept]
Processing 00000000.tx.427: N Eng J Med 1992;327:24854.[Abstract] Ihaka R, Gentleman R. 

Phrase: "N Eng J Med 1992"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ";327"

Phrase: ":"

Phrase: "24854."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ihaka R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gentleman R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.428: R: a language for data analysis and graphics. 

Phrase: "R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "a language for data analysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023008:Language [Language]

Phrase: "and"

Phrase: "graphics."
Processing 00000000.tx.429: J Comput Graph Stat 1996;5:299314. 

Phrase: "J Comput Graph Stat 1996"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0205548:Stat [Temporal Concept]
   804   C0681493:Graph [Intellectual Product]
   804   C2698021:Graph [Conceptual Entity]

Phrase: ";5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "299314."
Processing 00000000.tx.430: Cox R, Bouzekri N, Martin S, et al. 

Phrase: "Cox R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bouzekri N,"

Phrase: "Martin S,"

Phrase: "et al."
Processing 00000000.tx.431: Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. 

Phrase: "Angiotensin-1-converting enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "(ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ")"

Phrase: "plasma concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0683150:plasma concentration [Quantitative Concept]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "is"

Phrase: "influenced by multiple ACE-linked quantitative trait nucleotides."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   797   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   797   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   756   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   738   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0014442:Enzyme [Enzyme,Organic Chemical]
   738   C0021966:I- [Inorganic Chemical]
   738   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0392762:Quantitative [Quantitative Concept]
   738   C0439064:Multiple [Quantitative Concept]
   738   C0599883:Trait [Organism Attribute]
   704   C1517892:Link [Intellectual Product]
   704   C1704666:Link [Intellectual Product]
Processing 00000000.tx.432: Hum Mol Genet 2002;11:296977.[Abstract/Free FullText] Katzov H, Bennet AM, Kehoe P, et al. 

Phrase: "Hum Mol Genet 2002"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ";11"

Phrase: ":"

Phrase: "296977."

Phrase: "[Abstract/Free FullText"

Phrase: "] Katzov H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Bennet"

Phrase: "AM"

Phrase: ","

Phrase: "Kehoe P,"

Phrase: "et al."
Processing 00000000.tx.433: A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity. 

Phrase: "A cladistic model of ACE sequence variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0596525:enzyme model [Research Activity]
   739   C3161035:Model [Intellectual Product]

Phrase: "with implications"

Phrase: "for myocardial infarction,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0027051:Myocardial Infarction [Disease or Syndrome]
  1000   C0428953:MYOCARDIAL INFARCTION [Finding]
  1000   C2926063:Myocardial infarction [Clinical Attribute]
   861   C0021308:Infarction [Pathologic Function]
   861   C0027061:Myocardial [Tissue]
   861   C1522564:Myocardial [Spatial Concept]
   789 E C0333541:Infarcted [Functional Concept]

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "obesity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]
Processing 00000000.tx.434: Hum Mol Genet 2004;13:264757.[Abstract/Free FullText] Nagy Z, Esiri MM, Hindley NJ, et al. 

Phrase: "Hum Mol Genet 2004"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ";13"

Phrase: ":"

Phrase: "264757."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nagy Z,"

Phrase: "Esiri MM,"

Phrase: "Hindley NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "et al."
Processing 00000000.tx.435: Accuracy of clinical operational diagnostic criteria for Alzheimer's disease in relation to different pathological diagnostic protocols. 

Phrase: "Accuracy of clinical operational diagnostic criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0598285:Diagnostic Accuracy [Qualitative Concept]
   753   C0443131:Accuracy [Qualitative Concept]

Phrase: "for Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "in relation to different pathological diagnostic protocols."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0442711:Protocols [Intellectual Product]
   779 E C1507394:Protocol [Intellectual Product]
   779 E C1522729:Protocol [Intellectual Product]
   779 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.436: Dement Geriatr Cogn Disord 1998;9:21926.[CrossRef][ISI][Medline] Panza F, Solfrizzi V, D'Introno A, et al. 

Phrase: "Dement Geriatr Cogn Disord 1998"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0860630:dement [Mental or Behavioral Dysfunction]
   704 E C0011265:dementia [Mental or Behavioral Dysfunction]
   704 E C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ";9"

Phrase: ":"

Phrase: "21926."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Panza F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Solfrizzi V,"

Phrase: "D'Introno A,"

Phrase: "et al."
Processing 00000000.tx.437: Shifts in angiotensin 1 converting enzyme insertion allele frequency across Europe: implications for Alzheimer's disease risk. 

Phrase: "Shifts in angiotensin 1 converting enzyme insertion allele frequency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0333051:shifts [Functional Concept]
   708 E C2347509:Shift [Phenomenon or Process]

Phrase: "across Europe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015176:Europe [Geographic Area]

Phrase: ":"

Phrase: "implications for Alzheimer's disease risk."
Processing 00000000.tx.438: J Neurol Neurosurg Psychiatry 2003;74:115961.[Free FullText] Buss S, Mller-Thomsen T, Hock C, et al. 

Phrase: "J Neurol Neurosurg Psychiatry 2003"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0033872:Psychiatry [Professional or Occupational Group]
   804   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   733 E C0205487:Psychiatric [Functional Concept]

Phrase: ";74"

Phrase: ":"

Phrase: "115961."

Phrase: "[Free FullText"

Phrase: "] Buss S,"

Phrase: "Mller-Thomsen T,"

Phrase: "Hock C,"

Phrase: "et al."
Processing 00000000.tx.439: No association between DCP1 genotype and late-onset Alzheimer disease. 

Phrase: "No association between DCP1 genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "late-onset Alzheimer disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.440: Am J Med Genet 2002;114:4405.[CrossRef][ISI][Medline] Perry RT, Collins JS, Harrell LE, et al. 

Phrase: "Am"

Phrase: "J Med Genet 2002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ";114"

Phrase: ":"

Phrase: "4405."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Perry RT,"

Phrase: "Collins JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Harrell LE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439090:LE [Idea or Concept]
   861   C1423767:LE [Gene or Genome]

Phrase: "et al."
Processing 00000000.tx.441: Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. 

Phrase: "Investigation of association of 13 polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1261322:Investigation [Health Care Activity]
   753   C1552578:investigation [Idea or Concept]

Phrase: "in eight genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "in southeastern African American Alzheimer disease patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030705:Patients [Patient or Disabled Group]

Phrase: "as"

Phrase: "compared to age-matched controls."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1707455:Compared [Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.442: Am J Med Genet 2001;105:33242.[CrossRef][ISI][Medline] Comings DE, MacMurray JP. 

Phrase: "Am"

Phrase: "J Med Genet 2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ";105"

Phrase: ":"

Phrase: "33242."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Comings DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "MacMurray JP."
Processing 00000000.tx.443: Molecular heterosis: a review. 

Phrase: "Molecular heterosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020201:Heterosis [Quantitative Concept]

Phrase: ":"

Phrase: "a review."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]
Processing 00000000.tx.444: Mol Genet Metab 2000;71:1931.[CrossRef][ISI][Medline] Samani NJ, Thompson JR, O'Toole L, et al. 

Phrase: "Mol Genet Metab 2000"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ";71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ":"

Phrase: "1931."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Samani NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Thompson JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "O'Toole L,"

Phrase: "et al."
Processing 00000000.tx.445: A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. 

Phrase: "A meta-analysis of the association of the deletion allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0282458:Meta-Analysis [Intellectual Product]
   760   C0920317:Meta-Analysis [Research Activity]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1042496:Meta [Eukaryote]
   739   C1524024:analysis [Functional Concept]

Phrase: "of the angiotensin-converting enzyme gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1333402:Enzyme Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   756   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "with myocardial infarction."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0027051:Myocardial Infarction [Disease or Syndrome]
  1000   C0428953:MYOCARDIAL INFARCTION [Finding]
  1000   C2926063:Myocardial infarction [Clinical Attribute]
   861   C0021308:Infarction [Pathologic Function]
   861   C0027061:Myocardial [Tissue]
   861   C1522564:Myocardial [Spatial Concept]
   789 E C0333541:Infarcted [Functional Concept]
Processing 00000000.tx.446: Circulation 1996;94:70812.[Abstract/Free FullText] Staessen JA, Wang JG, Ginocchio G, et al. 

Phrase: "Circulation 1996"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ";94"

Phrase: ":"

Phrase: "70812."

Phrase: "[Abstract/Free FullText"

Phrase: "] Staessen JA,"

Phrase: "Wang JG,"

Phrase: "Ginocchio G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.447: The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. 

Phrase: "The deletion/insertion polymorphism of the angiotensin converting enzyme gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0678951:gene polymorphism [Genetic Function]
   739   C0032529:Polymorphism [Genetic Function]
   739   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "cardiovascular-renal risk."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.448: J Hypertens 1997;15:157992.[CrossRef][ISI][Medline] Sharma P. 

Phrase: "J Hypertens 1997"

Phrase: ";15"

Phrase: ":"

Phrase: "157992."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sharma P."
Processing 00000000.tx.449: Meta-analysis of the ACE gene in ischaemic stroke. 

Phrase: "Meta-analysis of the ACE gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0282458:Meta-Analysis [Intellectual Product]
   764   C0920317:Meta-Analysis [Research Activity]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1042496:Meta [Eukaryote]
   742   C1524024:analysis [Functional Concept]

Phrase: "in ischaemic stroke."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0948008:Ischaemic stroke [Disease or Syndrome]
  1000   C3272363:Ischemic Stroke [Disease or Syndrome]
   861   C0038454:Stroke [Disease or Syndrome]
   861   C0475224:Ischaemic [Functional Concept]
Processing 00000000.tx.450: J Neurol Neurosurg Psychiatry 1998;64:22730.[Abstract/Free FullText] Keavney B, McKenzie C, Parish S, et al. 

Phrase: "J Neurol Neurosurg Psychiatry 1998"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0033872:Psychiatry [Professional or Occupational Group]
   804   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   733 E C0205487:Psychiatric [Functional Concept]

Phrase: ";64"

Phrase: ":"

Phrase: "22730."

Phrase: "[Abstract/Free FullText"

Phrase: "] Keavney B,"

Phrase: "McKenzie C,"

Phrase: "Parish S,"

Phrase: "et al."
Processing 00000000.tx.451: Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. 

Phrase: "Large-scale test of hypothesised associations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0392757:test scale [Educational Activity]
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]

Phrase: "between the angiotensin-converting-enzyme insertion/deletion polymorphism"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   799   C0021107:Insertion [Therapeutic or Preventive Procedure]
   799   C0032529:Polymorphism [Genetic Function]
   799   C0441587:Insertion [Health Care Activity]
   799   C1442161:Deletion [Cell or Molecular Dysfunction]
   799   C1511760:Deletion [Genetic Function]
   799   C1512796:Insertion [Genetic Function]
   799   C1880274:Deletion [Activity]
   799   C1882417:Polymorphism [Qualitative Concept]
   799   C1883719:Insertion [Functional Concept]

Phrase: "and"

Phrase: "myocardial infarction in about 5000 cases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0027051:Myocardial Infarction [Disease or Syndrome]
   790   C0428953:MYOCARDIAL INFARCTION [Finding]
   790   C2926063:Myocardial infarction [Clinical Attribute]
   753   C0021308:Infarction [Pathologic Function]
   753   C0027061:Myocardial [Tissue]
   753   C1522564:Myocardial [Spatial Concept]

Phrase: "and"

Phrase: "6000 controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.452: Lancet 2000;355:43442.[ISI][Medline] Sayed-Tabatabaei FA, Houwing-Duistermaat JJ, van Duijn CM, et al. 

Phrase: "Lancet 2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ";355"

Phrase: ":"

Phrase: "43442."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sayed-Tabatabaei FA,"

Phrase: "Houwing-Duistermaat JJ,"

Phrase: "van Duijn CM,"

Phrase: "et al."
Processing 00000000.tx.453: Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness. 

Phrase: "Angiotensin-converting enzyme gene polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0678951:gene polymorphism [Genetic Function]
   804   C0032529:Polymorphism [Genetic Function]
   804   C1882417:Polymorphism [Qualitative Concept]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "and"

Phrase: "carotid artery wall thickness."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0507850:artery wall [Body Part, Organ, or Organ Component]
   812   C0677535:Wall [Manufactured Object]
   812   C1280412:Thickness [Qualitative Concept]
Processing 00000000.tx.454: A meta-analysis. 

Phrase: "A meta-analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.455: Stroke 2003;34:16349.[Abstract/Free FullText] Arregui A, Perry EK, Rossor M, et al. 

Phrase: "Stroke 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038454:Stroke [Disease or Syndrome]

Phrase: ";34"

Phrase: ":"

Phrase: "16349."

Phrase: "[Abstract/Free FullText"

Phrase: "] Arregui A,"

Phrase: "Perry EK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008415:EK [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Rossor M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.456: Angiotensin converting enzyme in Alzheimer's disease increased activity in caudate nucleus and cortical areas. 

Phrase: "Angiotensin converting enzyme in Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   753   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "activity in caudate nucleus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "cortical areas."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   861   C0001613:Cortical [Body Part, Organ, or Organ Component]
   861   C0007776:Cortical [Body Part, Organ, or Organ Component]
   861   C0022655:Cortical [Body Part, Organ, or Organ Component]
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]
   805 E C0234875:bark [Organism Attribute]
   805 E C2700441:Bark [Plant]
   777 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   777 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.457: J Neurochem 1982;38:14902.[ISI][Medline] Barnes NM, Cheng CH, Costall B, et al. 

Phrase: "J Neurochem 1982"

Phrase: ";38"

Phrase: ":"

Phrase: "14902."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Barnes NM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "Cheng CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: "Costall B,"

Phrase: "et al."
Processing 00000000.tx.458: Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease. 

Phrase: "Angiotensin converting enzyme density"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0178587:density [Quantitative Concept]
   756   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   741 E C0439794:Dense [Qualitative Concept]

Phrase: "is"

Phrase: "increased in temporal cortex"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   770   C0007776:Cortex [Body Part, Organ, or Organ Component]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442043:Temporal [Spatial Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C2362314:Temporal [Temporal Concept]
   770   C2700441:Cortex [Plant]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.459: Eur J Pharmacol 1991;200:28992.[CrossRef][ISI][Medline] Savaskan E, Hock C, Olivieri G, et al. 

Phrase: "Eur J Pharmacol 1991"

Phrase: ";200"

Phrase: ":"

Phrase: "28992."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Savaskan E,"

Phrase: "Hock C,"

Phrase: "Olivieri G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.460: Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia. 

Phrase: "Cortical alterations of angiotensin converting enzyme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "angiotensin II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003009:Angiotensin 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "AT1 receptor in Alzheimer's dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.461: Neurobiol Aging 2001;22:5416.[CrossRef][ISI][Medline] Hu J, Igarashi A, Kamata M, et al. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "2001"

Phrase: ";22"

Phrase: ":"

Phrase: "5416."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hu J,"

Phrase: "Igarashi A,"

Phrase: "Kamata M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.462: Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (Ab); 

Phrase: "Angiotensin-converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "degrades"

Phrase: "Alzheimer amyloid beta-peptide"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
   923   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   861   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "(Ab"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.463: retards Ab aggregation, deposition, fibril formation; 

Phrase: "retards"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0521111:retard [Qualitative Concept]
   944 E C0311403:Inhibited [Qualitative Concept]
   944 E C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0237477:Arrest [Temporal Concept]
   916 E C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "Ab aggregation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "deposition,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposition [Functional Concept]

Phrase: "fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: ";"
Processing 00000000.tx.464: and inhibits cytotoxicity. 

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.465: J Biol Chem 2001;276:478638.[Abstract/Free FullText] Hirawa N, Uehara Y, Kawabata Y, et al. 

Phrase: "J Biol Chem 2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ";276"

Phrase: ":"

Phrase: "478638."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hirawa N,"

Phrase: "Uehara Y,"

Phrase: "Kawabata Y,"

Phrase: "et al."
Processing 00000000.tx.466: Long-term inhibition of renin-angiotensin system sustains memory function in aged Dahl rats. 

Phrase: "Long-term inhibition of renin-angiotensin system"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "sustains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443318:sustain [Functional Concept]
  1000   C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: "memory function in aged Dahl rats."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0025260:Memory function [Mental Process]
           Memory
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C0700327:memory [Finding]
   753   C1705273:Function [Intellectual Product]
   753   C1706377:Memory [Manufactured Object]
Processing 00000000.tx.467: Hypertension 1999;34:496502.[Abstract/Free FullText] Sudilovsky A, Turnbull B, Croog SH, et al. 

Phrase: "Hypertension 1999"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020538:Hypertension [Disease or Syndrome]
   861   C1963138:Hypertension [Finding]

Phrase: ";34"

Phrase: ":"

Phrase: "496502."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sudilovsky A,"

Phrase: "Turnbull B,"

Phrase: "Croog SH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038108:SH [Geographic Area]

Phrase: "et al."
Processing 00000000.tx.468: Angiotensin converting enzyme and memory: preclinical and clinical data. 

Phrase: "Angiotensin converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: ":"

Phrase: "preclinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709630:Pre-clinical [Qualitative Concept]

Phrase: "and"

Phrase: "clinical data."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1516606:Clinical Data [Intellectual Product]
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.469: Int J Neurol 198788;2122:14562. 

Phrase: "Int J Neurol 198788"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0063789:INT [Organic Chemical]
   812   C3272375:INT [Intellectual Product]

Phrase: ";2122"

Phrase: ":"

Phrase: "14562."
Processing 00000000.tx.470: Ohrui T, Matsui T, Yamaya M, et al. 

Phrase: "Ohrui T,"

Phrase: "Matsui T,"

Phrase: "Yamaya M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.471: Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan. 

Phrase: "Angiotensin-converting enzyme inhibitors"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0003015:Angiotensin-Converting Enzyme Inhibitors [Pharmacologic Substance]
  1000   C2757044:Angiotensin-converting Enzyme Inhibitors [Molecular Function]
   966 E C3536837:Angiotensin Converting Enzyme Inhibitor [Pharmacologic Substance]
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   861   C0014432:Enzyme Inhibitors [Pharmacologic Substance]
   861   C1152555:enzyme inhibitors [Molecular Function]
   861   C2756995:Enzyme Inhibitors [Molecular Function]
   827 E C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "incidence of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021149:Incidence [Quantitative Concept]
   770   C0220856:incidence [Functional Concept]

Phrase: "in Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.472: J Am Geriatr Soc 2004;52:64950.[CrossRef][ISI][Medline] Ohrui T, Tomita N, Sato-Nakagawa T, et al. 

Phrase: "J"

Phrase: "Am"

Phrase: "Geriatr Soc 2004"

Phrase: ";52"

Phrase: ":"

Phrase: "64950."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ohrui T,"

Phrase: "Tomita N,"

Phrase: "Sato-Nakagawa T,"

Phrase: "et al."
Processing 00000000.tx.473: Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression. 

Phrase: "Effects of brain-penetrating ACE inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "on Alzheimer disease progression."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0242656:Disease Progression [Pathologic Function]
           progression
   901   C1947900:Disease progression NOS [Finding]
   827   C0449258:Progression [Functional Concept]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.474: Neurology 2004;63:13245.[Free FullText] Kehoe PG. 

Phrase: "Neurology 2004"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";63"

Phrase: ":"

Phrase: "13245."

Phrase: "[Free FullText"

Phrase: "] Kehoe PG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]
Processing 00000000.tx.475: The renin-angiotensin-aldosterone system and Alzheimer's disease? 

Phrase: "The renin-angiotensin-aldosterone system"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
  1000   C0086907:Renin-Angiotensin-Aldosterone System [Body System]
   923   C0035096:Renin-angiotensin system [Body System]
   923   C2984247:Renin-angiotensin system [Functional Concept]
   875   C1115104:renin aldosterone [Laboratory Procedure]
   812   C0002006:Aldosterone [Hormone,Pharmacologic Substance,Steroid]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0035094:Renin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0449913:System [Functional Concept]
   812   C1419338:RENIN [Gene or Genome]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   756 E C0022877:Lab [Manufactured Object,Organization]
   756 E C0587081:Labs [Finding]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "Alzheimer's disease?"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.476: J Renin Angiotensin Aldosterone Syst 2003;4:8093.[ISI][Medline] Agerholm-Larsen B, Nordestgaard BG, Steffensen R, et al. 

Phrase: "J Renin Angiotensin Aldosterone Syst 2003"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   839   C1115104:renin aldosterone [Laboratory Procedure]
   799   C0002006:Aldosterone [Hormone,Pharmacologic Substance,Steroid]
   799   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C0035094:Renin [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   799   C1419338:RENIN [Gene or Genome]
   743 E C0022877:Lab [Manufactured Object,Organization]
   743 E C0587081:Labs [Finding]

Phrase: ";4"

Phrase: ":"

Phrase: "8093."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Agerholm-Larsen B,"

Phrase: "Nordestgaard BG,"

Phrase: "Steffensen R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "et al."
Processing 00000000.tx.477: ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. 

Phrase: "ACE gene polymorphism"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0678951:gene polymorphism [Genetic Function]
   799   C0032529:Polymorphism [Genetic Function]
   799   C1882417:Polymorphism [Qualitative Concept]
   734   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   734   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]

Phrase: ":"

Phrase: "ischemic heart disease"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0010054:ischaemic heart disease [Disease or Syndrome]
  1000   C0151744:Ischaemic heart disease [Disease or Syndrome]
  1000   C1313980:Ischemic heart disease [Finding]
   901   C0018799:Heart disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0018787:Heart [Body Part, Organ, or Organ Component]
   827   C0475224:Ischaemic [Functional Concept]
   827   C1281570:Heart [Body Part, Organ, or Organ Component]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "longevity in 10,150 individuals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023980:Longevity [Temporal Concept]
Processing 00000000.tx.478: A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. 

Phrase: "A case-referent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706462:Referent [Conceptual Entity]

Phrase: "and"

Phrase: "retrospective cohort study"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C2985505:Retrospective Cohort Study [Research Activity]
   913   C0035363:Retrospective Study [Research Activity]
           retrospective
   901   C0009247:Cohort Study [Quantitative Concept]
   827   C0557651:Study [Manufactured Object]
   827   C0599755:Cohort [Population Group]
   827   C1514923:Retrospective [Qualitative Concept]
   827   C2603343:Study [Research Activity]

Phrase: "based on the Copenhagen City Heart Study."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   778   C0489835:Heart study [Diagnostic Procedure]
   757   C0225810:HEART, BASE [Body Location or Region]
   748   C0008848:City [Geographic Area]
   748   C0018787:Heart [Body Part, Organ, or Organ Component]
   748   C0557651:Study [Manufactured Object]
   748   C1281570:Heart [Body Part, Organ, or Organ Component]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   748   C2603343:Study [Research Activity]
   748   C3262831:City [Clinical Attribute]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.479: Circulation 1997;95:235867.[Abstract/Free FullText] Galinsky D, Tysoe C, Brayne CE, et al. 

Phrase: "Circulation 1997"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ";95"

Phrase: ":"

Phrase: "235867."

Phrase: "[Abstract/Free FullText"

Phrase: "] Galinsky D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "Tysoe C,"

Phrase: "Brayne CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "et al."
Processing 00000000.tx.480: Analysis of the apoe E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. 

Phrase: "Analysis of the apoe E/apo C-I,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "angiotensin converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "methylenetetrahydrofolate reductase genes as candidates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   845   C0919427:methylenetetrahydrofolate reductase gene [Gene or Genome]
   781   C1332838:Candidate Genes [Gene or Genome]
   760   C0017337:Genes [Gene or Genome]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "human longevity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023980:Longevity [Temporal Concept]
Processing 00000000.tx.481: Atherosclerosis 1997;129:17783.[CrossRef][ISI][Medline] Shimokata H, Yamada Y, Nakagawa M, et al. 

Phrase: "Atherosclerosis 1997"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0004153:Atherosclerosis [Disease or Syndrome]
   789 E C0333482:Atherosclerotic [Functional Concept]

Phrase: ";129"

Phrase: ":"

Phrase: "17783."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shimokata H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Yamada Y,"

Phrase: "Nakagawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.482: Distribution of geriatric disease-related genotypes in the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA). 

Phrase: "Distribution of geriatric disease-related genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "in the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA)."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   801   C0023981:Longitudinal Study [Research Activity]
   788   C0001811:Ageing [Organism Function]
   788   C0021622:institute [Organization]
   788   C0023980:Longevity [Temporal Concept]
   788   C0036397:Sciences [Occupation or Discipline]
   788   C0150312:In [Quantitative Concept]
   788   C0205127:Longitudinal [Spatial Concept]
   788   C0332285:In [Spatial Concept]
   788   C0557651:Study [Manufactured Object]
   788   C1272753:Institute [Idea or Concept]
   788   C2603343:Study [Research Activity]
   788   C3245503:national [Intellectual Product]
Processing 00000000.tx.483: J Epidemiol 2000;10(suppl):S4655.[Medline] Blanch H, Cabanne L, Sahbatou M, et al. 

Phrase: "J Epidemiol 2000"

Phrase: ";10"

Phrase: "(suppl):S4655."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "Blanch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0948786:blanch [Sign or Symptom]

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Cabanne L,"

Phrase: "Sahbatou M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.484: A study of French centenarians: are ACE and APOE associated with longevity? 

Phrase: "A study of French centenarians"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "are"

Phrase: "ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "associated with longevity?"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0023980:Longevity [Temporal Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.485: C R Acad Sci III 2001;324:12935.[ISI][Medline] Panza F, Solfrizzi V, D'Introno A, et al. 

Phrase: "C R Acad Sci III 2001"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   876   C1547548:C-III [Regulation or Law]
   827   C0722969:c r [Organic Chemical,Pharmacologic Substance]
   799   C0205090:R- [Spatial Concept]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C0439070:III [Intellectual Product]
   799   C0684010:R. [Professional or Occupational Group]
   799   C1553033:[c] [Quantitative Concept]
   799   C1705160:III [Qualitative Concept]
   799   C2603358:R' [Clinical Attribute]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ";324"

Phrase: ":"

Phrase: "12935."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Panza F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Solfrizzi V,"

Phrase: "D'Introno A,"

Phrase: "et al."
Processing 00000000.tx.486: Angiotensin I converting enzyme (ACE) gene polymorphism in centenarians: different allele frequencies between the North and South of Europe. 

Phrase: "Angiotensin I converting enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "(ACE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ")"

Phrase: "gene polymorphism in centenarians"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0678951:gene polymorphism [Genetic Function]
   770   C0032529:Polymorphism [Genetic Function]
   770   C1882417:Polymorphism [Qualitative Concept]

Phrase: ":"

Phrase: "different allele frequencies between the North"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0017270:Frequencies, Allele [Quantitative Concept]
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "South of Europe."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1710133:South [Spatial Concept]
Processing 00000000.tx.487: Exp Gerontol 2003;38:101520.[CrossRef][ISI][Medline] Da Cruz IB, Oliveira G, Taufer M, et al. 

Phrase: "Exp Gerontol 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1417055:EXP [Gene or Genome]

Phrase: ";38"

Phrase: ":"

Phrase: "101520."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Da Cruz IB,"

Phrase: "Oliveira G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Taufer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.488: Angiotensin I-converting enzyme gene polymorphism in two ethnic groups living in Brazil's southern region: association with age. 

Phrase: "Angiotensin I-converting enzyme gene polymorphism in two ethnic groups"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0678951:gene polymorphism [Genetic Function]
   739   C0032529:Polymorphism [Genetic Function]
   739   C1882417:Polymorphism [Qualitative Concept]

Phrase: "living in Brazil's southern region"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0006137:Brazil [Geographic Area]
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0376558:Living [Idea or Concept]
   760   C1710133:Southern [Spatial Concept]
   726 E C1548795:Live [Qualitative Concept]
   726 E C1634625:% live [Qualitative Concept]
   726 E C2982691:Live [Activity]

Phrase: ":"

Phrase: "association with age."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
Processing 00000000.tx.489: J Gerontol A Biol Sci Med Sci 2003;58:M8516.[Abstract/Free FullText] Alvarez R, Alvarez V, Lahoz CH, et al. 

Phrase: "J Gerontol"

Phrase: "A Biol Sci Med Sci 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3642273:SCI [Professional or Occupational Group]

Phrase: ";58"

Phrase: ":"

Phrase: "M8516."

Phrase: "[Abstract/Free FullText"

Phrase: "] Alvarez R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Alvarez V,"

Phrase: "Lahoz CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.490: Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease. 

Phrase: "Angiotensin converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "endothelial nitric oxide synthase DNA polymorphisms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   799   C0032529:polymorphisms [Genetic Function]
   766 E C1882417:Polymorphism [Qualitative Concept]
   734   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]

Phrase: "and"

Phrase: "late onset Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.491: J Neurol Neurosurg Psychiatry 1999;67:7336.[Abstract/Free FullText] Carbonell J, Allen R, Kalsi G, et al. 

Phrase: "J Neurol Neurosurg Psychiatry 1999"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0033872:Psychiatry [Professional or Occupational Group]
   804   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   733 E C0205487:Psychiatric [Functional Concept]

Phrase: ";67"

Phrase: ":"

Phrase: "7336."

Phrase: "[Abstract/Free FullText"

Phrase: "] Carbonell J,"

Phrase: "Allen R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kalsi G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.492: Variation in the DCP1 gene, encoding the angiotensin converting enzyme ACE, is not associated with increased susceptibility to Alzheimer's disease. 

Phrase: "Variation in the DCP1 gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:Variation [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the angiotensin converting enzyme ACE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   879   C0022709:angiotensin converting enzyme i [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   795   C0021966:I- [Inorganic Chemical]
   795   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with increased susceptibility"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0205217:Increased [Quantitative Concept]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C0442805:Increased [Functional Concept]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "to Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.493: Psychiatr Genet 2003;13:4750.[CrossRef][ISI][Medline] Chapman J, Wang N, Treves TA, et al. 

Phrase: "Psychiatr Genet 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ";13"

Phrase: ":"

Phrase: "4750."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chapman J,"

Phrase: "Wang N,"

Phrase: "Treves TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "et al."
Processing 00000000.tx.494: ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. 

Phrase: "ACE,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0022709:Angiotensin I-Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
  1000   C1413931:ANGIOTENSIN I-CONVERTING ENZYME [Gene or Genome]
   861   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "MTHFR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0066357:MTHFR [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0268615:MTHFR [Disease or Syndrome]
  1000   C0919427:MTHFR [Gene or Genome]

Phrase: "factor V Leiden,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0380964:factor V Leiden [Amino Acid, Peptide, or Protein]
  1000   C0584960:Factor V Leiden [Disease or Syndrome]
  1000   C2681926:FACTOR V LEIDEN [Gene or Genome]
  1000   C3542419:Factor V Leiden [Laboratory Procedure]
   734   C0015498:Factor V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C3274393:Factor V [Laboratory Procedure]

Phrase: "and"

Phrase: "APOE polymorphisms in patients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0032529:polymorphisms [Genetic Function]
   737 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "with vascular"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005847:vascular [Body Part, Organ, or Organ Component]
  1000   C1558950:VASCULAR [Finding]
  1000   C1801960:Vascular [Qualitative Concept]
   944 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   944 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C0005767:Blood [Tissue]
   900 E C0005768:blood [Body Substance]
   900 E C0229664:Blood [Body Substance]
   900 E C0392895:Bloods [Population Group]
   884 E C0333275:Bloody [Qualitative Concept]

Phrase: "and"

Phrase: "Alzheimer's dementia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.495: Stroke 1998;29:14014.[Abstract/Free FullText] Cheng CY, Hong CJ, Liu HC, et al. 

Phrase: "Stroke 1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038454:Stroke [Disease or Syndrome]

Phrase: ";29"

Phrase: ":"

Phrase: "14014."

Phrase: "[Abstract/Free FullText"

Phrase: "] Cheng CY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010622:CY [Geographic Area]
   861   C0332298:CY [Functional Concept]

Phrase: "Hong CJ,"

Phrase: "Liu HC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
   861   C1413512:Hc [Gene or Genome]

Phrase: "et al."
Processing 00000000.tx.496: Study of the association between Alzheimer's disease and angiotensin-converting enzyme gene polymorphism using DNA from lymphocytes. 

Phrase: "Study of the association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "between Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "angiotensin-converting enzyme gene polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0678951:gene polymorphism [Genetic Function]
   804   C0032529:Polymorphism [Genetic Function]
   804   C1882417:Polymorphism [Qualitative Concept]
   717   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DNA from lymphocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.497: Eur Neurol 2002;47:269.[CrossRef][ISI][Medline] Hu J, Miyatake F, Aizu Y, et al. 

Phrase: "Eur Neurol 2002"

Phrase: ";47"

Phrase: ":"

Phrase: "269."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hu J,"

Phrase: "Miyatake F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Aizu Y,"

Phrase: "et al."
Processing 00000000.tx.498: Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population. 

Phrase: "Angiotensin-converting enzyme genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017431:Genotype [Organism Attribute]
   756   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "is"

Phrase: "associated with Alzheimer disease"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "in the Japanese population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.499: Neurosci Lett 1999;277:657.[CrossRef][ISI][Medline] Isbir T, Agahan B, Yilmaz H, et al. 

Phrase: "Neurosci Lett 1999"

Phrase: ";277"

Phrase: ":"

Phrase: "657."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Isbir T,"

Phrase: "Agahan B,"

Phrase: "Yilmaz H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.500: Angiotensin converting enzyme gene polymorphism in Alzheimer's disease. 

Phrase: "Angiotensin converting enzyme gene polymorphism in Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0678951:gene polymorphism [Genetic Function]
   744   C0032529:Polymorphism [Genetic Function]
   744   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.501: Cell Biochem Funct 2000;18:1412.[CrossRef][ISI][Medline] Mattila KM, Rinne JO, Rytt M, et al. 

Phrase: "Cell Biochem Funct 2000"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ";18"

Phrase: ":"

Phrase: "1412."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mattila KM,"

Phrase: "Rinne JO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022418:JO [Geographic Area]

Phrase: "Rytt M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.502: Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E 4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology. 

Phrase: "Dipeptidyl carboxypeptidase 1 (DCP1)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0022709:Dipeptidyl Carboxypeptidase 1 [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1413931:DIPEPTIDYL CARBOXYPEPTIDASE 1 [Gene or Genome]
   901   C0058360:dipeptidyl carboxypeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0007075:Carboxypeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C3265462:Carboxypeptidase [Pharmacologic Substance]

Phrase: "and"

Phrase: "butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E 4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0596610:gene interaction [Genetic Function]
   708   C1704675:Interaction [Functional Concept]

Phrase: "as risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035648:risk factors [Quantitative Concept]
  1000   C1553898:risk factors [Idea or Concept]
   861   C0035647:Risk [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and in Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1515981:And [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "with coexisting Alzheimer pathology."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.503: J Med Genet 2000;37:76670.[Abstract/Free FullText] Monastero R, Caldarella R, Mannino M, et al. 

Phrase: "J Med Genet 2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ";37"

Phrase: ":"

Phrase: "76670."

Phrase: "[Abstract/Free FullText"

Phrase: "] Monastero R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Caldarella R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Mannino M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.504: Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease. 

Phrase: "Lack of association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332268:lack [Qualitative Concept]

Phrase: "between angiotensin converting enzyme polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]
   756   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "and"

Phrase: "sporadic Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205422:Sporadic [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.505: Neurosci Lett 2002;335:1479.[CrossRef][ISI][Medline] Myllykangas L, Polvikoski T, Sulkava R, et al. 

Phrase: "Neurosci Lett 2002"

Phrase: ";335"

Phrase: ":"

Phrase: "1479."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Myllykangas L,"

Phrase: "Polvikoski T,"

Phrase: "Sulkava R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "et al."
Processing 00000000.tx.506: Cardiovascular risk factors and Alzheimer's disease: a genetic association study in a population aged 85 or over. 

Phrase: "Cardiovascular risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0850624:cardiovascular risk factor [Disease or Syndrome]
   901   C0035648:risk factors [Quantitative Concept]
   901   C1553898:risk factors [Idea or Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "a genetic association study in a population"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C2717878:Study, Genetic Association [Molecular Biology Research Technique]
   800   C1517511:Genetic Population Study [Research Activity]
   774   C0681876:Population Study [Research Activity]
   774   C2348561:Study Population [Population Group]
   774   C2827447:Genetic Study [Research Activity]
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "85"

Phrase: "or"

Phrase: "over."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205136:Over [Spatial Concept]
Processing 00000000.tx.507: Neurosci Lett 2000;292:1958.[CrossRef][ISI][Medline] Palumbo B, Cadini D, Nocentini G, et al. 

Phrase: "Neurosci Lett 2000"

Phrase: ";292"

Phrase: ":"

Phrase: "1958."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Palumbo B,"

Phrase: "Cadini D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "Nocentini G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.508: Angiotensin converting enzyme deletion allele in different kinds of dementia disorders. 

Phrase: "Angiotensin converting enzyme deletion allele in different kinds of dementia disorders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.509: Neurosci Lett 1999;267:97100.[CrossRef][ISI][Medline] Richard F, Fromentin-David I, Ricolfi F, et al. 

Phrase: "Neurosci Lett 1999"

Phrase: ";267"

Phrase: ":"

Phrase: "97100."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Richard F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Fromentin-David I,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021107:Insertion [Therapeutic or Preventive Procedure]
   827   C0441587:Insertion [Health Care Activity]
   827   C1512796:Insertion [Genetic Function]
   827   C1883719:Insertion [Functional Concept]

Phrase: "Ricolfi F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.510: The angiotensin I converting enzyme gene as a susceptibility factor for dementia. 

Phrase: "The angiotensin I converting enzyme gene as a susceptibility factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1333402:Enzyme Gene [Gene or Genome]
   757   C0919453:Susceptibility Gene [Gene or Genome]
   757   C1955829:Gene Insertion [Cell or Molecular Dysfunction]
   739   C0017337:Gene [Gene or Genome]

Phrase: "for dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.511: Neurology 2001;56:15935.[Abstract/Free FullText] Scacchi R, De Bernardini L, Mantuano E, et al. 

Phrase: "Neurology 2001"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";56"

Phrase: ":"

Phrase: "15935."

Phrase: "[Abstract/Free FullText"

Phrase: "] Scacchi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "De Bernardini L,"

Phrase: "Mantuano E,"

Phrase: "et al."
Processing 00000000.tx.512: DNA polymorphisms of apolipoprotein B and angiotensin 1-converting enzyme genes and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer's disease. 

Phrase: "DNA polymorphisms of apolipoprotein B"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0032529:polymorphisms [Genetic Function]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "angiotensin 1-converting enzyme genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   823   C1333402:Enzyme Gene [Gene or Genome]
   804   C0017337:Genes [Gene or Genome]
   722   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "and"

Phrase: "relationships with lipid levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0439849:Relationships [Qualitative Concept]
   737 E C1705630:Relationship [Idea or Concept]
   737 E C1706279:Relationship [Idea or Concept]
   737 E C3540605:Relationship [Intellectual Product]

Phrase: "in Italian patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with vascular dementia"
Meta Candidates (Total=14; Excluded=8; Pruned=0; Remaining=6)
  1000   C0011269:Dementia, Vascular [Disease or Syndrome]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "or"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.513: Dement Geriatr Cogn Disord 1998;9:18690.[CrossRef][ISI][Medline] Wu C, Zhou D, Guan Z, et al. 

Phrase: "Dement Geriatr Cogn Disord 1998"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0860630:dement [Mental or Behavioral Dysfunction]
   704 E C0011265:dementia [Mental or Behavioral Dysfunction]
   704 E C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ";9"

Phrase: ":"

Phrase: "18690."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wu C,"

Phrase: "Zhou D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "Guan Z,"

Phrase: "et al."
Processing 00000000.tx.514: The association between angiotensin I converting enzyme gene polymorphism and Chinese late onset Alzheimer disease. 

Phrase: "The association between angiotensin I converting enzyme gene polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Chinese late onset Alzheimer disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   937   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   804   C0012634:Disease [Disease or Syndrome]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.515: (In Chinese). 

Phrase: "("

Phrase: "In Chinese"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008120:chinese [Language]
  1000   C0152035:Chinese [Population Group]

Phrase: ")."
Processing 00000000.tx.516: Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002;19:4014.[Medline] Yang JD, Feng G, Zhang J, et al. 

Phrase: "Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   866   C1089993:yi zhi [Plant]
   866   C1869287:yi-zhi [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   791   C0037712:ZA [Geographic Area]

Phrase: ";19"

Phrase: ":"

Phrase: "4014."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yang JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Feng G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Zhang J,"

Phrase: "et al."
Processing 00000000.tx.517: Association between angiotensin-converting enzyme gene and late onset Alzheimer's disease in Han Chinese. 

Phrase: "Association between angiotensin-converting enzyme gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "late onset Alzheimer's disease in Han Chinese."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   800   C0814122:late disease onset [Finding]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0277793:disease onset [Temporal Concept]
   748   C0012634:Disease [Disease or Syndrome]
Processing 00000000.tx.518: Neurosci Lett 2000;295:414.[CrossRef][ISI][Medline] Zuliani G, Ble' A, Zanca R, et al. 

Phrase: "Neurosci Lett 2000"

Phrase: ";295"

Phrase: ":"

Phrase: "414."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zuliani G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Ble'"

Phrase: "A,"

Phrase: "Zanca R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "et al."
Processing 00000000.tx.519: Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. 

Phrase: "Genetic polymorphisms in older subjects"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0032529:Genetic Polymorphisms [Genetic Function]
           polymorphisms
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "with vascular"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005847:vascular [Body Part, Organ, or Organ Component]
  1000   C1558950:VASCULAR [Finding]
  1000   C1801960:Vascular [Qualitative Concept]
   944 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   944 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C0005767:Blood [Tissue]
   900 E C0005768:blood [Body Substance]
   900 E C0229664:Blood [Body Substance]
   900 E C0392895:Bloods [Population Group]
   884 E C0333275:Bloody [Qualitative Concept]

Phrase: "or"

Phrase: "Alzheimer's dementia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.520: Acta Neurol Scand 2001;103:3048.[CrossRef][ISI][Medline] American Psychiatric Association. 

Phrase: "Acta Neurol Scand 2001"

Phrase: ";103"

Phrase: ":"

Phrase: "3048."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] American Psychiatric Association."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0004083:Association [Mental Process]
   827   C0205487:Psychiatric [Functional Concept]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
   755 E C0033872:Psychiatry [Professional or Occupational Group]
   755 E C0033873:Psychiatry [Biomedical Occupation or Discipline]
Processing 00000000.tx.521: Diagnostic and statistical manual of mental disorders: DSM-IV. 

Phrase: "Diagnostic and statistical manual of mental disorders"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
  1000   C1136324:Diagnostic and Statistical Manual of Mental Disorders [Intellectual Product]
   877   C0599833:Diagnostic and Statistical Manual [Intellectual Product]
   818   C0004936:Mental disorders [Mental or Behavioral Dysfunction]
   795   C0011900:Diagnostic [Finding]
   795   C0012634:Disorders [Disease or Syndrome]
   795   C0024763:Manual [Intellectual Product,Manufactured Object]
   795   C0038215:Statistical [Occupation or Discipline]
   795   C0175674:Manual [Functional Concept]
   795   C0229992:mental [Mental Process]
   795   C0348026:Diagnostic [Functional Concept]
   785 E C0033975:mental disorder [Mental or Behavioral Dysfunction]
   768 E C0152097:diaphragm disorders [Disease or Syndrome]
   760 E C0277577:PSYCHIC DISORDER [Mental or Behavioral Dysfunction]
   712 E C0229993:Psychic [Functional Concept]

Phrase: ":"

Phrase: "DSM-IV."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220952:DSM-IV [Intellectual Product]
Processing 00000000.tx.522: 4th ed. 

Phrase: "4th ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]
Processing 00000000.tx.523: Washington, DC: American Psychiatric Association, 1994. 

Phrase: "Washington,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043038:Washington [Geographic Area]

Phrase: "DC"

Phrase: ":"

Phrase: "American Psychiatric Association,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0004083:Association [Mental Process]
   827   C0205487:Psychiatric [Functional Concept]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
   755 E C0033872:Psychiatry [Professional or Occupational Group]
   755 E C0033873:Psychiatry [Biomedical Occupation or Discipline]

Phrase: "1994."
Processing 00000000.tx.524: Khachaturian ZS. 

Phrase: "Khachaturian ZS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043459:ZS [Congenital Abnormality,Disease or Syndrome]
Processing 00000000.tx.525: Diagnosis of Alzheimer's disease. 

Phrase: "Diagnosis of Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011900:Diagnosis [Finding]
   770   C1704338:diagnosis [Qualitative Concept]
   770   C1704656:DIAGNOSIS [Research Activity]
Processing 00000000.tx.526: Arch Neurol 1985;42:1097105.[CrossRef][ISI][Medline]

Phrase: "Arch Neurol 1985"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ";42"

Phrase: ":"

Phrase: "1097105."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

